Micropollutants and Sustainable Development: Bridging Environmental Chemistry and SDG Implementation for a Safer Future

Abstract

This article examines the critical intersection of micropollutant environmental chemistry and the implementation of the UN Sustainable Development Goals (SDGs), with a specific focus on implications for researchers and drug development professionals. It explores the foundational science of emerging organic micropollutants (EOMs)—including pharmaceuticals, pesticides, and personal care products—and their direct challenges to achieving SDG targets for clean water, good health, and responsible consumption. The content covers advanced detection and remediation technologies, such as adsorption-based nanotechnology and machine learning for wastewater treatment prediction. It further discusses optimizing chemical processes through Green Chemistry principles and the Safe and Sustainable by Design (SSbD) framework. By synthesizing current research and regulatory trends, this article provides a comprehensive roadmap for integrating sustainability into chemical innovation and environmental management, aiming to mitigate the impacts of micropollutants on ecosystems and human health within the 'One Health' context.

Understanding Micropollutants: Defining the Challenge for SDGs and Global Health

Emerging Micropollutants (EMs) represent a diverse group of chemical substances detected in the environment at trace concentrations, typically ranging from nanograms per liter (ng/L) to micrograms per liter (μg/L), that pose potential risks to ecosystems and human health but are not yet comprehensively regulated or understood [1] [2]. The term "emerging" does not necessarily indicate that these contaminants are newly introduced; rather, it reflects the growing scientific recognition of their environmental presence and potential hazards, alongside improvements in analytical techniques that enable their detection at increasingly low concentrations [3]. These compounds originate from various anthropogenic activities, including industrial, agricultural, and domestic processes, and their persistence, bioaccumulative potential, and resistance to conventional treatment methods have established them as a significant environmental challenge [1] [4].

The scientific community characterizes emerging micropollutants based on several key attributes: diverse origins and nature, potential for adverse effects on biota, and the ability to persist, bioaccumulate, and transport through environmental compartments [1]. These contaminants can be polar or non-polar, organic or inorganic, dissolved or undissolved, and metabolizable or persistent, making them particularly challenging to monitor and manage [1]. Their environmental significance is amplified by their pseudo-persistent nature – even when individual compounds degrade relatively quickly, their continuous introduction into the environment creates a perpetual presence [5]. This persistent environmental footprint threatens ecosystem stability and represents a formidable challenge for environmental chemists and policymakers working toward Sustainable Development Goal (SDG) targets, particularly SDG 6 (Clean Water and Sanitation), SDG 11 (Sustainable Cities and Communities), and SDG 14 (Life Below Water) [6] [3].

Major Classes of Emerging Micropollutants

Emerging micropollutants encompass a broad spectrum of chemical compounds with diverse structures, applications, and environmental behaviors. The table below summarizes the primary classes, their characteristics, and representative examples.

Table 1: Major Classes of Emerging Micropollutants

Class	Subclasses	Primary Sources	Representative Compounds	Key Characteristics
Pharmaceuticals & Personal Care Products (PPCPs)	Antibiotics, analgesics, antidepressants, lipid regulators, disinfectants [1] [7]	Human and veterinary excretion, wastewater discharge, improper medication disposal [7]	Carbamazepine, Diclofenac, Ibuprofen, Sulfamethoxazole, Erythromycin, Triclocarban [2] [7] [8]	Designed for biological activity, persistent, can lead to antibiotic resistance [7]
Endocrine Disrupting Compounds (EDCs)	Natural & synthetic hormones, industrial chemicals [1]	Wastewater effluent, industrial discharge [1]	17-beta-estradiol, Bisphenol A (BPA), Alkyl-hydroxybenzoates [2] [7]	Interfere with hormonal systems at very low doses [2]
Persistent Organic Pollutants (POPs)	Pesticides, industrial chemicals, flame retardants [2] [4]	Agricultural runoff, industrial effluents, atmospheric deposition [4]	Atrazine, Glyphosate, Polychlorinated Biphenyls (PCBs), Polycyclic Aromatic Hydrocarbons (PAHs) [2] [4]	High persistence, bioaccumulation potential, and long-range environmental transport [4]
Industrial Chemicals	Per- and polyfluoroalkyl substances (PFAS), plasticizers, surfactants [1] [4] [3]	Industrial effluents, product leaching, fire-fighting foams [4]	PFOA, PFOS, Nonylphenol [4] [9]	Extreme persistence (e.g., "forever chemicals"), thermal and chemical stability [4] [9]
Other Emerging Contaminants	Microplastics (MPs)/Nanoplastics (NPs), Antibiotic Resistance Genes (ARGs) [5] [4]	Plastic waste fragmentation, wastewater treatment plants, agricultural runoff [5] [4]	Polyethylene fragments, PS beads [5]	Act as vectors for other contaminants, facilitate horizontal gene transfer [5] [4]

Emerging micropollutants enter the environment through multiple pathways, creating a complex cycle of contamination that affects all environmental compartments—water, soil, and air. The primary sources are intrinsically linked to modern societal and industrial activities.

• Urban and Municipal Sources: Wastewater Treatment Plants (WWTPs) are major conduits for micropollutants. PPCPs enter sewage systems through human excretion (parent compounds and metabolites) and improper disposal of unused medications [1] [7]. Conventional WWTPs, designed to remove nutrients and organic matter, are often ineffective at completely degrading these complex synthetic compounds, leading to their discharge into rivers, lakes, and coastal waters [1] [8]. This treated effluent, along with combined sewer overflows, constitutes a significant continuous source of contamination in aquatic environments [3].
• Agricultural and Aquacultural Activities: The application of pesticides, herbicides, and fertilizers introduces various agrochemicals into soils, which can then leach into groundwater or be transported to surface waters via runoff [1]. Veterinary pharmaceuticals and hormones used in concentrated animal feeding operations (CAFOs) are excreted by livestock and applied to fields in manure, subsequently reaching water bodies [7]. Aquaculture also directly releases pharmaceuticals, including antibiotics, into aquatic systems [7].
• Industrial Discharges: Manufacturing facilities, particularly from pharmaceutical and chemical industries, can release process wastewaters containing high concentrations of specific micropollutants [2]. Industrial effluents are a primary source of PFAS, plasticizers, and other synthetic chemicals [4] [9].
• Diffuse and Other Sources: Urban runoff from roads and surfaces carries a mixture of contaminants, including tire wear particles, MPs, and adsorbed chemicals [3]. Atmospheric deposition can also transport volatile compounds and particulate-bound pollutants over long distances [4]. The fragmentation of larger plastic debris through weathering leads to the widespread distribution of MPs and NPs across global ecosystems, from urban waterways to remote regions [5] [4].

Diagram: Environmental Pathways and Fate of Emerging Micropollutants

Analytical Detection and Methodologies

Accurately detecting and quantifying emerging micropollutants at trace levels (ng/L to μg/L) in complex environmental matrices requires sophisticated analytical techniques. The field has advanced significantly with the development of highly sensitive and selective hybrid instrumentation.

Core Analytical Techniques

The predominant approach involves coupling powerful separation techniques with highly sensitive mass spectrometric detection.

Table 2: Key Analytical Methods for Detecting Emerging Micropollutants

Analytical Technique	Principle of Operation	Typical Target Analytes	Sensitivity Range	Key Advantages
Liquid Chromatography with\nTandem Mass Spectrometry\n(LC-MS/MS or UPLC-HR-QTOF-MS) [2] [8]	Separation via liquid chromatography followed by ionization and mass-based detection/identification.	Pharmaceuticals, polar pesticides, personal care products [8]	ng/L to μg/L	High sensitivity and selectivity; can identify unknown compounds (HRMS) [8]
Gas Chromatography with\nMass Spectrometry (GC-MS) [2]	Separation via gas chromatography of volatile compounds, followed by mass-based detection.	Volatile organic compounds, some pesticides, fragrances [2]	ng/L to μg/L	Excellent for volatile and semi-volatile compounds; robust libraries for identification [2]
Hybrid Techniques\n(Chromatography coupled with Spectroscopy) [2]	Combines separation power of chromatography with detection capabilities of various spectroscopic methods.	Broad range of organic micropollutants [2]	Varies with detector	Versatile; can provide structural information [2]

Standardized Experimental Workflow

A typical analytical protocol for determining pharmaceutical micropollutants in wastewater, as exemplified in recent research, involves several critical stages to ensure accuracy and reliability [8].

Diagram: Analytical Workflow for Pharmaceutical Micropollutants in Wastewater

Detailed Experimental Protocols:

• Sample Collection and Preservation: Following standardized procedures (e.g., ISO guidelines), collect wastewater samples as composites over a defined period (e.g., 8-hour working day) to ensure representativeness. Use sterile high-density polyethylene bottles. Immediately preserve samples at 4°C during transport and storage to minimize microbial degradation and chemical changes [8].
• Sample Preparation and Extraction: Employ Solid-Phase Extraction (SPE) as the primary technique for extracting and concentrating target analytes from aqueous samples. Select SPE sorbents (e.g., Oasis HLB, C18) based on the physicochemical properties (polarity, hydrophobicity) of the target micropollutants. Pass a known volume of filtered sample through the conditioned SPE cartridge. Elute trapped analytes with a small volume of organic solvent (e.g., methanol, acetonitrile) [8].
• Clean-up and Pre-concentration: Gently evaporate the eluate under a stream of nitrogen to near dryness. Reconstitute the residue in a smaller volume of a solvent compatible with the subsequent analytical instrument (e.g., methanol/water mixture). This step pre-concentrates the analytes, enhancing detection sensitivity [8].
• Instrumental Analysis: Analyze the extracts using Ultra-Performance Liquid Chromatography coupled to High-Resolution Quadrupole Time-of-Flight Mass Spectrometry (UPLC-HR-QTOF-MS). This provides chromatographic separation followed by accurate mass measurement, enabling the identification and quantification of a wide range of pharmaceuticals and their transformation products with high confidence [8].
• Data Processing and Quantification: Use internal standard calibration (e.g., isotope-labeled analogs of target analytes) for precise quantification. This corrects for potential matrix effects and variations in sample preparation. Perform quality control checks, including blanks and spikes, to validate the analytical run [8].

The Researcher's Toolkit: Essential Reagents and Materials

Table 3: Key Research Reagent Solutions and Materials

Item	Function/Application	Specific Examples & Notes
Solid-Phase Extraction (SPE) Cartridges	Extraction and pre-concentration of analytes from aqueous samples.	Oasis HLB (hydrophilic-lipophilic balanced), C18-bonded silica; choice depends on analyte polarity [8].
LC-MS Grade Solvents	Mobile phase for chromatography and sample preparation.	Methanol, Acetonitrile, Water; high purity is critical to minimize background noise and ion suppression [8].
Analytical Standards	Identification and quantification of target analytes.	Certified reference material for each target micropollutant (e.g., Carbamazepine, Diclofenac); internal standards (e.g., isotope-labeled) are essential for accurate quantification [8].
UPLC-HR-QTOF-MS System	High-resolution separation and accurate mass detection.	Enables targeted and non-targeted screening; provides high confidence in compound identification [8].

Emerging micropollutants constitute a vast and chemically diverse group of environmental contaminants whose defining characteristic is their potential to cause harm despite their trace concentrations. Their origins are deeply rooted in modern societal and industrial processes, making them a persistent challenge. Advances in analytical chemistry, particularly high-resolution mass spectrometry, have been pivotal in uncovering the scale and complexity of this contamination. Effective management of these substances is inextricably linked to the achievement of several UN SDGs, necessitating a multidisciplinary approach that integrates cutting-edge science, innovative treatment technologies, and robust, globally equitable policy frameworks [6] [3]. Future research must prioritize closing significant knowledge gaps, including the long-term ecological impacts of chronic exposure to complex mixtures of micropollutants and the development of more effective, scalable remediation technologies.

Micropollutants (MPs) represent a category of anthropogenic chemicals detected in the environment at trace concentrations, typically ranging from nanograms to micrograms per liter [10]. These substances, characterized by their persistence, bioaccumulation potential, and biological activity, include pharmaceuticals, personal care products, pesticides, industrial chemicals, and microplastics [10] [5]. Their continuous introduction into ecosystems through multiple pathways, particularly from inadequately treated wastewater, creates a complex challenge that transcends traditional environmental boundaries [11] [7]. Within the framework of the United Nations Sustainable Development Goals (SDGs), MPs directly undermine the targets of SDG 6 (Clean Water and Sanitation), SDG 3 (Good Health and Well-being), and SDG 15 (Life on Land). This technical review examines the mechanistic pathways through which MPs impact these interconnected goals and presents advanced methodologies for their analysis and mitigation, providing researchers with the experimental protocols necessary to address this pressing environmental issue.

Micropollutant Pathways and Direct Impacts on SDGs

The following diagram illustrates the primary pathways through which micropollutants originate, transport through the environment, and ultimately impact the targets of SDGs 6, 3, and 15.

Quantitative Analysis of Micropollutant Occurrence

The table below summarizes key quantitative data on micropollutant occurrence in different environmental matrices, highlighting their pervasive nature and the risk they poses to multiple SDGs.

Table 1: Quantitative Data on Micropollutant Occurrence and Impact Pathways

Environmental Matrix	Example Micropollutants Detected	Typical Concentration Range	Primary Impact Pathway	Related SDG Targets
Treated Wastewater Effluent	Carbamazepine, Diclofenac, Gabapentin, Benzotriazoles [12]	ng/L - μg/L [7]	Direct contamination of surface water; incomplete removal in conventional WWTPs [11]	SDG 6.3: Improve water quality [13]
Agricultural Soils (WW-irrigated)	Telmisartan, Venlafaxine, Carbamazepine, Citalopram [12]	Variable - concentrations show gradual increase over time [12]	Soil accumulation; plant uptake; leaching to groundwater [10] [12]	SDG 15.3: Combat desertification and restore degraded soil
Leachate from Amended Soils	Sertraline, Benzotriazoles, Gabapentin, Tramadol [12]	Approximately 20% of compounds from wastewater detected in leachate [12]	Groundwater contamination; sertraline leaches despite high sorption expectation [12]	SDG 6.1: Safe drinking water [13]
Edible Plant Tissues	Gabapentin, Tramadol, Carbamazepine, Venlafaxine [12]	Accumulation observed mainly in vegetables from WW-irrigated beds [12]	Direct human exposure through food chain; chronic health risks [14]	SDG 3.9: Reduce illnesses from pollution [15]
Surface Water Bodies	Ibuprofen, Ciprofloxacin, Carbamazepine (EU Watch List) [11]	ng/L - μg/L [5]	Ecological stress on aquatic life; source for drinking water [11]	SDG 6.6: Protect water-related ecosystems [13]

Advanced Analytical and Remediation Methodologies

Experimental Protocol for Tracking Micropollutant Fate in Soil-Plant Systems

This detailed protocol is designed to simulate and monitor the fate of MPs in agricultural settings using reclaimed wastewater or biosolids, based on the comprehensive study by [12].

1. Experimental Setup and Microcosm Preparation

• Raised Bed Construction: Establish multiple raised bed systems (recommended minimum 1m x 1m x 0.8m depth) with controlled drainage collection. Use representative agricultural soil (e.g., sandy loam) and characterize its physicochemical properties (pH, CEC, SOM).
• Treatment Application:
  • WW Irrigation Group: Irrigate with secondary-treated wastewater effluent. Characterize the wastewater for a broad spectrum of MPs (e.g., 75+ substances) via LC-MS/MS before application.
  • Biosolid Amendment Groups: Incorporate either sewage sludge or composted sewage sludge into the soil at agronomically relevant rates (e.g., 10-30 tons dry weight/hectare). Homogenize thoroughly.
• Control Group: Irrigate with clean water and use unamended soil.
• Cultivation: Plant a mixture of vegetables (e.g., leafy greens, root vegetables) or a monoculture like maize to represent different uptake mechanisms.

2. Sampling Strategy and Timeline

• Conduct a longitudinal study over at least one growing season (12+ months).
• Water Sampling: Collect and analyze input wastewater, precipitation, and drained leachate monthly. Use automated samplers for flow-proportional composite samples.
• Soil Sampling: Collect soil cores (0-20cm, 20-40cm depth) at planting, mid-season, and post-harvest. Analyze for MP concentration and soil properties.
• Plant Sampling: At harvest, collect and separately analyze edible and non-edible plant parts (roots, stems, leaves, fruits). Rinse, freeze-dry, and homogenize tissues prior to extraction.

3. Analytical Techniques for Micropollutant Quantification

• Extraction: For water samples, use solid-phase extraction (SPE) with hydrophilic-lipophilic balanced (HLB) cartridges. For solid matrices (soil, plant tissue), employ accelerated solvent extraction (ASE) or ultrasonic extraction with methanol/acetonitrile/water mixtures.
• Instrumental Analysis: Utilize liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in multiple reaction monitoring (MRM) mode. Ensure calibration with isotopically labeled internal standards for each target compound to correct for matrix effects.
• Quality Control: Include procedural blanks, matrix spikes, and duplicate samples in each batch. Report method detection limits (MDLs) and recoveries.

4. Data Analysis and Risk Assessment

• Calculate mass balances to track the fate of applied MPs (e.g., fraction taken up by plants, leached, retained in soil, degraded).
• Determine plant uptake factors (Concentrationplant / Concentrationsoil).
• Perform human health risk assessment for detected compounds in edible parts by comparing estimated daily intake (EDI) to acceptable daily intakes (ADIs), if available.

Technical Protocol for Evaluating Advanced Wastewater Treatment Technologies

This protocol assesses the effectiveness of advanced oxidation and adsorption processes for MP removal, critical for upgrading WWTPs to protect water quality (SDG 6.3) [11].

1. Pilot-Scale Treatment System Configuration

• Ozonation Unit: Use a bench-top or pilot-scale ozonation reactor. Ozone is generated from pure oxygen or air. Key operational parameters to monitor and control include:
  • Ozone Dose: 3-20 mg/L (requires precise ozone generation and measurement).
  • Hydraulic Retention Time (HRT): 10-20 minutes in a continuous-flow bubble column.
  • pH Control: Maintain pH 7-8; adjust with NaOH/H2SO4 as pH influences ozone decomposition and radical formation.
• Activated Carbon Systems:
  • Powdered Activated Carbon (PAC) Reactor: Apply PAC doses of 10-20 mg/L to secondary effluent in a contact reactor with 60-120 minutes of contact time, followed by settling or filtration.
  • Granular Activated Carbon (GAC) Filter: Set up a fixed-bed filter with a bed depth of 1.5-3 meters and an empty bed contact time (EBCT) of 15-30 minutes. Monitor for breakthrough.

2. Experimental Procedure and Monitoring

• Influent Characterization: Use real or synthetic wastewater secondary effluent. Pre-characterize for a wide range of MPs (e.g., pharmaceuticals, pesticides, industrial chemicals) and standard water quality parameters (DOC, UV254, pH, alkalinity).
• Bench-Scale Batch Tests: Before piloting, conduct jar tests for ozonation and PAC to determine optimal doses and kinetics for specific MP mixtures.
• Pilot-Scale Operation: Operate systems continuously. Collect influent and effluent samples at regular intervals over an extended period (weeks to months) to assess performance stability and GAC breakthrough.
• Analysis: Quantify target MPs via LC-MS/MS. Also, monitor for potential transformation products (TPs) formed during ozonation using high-resolution mass spectrometry (HRMS). Assess overall water quality changes (DOC removal, UV254 reduction).

3. Performance and Cost-Benefit Analysis

• Removal Efficiency: Calculate percent removal for each target MP. Group compounds by their physicochemical properties (e.g., octanol-water coefficient, presence of specific functional groups) to understand removal mechanisms.
• Cost Estimation: Track operational expenditures (OPEX), including energy consumption for ozone generation, carbon consumption and reactivation costs, and chemical usage for pH adjustment.
• Effectiveness Assessment: Compare technologies based on removal breadth (number of MPs removed >80%), robustness to variable inflows, and operational complexity, as highlighted in European studies [11].

The Scientist's Toolkit: Essential Reagents and Materials

Table 2: Key Research Reagents and Materials for Micropollutant Analysis and Remediation Studies

Item	Specification / Example	Primary Function in Research
HLB Solid-Phase Extraction Cartridges	Oasis HLB, 60 mg, 3 cc	Extraction and pre-concentration of a wide range of hydrophilic and lipophilic MPs from water samples prior to instrumental analysis.
LC-MS/MS Grade Solvents	Methanol, Acetonitrile, Water	Used as mobile phases in LC-MS/MS and for sample extraction. High purity is critical to minimize background noise and ion suppression.
Isotopically Labeled Internal Standards	e.g., Carbamazepine-d10, Diclofenac-d4	Added to all samples and calibration standards to correct for matrix effects and losses during sample preparation, ensuring quantitative accuracy.
Powdered & Granular Activated Carbon	Wood-based or coal-based, specific mesh sizes	Sorbent material for adsorption experiments; used to evaluate removal efficiency in batch (PAC) and column (GAC) studies.
Reverse Phase LC Columns	C18, 2.1 x 100 mm, 1.8 μm particle size	Stationary phase for chromatographic separation of complex mixtures of MPs, enabling resolution of individual analytes before mass spectrometric detection.
Ozone Generator	Lab-scale, fed with pure oxygen	Produces ozone gas for advanced oxidation process (AOP) experiments to evaluate the degradation kinetics of MPs and formation of TPs.
Certified Reference Material (CRM)	e.g., CRM for pharmaceuticals in sludge	Used for method validation and quality control to ensure the accuracy and precision of analytical measurements in complex matrices.

The pervasive nature of micropollutants creates a critical intersection between environmental chemistry, public health, and sustainable development policy. The experimental data and protocols presented provide a scientific foundation for action. Addressing the micropollutant challenge is fundamental to achieving the interconnected ambitions of SDG 6, 3, and 15. This requires a dual strategy: advancing technical capacity for monitoring and removal, and implementing robust policies that promote pollution prevention at the source. Continued research into the long-term ecological and health impacts, the synergistic effects of compound mixtures, and the development of cost-effective, advanced treatment technologies is imperative to safeguard ecosystem integrity and public health for current and future generations.

Pharmaceuticals as contaminants of emerging concern (CECs) represent a critical challenge at the intersection of public health, environmental science, and sustainable development. These substances, designed to be biologically active, are increasingly detected in global water systems at low levels, where they may impact aquatic life through endocrine disruption and other subtle toxicological effects that conventional wastewater treatment cannot fully eliminate [16] [17]. This whitepaper examines the environmental footprint of pharmaceuticals throughout their lifecycle and advocates for the integration of green chemistry principles and benign-by-design approaches in drug development as essential strategies for pollution prevention at the source [18]. Aligning pharmaceutical innovation with the United Nations Sustainable Development Goals (SDGs), particularly Clean Water & Sanitation (SDG 6) and Responsible Consumption & Production (SDG 12), is not merely an environmental consideration but a fundamental component of sustainable drug development that requires collaboration across disciplines [19] [20].

Environmental Fate and Impact of Pharmaceutical Contaminants

Pathways to Environmental Contamination

The journey of pharmaceuticals from administration to aquatic systems is complex and multifaceted. Primary sources include excretion (30-90% of orally administered doses are excreted in urine as parent compounds or metabolites), improper disposal of unused medications, and effluents from manufacturing plants and hospitals [17]. Veterinary applications contribute through the spreading of manure and sludge on agricultural land and direct release from aquaculture [17]. Once released, these substances navigate through wastewater treatment plants, many of which are not designed to remove complex synthetic molecules, eventually reaching surface waters, groundwater, and even drinking water [18] [17].

Ecological Impacts on Aquatic Systems

The continuous infusion of pharmaceuticals into water bodies creates a scenario of chronic, low-level exposure for aquatic organisms, with effects that may not be captured by traditional toxicity testing [16] [17]. Nonsteroidal anti-inflammatory drugs (NSAIDs), among the most frequently detected pharmaceuticals in Italian waters, cause cellular damage to fish with adverse effects on respiration, growth, and reproductive capacity [17]. Of particular concern are endocrine-disrupting compounds like the synthetic estrogen 17α-ethinylestradiol (EE2), which can induce feminization of male fish and alter reproductive success at minute concentrations (ng/L) [16] [17]. Antipsychotic drugs can alter fish behavior by interfering with neurotransmitter systems shared across vertebrates [17].

Table 1: Select Pharmaceuticals and Their Documented Ecological Effects

Pharmaceutical	Therapeutic Class	Documented Ecological Effects
17α-ethinylestradiol	Synthetic estrogen	Endocrine disruption, feminization of male fish, population-level reproductive effects [17]
Ibuprofen	Anti-inflammatory	Growth stimulation in cyanobacteria, growth inhibition in aquatic plants [17]
Carbamazepine	Analgesic/Antiepileptic	Inhibition of emergence in Chironomus riparius [17]
Antibiotics (e.g., Tetracyclines, Macrolides)	Anti-infectives	Development and spread of antibacterial resistance; alteration of environmental microbiota [17]
Diclofenac	Analgesic/Anti-inflammatory	Inhibition of basal EROD activity in rainbow trout hepatocyte cultures [17]

Challenges for Traditional Risk Assessment

The unique properties of pharmaceutical CECs present distinct challenges for conventional water quality criteria and risk assessment frameworks. Unlike traditional pollutants, many pharmaceuticals demonstrate low acute toxicity but cause significant reproductive or developmental effects at very low exposure levels [16]. Effects from early life-stage exposure may not manifest until adulthood, requiring more sophisticated testing methodologies and endpoints than those outlined in existing guidelines [16]. Furthermore, the reality of mixture effects—where combinations of compounds interact to produce unforeseen toxicological outcomes—complicates accurate risk prediction [17].

Pharmaceutical Pollution and Sustainable Development Goals

The pervasive nature of pharmaceutical pollution directly threatens the achievement of multiple United Nations Sustainable Development Goals. While SDG 6 (Clean Water and Sanitation) is most directly implicated, pharmaceutical contaminants undermine at least 12 of the 17 SDGs through direct and indirect pathways [19].

Table 2: Pharmaceutical Contamination's Impact on Select UN Sustainable Development Goals

Sustainable Development Goal	Relevance to Pharmaceutical Contamination
SDG 3: Good Health & Well-Being	Chemistry enables medical breakthroughs, but pharmaceutical pollution can contribute to antibiotic resistance and indirect health risks through environmental exposure [20].
SDG 6: Clean Water & Sanitation	Pharmaceutical micropollutants compromise water quality despite treatment; green chemistry and pollution prevention are needed to protect water resources [18] [20].
SDG 12: Responsible Consumption & Production	Transitioning to a circular economy in chemical manufacturing, including molecule recycling and reuse, is essential for reducing pharmaceutical environmental footprints [20].
SDG 14: Life Below Water	(Micro)plastics and pharmaceuticals directly impact marine ecosystems; SDG indicator 14.1.1b specifically addresses reducing impacts from (micro)plastics [19].

The environmental release of pharmaceuticals creates tension between different SDGs—particularly between SDG 3 (which benefits from pharmaceutical innovation) and SDG 6 and SDG 14 (which are compromised by pharmaceutical pollution) [19] [20] [17]. This conflict underscores the necessity of developing pharmaceuticals that maintain therapeutic efficacy while having reduced environmental persistence and toxicity.

Analytical Methodologies for Pharmaceutical Contaminants

Sample Collection and Preparation Protocols

Water Sampling Protocol:

• Grab Sampling: Collect 1L water samples in pre-cleaned amber glass bottles. Add 1 g sodium azide to inhibit microbial degradation.
• Solid Phase Extraction (SPE): Pass samples through Oasis HLB cartridges (200 mg, 6 cc) after conditioning with 5 mL methanol and 5 mL ultrapure water. Elute with 2×4 mL methanol into collection tubes.
• Concentration: Evaporate extracts to dryness under gentle nitrogen stream and reconstitute in 100 µL methanol for LC-MS/MS analysis [17].

Sediment/Biosolid Sampling:

• Collect samples using stainless steel corers, freeze-dry, and homogenize.
• Perform accelerated solvent extraction (ASE) with methanol:water (50:50, v/v) at 100°C and 1500 psi.
• Concentrate extracts and clean up using mixed-mode cation exchange SPE cartridges [17].

Instrumental Analysis and Quantification

Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Conditions:

• Column: Kinetex C18 (100 mm × 4.6 mm, 2.6 µm)
• Mobile Phase: (A) 0.1% formic acid in water; (B) 0.1% formic acid in acetonitrile
• Gradient: 5% B to 95% B over 15 minutes, hold 3 minutes
• Flow Rate: 0.3 mL/min; Injection Volume: 10 µL
• MS Detection: Electrospray ionization (ESI) in positive and negative modes; multiple reaction monitoring (MRM) with two transitions per compound [17]

Quality Assurance/Quality Control (QA/QC):

• Include procedure blanks, duplicates, and matrix spikes in each batch
• Use isotope-labeled internal standards for quantification (e.g., carbamazepine-d10, ibuprofen-d3)
• Maintain calibration curves with R² > 0.995
• Implement continuing calibration verification every 10 samples [17]

Experimental Workflow Visualization

Figure 1: Analytical workflow for pharmaceutical contaminant detection in environmental samples.

The Scientist's Toolkit: Essential Research Reagents and Materials

Successful analysis and monitoring of pharmaceutical CECs requires specialized reagents and materials designed to handle trace-level concentrations in complex environmental matrices.

Table 3: Essential Research Reagents for Pharmaceutical Contaminant Analysis

Reagent/Material	Specifications	Function/Purpose
Solid Phase Extraction Cartridges	Oasis HLB (200 mg, 6 cc); mixed-mode cation exchange	Extraction and cleanup of pharmaceutical compounds from aqueous samples; reduces matrix effects [17]
Isotope-Labeled Internal Standards	Carbamazepine-d10, Ibuprofen-d3, Erythromycin-¹³C₂	Quantification via isotope dilution mass spectrometry; corrects for matrix effects and recovery variations [17]
LC-MS/MS Mobile Phase Additives	LC-MS grade formic acid, ammonium acetate	Enhances ionization efficiency in mass spectrometry; modifies retention in chromatographic separation [17]
Chromatographic Columns	Kinetex C18 (100 mm × 4.6 mm, 2.6 µm) or equivalent	High-resolution separation of pharmaceutical compounds and metabolites prior to mass spectrometric detection [17]
Reference Standards	Pharmaceutical compounds of interest (>95% purity)	Method development, calibration, and identification; enables quantification of target analytes [17]

Green Chemistry Solutions for Sustainable Drug Development

Benign-by-Design Molecular Strategies

The benign-by-design approach represents a paradigm shift in pharmaceutical development, where environmental considerations are integrated at the molecular design stage rather than addressed post-production. Key strategies include:

• Designing for Biodegradability: Molecular structures can be engineered to include "environmental cleavage points" such as ester bonds or other hydrolyzable groups that facilitate breakdown in environmental compartments [18].
• Reducing Persistence: Modifying molecular structures to avoid extreme resistance to microbial, photolytic, and hydrolytic degradation minimizes accumulation in water bodies [18].
• Managing Metabolite Toxicity: Considering potential environmental transformation pathways and metabolites during drug design to ensure breakdown products are less harmful than parent compounds [18].

Green Chemistry Principles in Pharmaceutical R&D

Application of the 12 Principles of Green Chemistry to drug development offers a framework for reducing environmental impact:

• Prevention: Preventing waste generation rather than treating or cleaning up after formation [18] [20].
• Atom Economy: Designing synthetic routes that maximize incorporation of all starting materials into the final product [20].
• Less Hazardous Chemical Syntheses: Designing synthetic methodologies that use and generate substances with little or no toxicity to human health and the environment [20].
• Designing for Degradation: Chemical products should be designed so that at the end of their function they break down into innocuous degradation products [18] [20].

Integrated Drug Development Workflow

Figure 2: Integrated drug development workflow incorporating environmental considerations.

Future Perspectives and Research Priorities

Addressing the challenge of pharmaceutical CECs requires coordinated efforts across multiple sectors. Research priorities should include:

• Advanced Treatment Technologies: Developing more energy-efficient, cost-effective advanced oxidation processes and adsorption media specifically tailored to pharmaceutical removal [18] [20].
• Standardized Testing Frameworks: Establishing standardized international protocols for assessing environmental persistence, bioaccumulation, and toxicity of pharmaceuticals that account for real-world exposure scenarios [16].
• Circular Economy Approaches: Implementing closed-loop systems for pharmaceutical manufacturing that minimize waste and water usage while enabling molecule recovery and reuse [20].
• Interdisciplinary Collaboration: Fostering deeper collaboration between medicinal chemists, environmental scientists, engineers, and toxicologists to bridge knowledge gaps and develop holistic solutions [18].

The integration of green and sustainable chemistry principles into pharmaceutical development represents not merely a technical challenge but a fundamental evolution in how we conceptualize drug design—one that balances therapeutic innovation with environmental stewardship and aligns with the broader objectives of the UN Sustainable Development Goals [18] [20].

Emerging organic micropollutants (EOMs) represent a broad class of chemical compounds that have garnered significant scientific concern due to their persistent presence in aquatic environments and potential to cause harm at even trace concentrations. These substances, typically present in water at levels ranging from nanograms to micrograms per liter, originate from various sources including pharmaceuticals, personal care products, industrial chemicals, pesticides, and endocrine disruptors [1]. What distinguishes micropollutants from conventional pollutants is their triple threat characteristics: inherent toxicity, environmental persistence, and bioaccumulative potential [21]. This combination of properties enables them to resist degradation, accumulate in living organisms, and exert toxic effects over prolonged periods, creating a systemic risk that transcends traditional pollution boundaries and threatens ecosystem stability and human health.

The systemic nature of micropollutant risk emerges from the complex interplay between their chemical properties and biological impacts. Unlike conventional pollutants that may dilute or degrade rapidly, micropollutants persist in environmental compartments, undergo long-range transport, and accumulate in food chains, resulting in disproportionate impacts relative to their environmental concentrations [21]. Recent studies detecting numerous pharmaceuticals, personal care products, and per- and polyfluoroalkyl substances (PFAS) in virtually all environmental matrices—from remote alpine waters to deep groundwater aquifers—confirm the pervasive nature of this challenge [22] [23] [24]. Understanding the mechanisms behind toxicity, persistence, and bioaccumulation is therefore fundamental to assessing the systemic risks posed by these substances and developing effective mitigation strategies within the framework of sustainable development goals.

Fundamental Risk Concepts: The PBT Framework

The Triad of Properties Creating Systemic Risk

The PBT framework—Persistence, Bioaccumulation, and Toxicity—provides a foundational model for understanding why micropollutants pose disproportionate environmental threats compared to conventional pollutants.

• Persistence: Chemicals classified as persistent possess structural characteristics that enable them to resist natural degradation processes including photolysis, chemical hydrolysis, and microbial biodegradation [21]. This environmental longevity is often facilitated by the presence of halogen atoms (particularly fluorine, chlorine, or bromine) in synthetic organic compounds, which create strong molecular bonds resistant to breakdown. For instance, poly- and perfluoroalkyl substances (PFAS) contain carbon-fluorine bonds, among the strongest in organic chemistry, granting them extreme stability and earning them the designation "forever chemicals" [23]. Metals such as lead, mercury, and arsenic represent a special persistence category as elemental substances that cannot be broken down further [21].

• Bioaccumulation: This property refers to the ability of chemicals to accumulate in living organisms at concentrations exceeding those in the surrounding environment [21]. The bioaccumulation potential of a substance can be predicted by examining its partition coefficient, which measures its preferential dissolution in organic solvents versus water. When this concentration gradient exceeds 1,000, the chemical is likely to bioaccumulate; values exceeding 5,000 indicate high bioaccumulation potential [21]. Fat-soluble bioaccumulative chemicals tend to reside primarily in lipid-rich tissues and are often found at elevated levels in breast milk, creating exposure pathways that bypass traditional environmental dilution.

• Toxicity: PBT chemicals can manifest various toxic properties resulting in diverse adverse health effects, including mutagenic damage to DNA, cancer, neurological impairment, reproductive and developmental abnormalities, and immune system damage [21]. The toxicity of micropollutants is particularly concerning because many pharmaceutical compounds and pesticides are specifically designed to produce biological effects at low concentrations, making them potentially hazardous even at trace environmental levels [7].

Visualizing the PBT Amplification Cycle

The systemic risk of micropollutants emerges from the cyclical relationship between persistence, bioaccumulation, and toxicity, which amplifies their impact throughout ecosystems. The following diagram illustrates this reinforcing cycle:

Figure 1: The self-reinforcing PBT cycle that amplifies micropollutant risk in ecosystems.

This cyclical relationship demonstrates how persistence enables continuous exposure, leading to bioaccumulation across trophic levels, which in turn elevates internal doses to toxicologically relevant levels. The resulting ecosystem impacts often contribute to further environmental loading, creating a feedback loop that magnifies risks over time [21] [1].

Major Micropollutant Classes and Quantitative Risk Assessment

High-Priority Micropollutant Categories

Micropollutants encompass diverse chemical classes with varying properties and environmental behaviors. Recent prioritization studies have identified several categories of particular concern based on their persistence, bioaccumulation potential, toxicity, and prevalence in environmental matrices [1].

Table 1: High-Priority Micropollutant Classes and Their Characteristics

Category	Representative Compounds	Primary Sources	Key Concerns
Pharmaceuticals	Sulfamethoxazole, Carbamazepine, Metformin, Citalopram	Wastewater treatment plants, hospital effluents, pharmaceutical manufacturing	Biological activity at low concentrations, antibiotic resistance development, endocrine disruption [25] [22] [7]
Per- and Polyfluoroalkyl Substances (PFAS)	PFOA, PFOS, PFHxS	Industrial discharges, firefighting foams, consumer products	Extreme persistence, bioaccumulation in blood and organs, immunological and developmental effects [23] [21]
Pesticides	Neonicotinoids, Herbicides, Organophosphates	Agricultural runoff, urban landscaping	Acute toxicity to non-target species, chronic ecological impacts, groundwater contamination [24]
Personal Care Products	Musk fragrances, UV filters, disinfectants	Domestic wastewater, recreational activities	Pseudopersistance due to continuous release, bioaccumulation in aquatic organisms [1]
Brominated Flame Retardants	Polybrominated diphenyl ethers (PBDEs)	Plastics, foam, fabrics, electronics	Neurodevelopmental toxicity, persistence, bioaccumulation in human populations [21]

Quantitative Risk Assessment Data

Risk assessment of micropollutants requires evaluating both ecological and human health impacts through standardized metrics. Recent monitoring studies provide concerning data on specific high-risk compounds detected in various environmental compartments.

Table 2: Risk Quotients for Selected High-Priority Micropollutants

Compound	Category	Human Risk Quotient (Babies)	Ecological Risk Quotient	Most Vulnerable Organism
Citalopram	Pharmaceutical	19.116	0.1-1.0	Daphnia [22]
Irbesartan	Pharmaceutical	1.104	3.500	Fish [22]
Clarithromycin	Pharmaceutical	<1	1.500	Algae [22]
Sulfamethoxazole	Pharmaceutical	<1	N/A	Aquatic organisms [25]
Venlafaxine	Pharmaceutical	<1	0.1-1.0	Aquatic organisms [22]

Risk quotients (RQs) greater than 1.0 indicate high risk, with citalopram and irbesartan presenting particularly concerning profiles for human health, especially in vulnerable populations like infants [22]. Ecological risk assessments have identified herbicides, organophosphorus esters, and insecticides as presenting the greatest risks to algae, invertebrates, and fish, respectively [24]. The elevated human risk quotients in babies highlight the heightened susceptibility of developing organisms to micropollutant exposures.

Experimental Approaches for Micropollutant Risk Assessment

Methodologies for Assessing Micropollutant Fate

Understanding micropollutant behavior in environmental systems requires sophisticated experimental approaches to delineate removal mechanisms and transformation pathways. Bio-electrochemical systems (BESs) represent one advanced methodology for differentiating between key processes governing micropollutant fate [25].

Experimental Protocol: Distinguishing Sorption and Degradation Mechanisms

• Electrode Preparation: Utilize carbon-based electrodes (graphite felt, graphite rod, graphite granules) and granular activated carbon as reference sorbent. Prepare experimental setups with identical materials but different operational conditions [25].

• Sorption Experiments: Conduct separate sorption experiments without potential application to establish baseline sorption capacities for each electrode material across target micropollutants at environmentally relevant concentrations (ng/L-μg/L range) [25].

• Electrochemical Degradation: Apply controlled electrode potentials (-0.3V, 0V, +0.955V) to graphite felt electrodes to evaluate potential-dependent degradation. Utilize analytical standards to track parent compound disappearance and transformation product formation [25].

• Bio-electrochemical Conditions: Establish systems with electro-active microorganisms to assess combined biological and electrochemical degradation. Compare removal efficiencies to abiotic electrochemical conditions to distinguish biological contribution [25].

• Analytical Quantification: Employ LC-MS/MS for quantitative analysis of parent compounds and transformation products. Use controlled experiments with isotopically labeled standards to confirm transformation pathways and address matrix effects [25].

This methodology revealed that sorption to electrodes is crucial for guaranteeing high electrochemical degradation, with granular activated carbon showing the highest sorption capacity while graphite felt electrodes demonstrated enhanced removal at higher anode potentials (+0.955V) [25].

The Researcher's Toolkit: Essential Reagents and Materials

Table 3: Essential Research Materials for Micropollutant Fate Experiments

Material/Reagent	Specifications	Experimental Function
Carbon-based Electrodes	Graphite felt, graphite rod, graphite granules, granular activated carbon	Sorbent materials and electron transfer surfaces for sorption and degradation studies [25]
Analytical Standards	Certified reference materials (e.g., sulfamethoxazole, metformin, chloridazon)	Quantification and identification of parent compounds and transformation products [25]
Isotopically Labeled Standards	¹³C or ²H-labeled analogs of target micropollutants	Internal standards for mass spectrometry quantification and transformation pathway elucidation [25]
LC-MS/MS System	High-performance liquid chromatography coupled to tandem mass spectrometry	Sensitive detection and quantification at trace concentrations (ng/L) [25] [24]
Potentiostat	Three-electrode system with controlled potential application	Applying precise electrochemical conditions for degradation experiments [25]

Visualizing the Experimental Workflow

The complex process of assessing micropollutant fate mechanisms can be visualized through the following experimental workflow:

Figure 2: Experimental workflow for distinguishing micropollutant removal mechanisms.

This methodology enabled researchers to determine that removal efficiencies >80% could be achieved for all studied micropollutants at high anode potentials (+0.955V), indicating greater susceptibility to oxidation than reduction, and that detection of transformation products confirmed (bio)-electrochemical degradation pathways [25].

Environmental Fate and Real-World Distribution Patterns

Spatial Distribution and Anthropogenic Drivers

Comprehensive monitoring studies reveal distinct spatial patterns in micropollutant distribution driven by anthropogenic activities. A megacity-scale study of Beijing's surface waters detected 133 micropollutants, with concentrations significantly higher in southern areas with more intensive human activities compared to northern regions [24]. Neonicotinoid pesticides showed the highest mean concentration (311 ng·L⁻¹), followed by organophosphate esters (225 ng·L⁻¹) and antiviral drugs (150 ng·L⁻¹) [24].

The distribution and risks of micropollutants are strongly correlated with human land use patterns. Watershed analysis demonstrates that cropland and impervious surfaces are primary drivers of micropollutant contamination, with land use in riparian zones greater than 2 km showing significant influence on chronic chemical risks to aquatic organisms [24]. This spatial relationship underscores the importance of watershed-scale management approaches rather than localized intervention strategies.

Climate conditions and human activities collectively explain the exposure risks to various trophic levels, creating complex multiple-stressor scenarios that complicate risk assessment and mitigation [24]. This understanding aligns with the systemic risk paradigm, wherein micropollutant impacts emerge from interconnected environmental and anthropogenic factors operating across different spatial and temporal scales.

Transformation Pathways and Environmental Persistence

The environmental fate of micropollutants is governed by transformation mechanisms including photodegradation, redox reactions, and covalent bond formation with natural organic matter [26]. Understanding these pathways is essential for predicting persistence and formation of potentially hazardous transformation products.

Advanced oxidation processes have shown promise for degrading persistent compounds, with studies indicating that photosensitizing effects of dissolved organic matter can either promote or inhibit photochemical transformation depending on specific environmental conditions [26]. Similarly, redox transformations mediated by natural organic matter can significantly influence the sorption and degradation behavior of ionogenic organic micropollutants such as antibiotics [26].

The persistence of certain micropollutant classes is particularly concerning. PFAS, for instance, demonstrate such extreme environmental stability that they are known as "forever chemicals," with perfluorooctanoic acid (PFOA), perfluorooctanesulfonic acid (PFOS), and related compounds detected in the blood of nearly 99% of individuals sampled in national biomonitoring studies [23] [21]. This ubiquitous human contamination reflects the environmental persistence and mobility of these substances.

Alignment with Global Sustainability Frameworks

The micropollutant challenge directly intersects with multiple United Nations Sustainable Development Goals (SDGs), particularly Clean Water and Sanitation (SDG 6), Good Health and Well-Being (SDG 3), Responsible Consumption and Production (SDG 12), and Climate Action (SDG 13) [20]. Addressing micropollutant contamination requires developing greener chemical alternatives, implementing advanced treatment technologies, and adopting circular economy approaches that minimize waste and pollution [20] [27].

The recently enacted European Urban Wastewater Treatment Directive (UWWTD) exemplifies the regulatory response to micropollutant concerns, establishing stringent standards focused on monitoring twelve specific indicator compounds and requiring an 80% reduction in micropollutant loads from major treatment plants [22]. This regulatory evolution reflects growing recognition of the systemic risks posed by these substances and the need for comprehensive management strategies.

Micropollutants represent a systemic environmental risk due to the interplay of their inherent toxicity, environmental persistence, and bioaccumulative potential. This triple threat profile, combined with continuous introduction into ecosystems and inadequacy of conventional treatment approaches, creates a complex challenge that demands integrated solutions [27] [1].

Addressing this systemic risk requires fundamental shifts in chemical design, wastewater treatment infrastructure, and regulatory frameworks. Green chemistry principles that prioritize inherent safety and sustainability in molecular design offer promising pathways forward [27]. As emphasized in the recent Nobel Declaration on "Chemistry for the Future," transitioning to a new chemistry for sustainability model is essential: "We don't need to have a forever chemicals crisis. We don't need to have any of these things because we have the solutions" [27].

The systemic risk posed by micropollutants ultimately stems from a disconnect between chemical innovation and environmental sustainability. Closing this gap through collaborative efforts across scientific disciplines, industrial sectors, and policy domains represents one of the most pressing challenges in environmental chemistry today—and an essential prerequisite for achieving sustainable development goals that safeguard both planetary health and human well-being.

The One Health concept represents an integrated, unifying approach that aims to sustainably balance and optimize the health of people, animals, and ecosystems. This approach recognizes that human health is intricately connected to the health of other animals and the environment they collectively inhabit [28]. The conceptual foundation of One Health has evolved significantly since the mid-20th century when veterinarian Calvin Schwabe first proposed the "One Medicine" concept, highlighting the integrated, cross-disciplinary perspective that veterinary medicine could contribute to general medicine [28]. Throughout the 21st century, this idea expanded to encompass the health of the wider ecosystem, including plants, wild animals, and their geographical contexts, culminating in the formal "One Health" concept that acknowledges the intricate interconnections among all components of the health spectrum [28].

The relevance of One Health has been sharply highlighted by recent global challenges, including the COVID-19 pandemic and the noticeable effects of climate change, which have encouraged national and international cooperation to apply One Health strategies to address key issues of health and welfare [28]. The United Nations Sustainable Development Goals (SDGs) have established targets that align closely with One Health principles, including health and wellbeing (SDG 3), clean water and sanitation (SDG 6), climate action (SDG 13), and sustainability in marine (SDG 14) and terrestrial ecosystems (SDG 15) [28]. Recognizing the importance of cross-disciplinary, multinational collaboration, four global organizations have formed the One Health Quadripartite: the World Health Organization (WHO), the World Organization for Animal Health (WOAH), the UN Food and Agriculture Organization (FAO), and the UN Environment Programme (UNEP) [28].

The Chemical Pollution Crisis and Planetary Boundaries

The chemical pollution crisis represents a severe global threat that challenges the foundations of the One Health paradigm. Since the Industrial Revolution, industrialization has introduced unprecedented quantities of new contaminants into the environment, including heavy metals, industrial chemicals, and particulate matter [4]. With the onset of the Anthropocene, humans have increasingly depleted natural resources and developed novel chemical entities in pursuit of global development, resulting in waste streams that transgress planetary boundaries, disrupt natural ecosystems, and induce changes in agricultural practices [4].

The production of synthetic chemicals has surged dramatically since the mid-twentieth century, marking what is often referred to as the second chemical revolution [4]. This surge is evidenced by the rapid growth of the Chemical Abstract Service Registry, which expanded from 20 million substances in 2002 to over 204 million by 2023, suggesting an addition of nearly 15,000 new chemicals daily [4]. A critical analysis by Persson et al. (2022) highlighted that humanity has exceeded the planetary boundary for novel entities, as the rate of chemical production vastly outpaces both hazard assessments and the establishment of regulatory measures [4] [29]. Bernhardt et al. similarly argued that synthetic chemicals represent powerful agents of global change with cascading effects throughout ecosystems [4].

Table 1: Categories of Emerging Contaminants of Concern in One Health

Category	Primary Sources	Key Examples	One Health Concerns
Per- and poly-fluoroalkyl substances (PFAS)	Industrial production, consumer products	PFOA, PFOS	Environmental persistence, bioaccumulation, endocrine disruption in humans and animals
Pharmaceuticals and Personal Care Products (PPCPs)	Human and veterinary medicine, consumer use	Antibiotics, antidepressants, cosmetics	Antimicrobial resistance, endocrine disruption, ecological imbalance
Micro/nano-plastics	Plastic degradation, consumer products	Polyethylene, polypropylene fragments	Physical harm through ingestion, chemical leaching, ecosystem-wide impacts
Antimicrobial Resistance Genes (ARGs)	Misuse of antibiotics in human and veterinary medicine	Beta-lactamase genes	Treatment failures in humans and animals, spread of untreatable infections
Pesticides	Agricultural applications	Neonicotinoids, glyphosate	Neurotoxicity, pollinator decline, soil and water contamination
Industrial Chemicals	Industrial processes, manufacturing	Bisphenols, phthalates	Endocrine disruption, developmental abnormalities, reproductive impacts

The planetary boundaries framework identifies nine critical Earth system processes, including "novel entities" comprising new chemical substances, new forms of existing substances, and modified life forms [29]. Evidence indicates that chemical impacts on environmental and human health occur across local to global scales, although quantification remains challenging due to system complexity [29]. Particularly alarming is the rate of increase in chemical production and use, which exceeds most other global indicators, including population growth rate, emissions of carbon dioxide, and agricultural land use [29]. This acceleration in chemical production occurs despite sufficient evidence of chemical impacts on environmental and human health across local to global scales [29].

Emerging Contaminants: A One Health Perspective

Emerging contaminants (ECs), also referred to as contaminants of emerging concern (CECs), are defined as newly identified synthetic or naturally occurring chemicals or biological agents that are detected in the environment and potentially hazardous or recently determined to be hazardous to humans and ecosystems [4]. The risks associated with these contaminants are not fully understood, creating significant challenges for risk assessment and regulatory frameworks. ECs may include pharmaceuticals and personal care products (PPCPs), per- and poly-fluoroalkyl substances (PFAS), emerging pathogens, cyanotoxins, pesticides, industrial chemicals, micro/nano plastics, nanomaterials, antibiotic resistance genes (ARGs), and other exogenous substances found in the environment but not yet well understood in terms of their impacts on humans and natural ecosystems [4].

These contaminants enter the environment through various pathways, including industrial discharge, agricultural runoff, and improper waste disposal, leading to air, water, soil, and food contamination [4]. They frequently become part of complex mixtures of chemical pollutants and biological hazards, with the potential to undergo additional transformation and long-range transport, creating unforeseen and uncharacterized chemicals and causing chemical pollution in areas distant from the source [4]. This complexity presents substantial challenges for monitoring, assessment, and regulation within a One Health framework.

The historical perspective on ECs reveals a troubling pattern where substances transition from being celebrated as beneficial chemicals to contaminants of significant concern. Examples of such evolving contaminants include plastics and their by-products, atrazine, triphenyl phosphate, tungsten, PFAS, chlorofluorocarbons, neonicotinoids, glyphosate, and many others [4]. This evolution in classification is attributed to improved detection capabilities for inorganic and organic contaminants at trace levels and a better understanding of their wider ecosystem and health effects through the integrated lens of One Health.

Table 2: Quantitative Data on Global Impact of Selected Emerging Contaminants

Contaminant Category	Global Production/Volume	Environmental Persistence	Key Health Impacts	Regulatory Status
Plastics	460 million tons in 2019 (doubled since 2000) [4]	Centuries to millennia; degrades to microplastics	Physical harm, chemical leaching, endocrine disruption	Limited international regulation
PFAS	Thousands of variants in commercial use	Extreme persistence; "forever chemicals"	Immune system effects, cancer, developmental toxicity	Increasing regulatory scrutiny in developed countries
Pharmaceuticals	>1000 active pharmaceutical ingredients in use [29]	Varies; some highly persistent	Antimicrobial resistance, endocrine disruption	Mostly unregulated in environmental compartments
Pesticides	4.1 million tons annually (global market)	Days to decades	Neurotoxicity, carcinogenicity, ecosystem disruption	Variable regulation; many banned substances still in use

One Health and Sustainable Development Goals

The interlinkages between One Health and the United Nations Sustainable Development Goals (SDGs) provide a critical framework for addressing the complex challenges of environmental contamination and its impacts on human and animal health. The SDGs establish targets that align closely with One Health principles, including health and wellbeing (SDG 3), clean water and sanitation (SDG 6), climate action (SDG 13), and sustainability in marine (SDG 14) and terrestrial ecosystems (SDG 15) [28]. These interconnections highlight the necessity of integrated approaches to achieve sustainable development while safeguarding the health of all components of the ecosystem.

The role of One Health in achieving SDG 14 (Life Below Water) is particularly significant, as oceans face extreme threats from increasing eutrophication, acidification, warming, and plastic pollution [30]. Healthy oceans are essential for human survival and life on Earth, covering three-quarters of the Earth's surface, containing 97% of the Earth's water, and accounting for 99% of the living space on the planet by volume [30]. Oceans provide crucial natural resources including food, medicines, biofuels, and other products; help break down and remove waste and pollution; and serve as the largest carbon sink on the planet [30]. However, ocean pollution is reaching extreme levels, with over 17 million metric tons of plastic clogging the ocean in 2021, a figure expected to double or triple by 2040 [30]. Additionally, ocean acidification threatens marine life, disrupts food webs, and impairs important services provided by marine ecosystems, ultimately jeopardizing our own food security [30].

The implementation of SDG 6 (Clean Water and Sanitation) similarly depends on One Health approaches, as water systems connect human, animal, and environmental health through complex pathways. The University of Manitoba, designated as the SDG Hub for Goal 6, exemplifies this integrated approach through its interdisciplinary research on water systems to help build sustainable, resilient communities in Manitoba and across Canada [31]. University researchers examine three primary areas related to water system sustainability: economic, social/equity, and environmental dimensions, each with unique perspectives and critical overlaps [31]. Their expertise in managing water quantity and quality at regional, watershed, and farm levels contributes to the long-term sustainability of land, rivers, and lakes, while their work integrates technical water and wastewater expertise with Indigenous knowledge to address the needs of remote and Indigenous communities [31].

Methodological Frameworks for One Health Research

Analytical Techniques for Emerging Contaminants

The detection and quantification of emerging contaminants in environmental matrices require sophisticated analytical methodologies with high sensitivity and specificity. High-resolution mass spectrometry (HRMS) has emerged as a cornerstone technology for the identification of unknown transformation products and metabolites of ECs in complex environmental samples [32]. When coupled with liquid chromatography (LC) or gas chromatography (GC), HRMS enables the detection of contaminants at trace concentrations (ng/L to pg/L) in water, soil, biota, and air samples. The development of non-targeted screening approaches using HRMS allows for the comprehensive detection of thousands of chemical features in environmental samples, facilitating the discovery of previously unrecognized contaminants [32].

Stable isotope-labeled internal standards play a critical role in the accurate quantification of ECs, correcting for matrix effects and analytical variability. For the analysis of metals and metalloids, inductively coupled plasma mass spectrometry (ICP-MS) provides exceptional sensitivity and multi-element capabilities, essential for assessing contamination across environmental compartments [32]. The application of passive sampling devices, including polar organic chemical integrative samplers (POCIS) and semipermeable membrane devices (SPMDs), enables time-integrated monitoring of ECs, providing a more representative picture of contaminant occurrence than grab sampling alone [32].

Diagram 1: Analytical Workflow for Emerging Contaminants in One Health Research

Molecular and 'Omics Approaches in Exposure Science

The integration of 'omics technologies has revolutionized our understanding of the mechanisms through which environmental contaminants impact biological systems across the One Health spectrum. Transcriptomics enables the comprehensive analysis of gene expression changes in response to contaminant exposure, revealing pathway-specific effects in humans, animals, and ecologically relevant species [32]. Proteomics provides insights into post-translational modifications and protein expression patterns, connecting contaminant exposure to functional changes in biological systems [33]. Metabolomics captures the global profile of small molecules in biological samples, offering a sensitive readout of physiological responses to environmental stressors [32].

The application of high-throughput sequencing technologies facilitates the study of antibiotic resistance genes (ARGs) across environmental compartments, allowing researchers to track the dissemination of resistance determinants between environmental bacteria, animal microbiota, and human pathogens [4]. Metagenomic approaches enable culture-independent characterization of microbial community responses to contaminant exposure, revealing shifts in ecosystem function and potential impacts on biogeochemical cycling [32]. The integration of multiple 'omics datasets through bioinformatic pipelines provides systems-level insights into the complex interactions between contaminants and biological systems across the One Health continuum.

Table 3: Research Reagent Solutions for One Health Environmental Monitoring

Reagent/Category	Specific Examples	Primary Function	Application in One Health
Stable Isotope-Labeled Standards	¹³C- or ¹⁵N-labeled analogs of target analytes	Internal standards for quantification	Correct for matrix effects in mass spectrometry; enable precise measurement of contaminants across environmental, animal, and human samples
Molecular Biology Kits	DNA/RNA extraction kits, PCR master mixes, sequencing libraries	Nucleic acid purification and amplification	Detect pathogen presence, antibiotic resistance genes, and gene expression changes in environmental and biological samples
Cell-Based Assay Systems	Reporter gene assays, cytotoxicity assays	Mechanism-based toxicity screening	High-throughput screening of contaminant effects on cellular pathways relevant to human, animal, and ecosystem health
Immunoassay Reagents	ELISA kits, antibodies against specific contaminants	Sensitive detection of target analytes	Rapid screening of contaminant presence in field samples; useful for veterinary, human health, and environmental monitoring
Passive Sampling Media	Sorbent phases for POCIS, SPMD	Time-integrated contaminant sampling	Monitor spatial and temporal trends of contaminant occurrence across watersheds, agricultural areas, and wildlife habitats
Bioinformatic Tools	Metagenomic analysis pipelines, molecular networking software	Data analysis and interpretation	Integrate complex datasets from environmental monitoring, animal surveillance, and human biomonitoring

Environmental Chemistry and Fate of Micropollutants

Multi-Compartment Transport and Transformation

The environmental fate of micropollutants is governed by complex processes that occur across multiple environmental compartments, including air, water, soil, and biota. Understanding these processes is essential for predicting exposure and impacts within the One Health framework. Adsorption-desorption processes control the distribution of contaminants between aqueous and solid phases, influenced by contaminant properties (hydrophobicity, charge) and environmental characteristics (organic matter content, pH, mineral composition) [32]. Photochemical degradation represents a significant transformation pathway for many ECs in surface waters and atmospheric compartments, with reaction rates dependent on light intensity, water chemistry, and molecular structure [32].

Biotransformation processes mediated by microorganisms, plants, and animals can significantly alter the fate and effects of ECs in the environment. Aerobic and anaerobic microbial degradation can lead to complete mineralization of some contaminants or transformation to more persistent and potentially more toxic metabolites [32]. The root zone of plants represents a particularly active site for contaminant transformation, where rhizosphere microorganisms and plant enzymes interact to degrade or transform organic pollutants [32]. These transformation processes must be considered within a One Health context, as metabolites may exhibit different toxicity, mobility, and bioaccumulation potential compared to parent compounds.

Bioaccumulation and Trophic Transfer

Bioaccumulation of ECs in aquatic and terrestrial organisms represents a critical pathway for exposure across the One Health spectrum, with potential impacts on ecosystem integrity, animal health, and human consumers of contaminated food resources. The bioconcentration factor (BCF) and bioaccumulation factor (BAF) are key parameters used to quantify the potential for contaminants to accumulate in organisms from water and food sources, respectively [4]. Lipophilic compounds with high octanol-water partition coefficients (log KOW > 4) generally exhibit the greatest bioaccumulation potential, though exceptions exist for compounds that undergo metabolic transformation or bind to specific tissues.

Trophic transfer of ECs through food webs can lead to biomagnification, where contaminant concentrations increase at successive trophic levels, resulting in particularly high exposures for top predators, including humans [4]. This phenomenon has been well-documented for legacy pollutants such as PCBs and DDT, and is increasingly recognized as relevant for certain ECs, including PFAS and some brominated flame retardants [4]. The trophic magnification factor (TMF) provides a quantitative measure of biomagnification potential, with values greater than 1 indicating tendency for increased concentrations at higher trophic levels.

Diagram 2: Pathways of Contaminant Transfer in One Health Context

Implementation Challenges and Research Priorities

Knowledge Gaps and Monitoring Limitations

Significant challenges remain in implementing comprehensive One Health approaches to chemical pollution management. Geographical disparities in monitoring data represent a critical limitation, with current assessments heavily biased toward data-rich regions (Europe and North America), while many low- and middle-income countries lack basic monitoring capacity [29]. This disparity is particularly concerning given evidence that concentrations of hazardous chemicals in some low-income countries may be significantly higher than in high-income regions due to combinations of waste mismanagement, poor sanitation and water treatment, continued use of high-risk chemicals phased out in developed countries, and the high use of region-specific compounds [29].

The regulatory challenge posed by the vast number of chemicals in commerce represents another critical limitation. As of February 2024, the US Environmental Protection Agency Toxic Substances Control Act Chemical Substance Inventory contains 86,741 potentially hazardous chemicals, with 42,293 currently commercially active [4]. Additionally, the NORMAN network of reference laboratories has identified over 700 of the most discussed emerging contaminants, while Wang et al. identified that over 350,000 chemicals and chemical mixtures have been registered for commercial use worldwide [4]. The continuous expansion of these inventories, coupled with the ongoing discovery of new substances and increased scrutiny of existing ones, creates an almost insurmountable challenge for traditional chemical-by-chemical risk assessment and management approaches [4].

International Science-Policy Interfaces

The establishment of an effective international science-policy interface for chemicals and waste represents a critical priority for implementing One Health approaches at global scales. While analogous bodies exist for climate change (Intergovernmental Panel on Climate Change, IPCC) and biodiversity (Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services, IPBES), no equivalent overarching intergovernmental science-policy body addresses chemical pollution and its effects on humans and the environment [29]. Such a body would facilitate enhanced bidirectional communication between policy-makers and scientists on a global scale with broad involvement of the wider scientific community to mobilize worldwide expertise to respond to the chemical threat [29].

Major challenges for a novel science-policy body on chemicals and wastes include fostering global knowledge production on exposure, impacts and governance beyond data-rich regions; covering the entirety of hazardous chemicals and mixtures; following a One Health perspective considering risks to ecosystems, ecosystem services and human health; and striving for solution-oriented assessments based on systems thinking [29]. Such a body would need to conduct assessments that move beyond current approaches, which are limited in geographical coverage, the number of chemicals considered, the lack of consideration of ambient mixtures, the absence of science-based absolute pollution reduction targets, and insufficient systems thinking [29].

The One Health paradigm provides an essential framework for addressing the complex interconnections between environmental contamination, animal health, and human well-being. The escalating crisis of chemical pollution severely threatens these interconnected health domains globally, necessitating integrated approaches that recognize the inextricable links between healthy ecosystems, healthy animals, and healthy people [28]. The concept acknowledges that the health of humans, animals, their behavior, and their environment are all closely interlinked, echoing the ancient wisdom of a "healthy mind in a healthy body" extended to the planetary scale [28].

Future directions for One Health research and implementation must prioritize the development of novel assessment frameworks that can accommodate the complexity of chemical mixtures and their impacts across multiple biological levels and species boundaries. The integration of green chemistry principles into chemical design and production processes represents a critical opportunity for pollution prevention at its source [4]. Similarly, the application of advanced monitoring technologies, including sensor networks, remote sensing, and citizen science approaches, can help address critical data gaps, particularly in resource-limited settings [29].

The implementation of the United Nations Sustainable Development Goals provides a crucial platform for advancing One Health approaches globally, with specific targets related to health and wellbeing, clean water and sanitation, climate action, and sustainability in marine and terrestrial ecosystems [28]. Achieving these goals will require unprecedented levels of interdisciplinary collaboration and international cooperation, bringing together expertise from medicine, veterinary science, environmental science, public health, social sciences, and many other disciplines [28]. Only through such integrated approaches can we hope to address the complex challenges posed by chemical pollution and safeguard the health of people, animals, and ecosystems for future generations.

Detection and Remediation: Advanced Analytical and Engineering Solutions for Micropollutant Management

Advanced Analytical Techniques for Micropollutant Monitoring and Risk Analysis

The pervasive presence of organic micropollutants (OMPs) in water resources represents a significant challenge to achieving Sustainable Development Goal (SDG) 6 (Clean Water and Sanitation). These substances, detected at concentrations from nanograms to micrograms per liter, pose documented risks to aquatic ecosystems and human health, including carcinogenicity and endocrine disruption [34]. This whitepaper delineates advanced analytical frameworks for OMP identification, quantification, and risk prioritization, underscoring the role of sophisticated instrumentation and predictive modeling in environmental chemistry. The discussion is situated within the imperative for integrated emission management and green chemistry principles to support sustainable water resource management [18].

Organic micropollutants encompass a broad spectrum of substances, including pharmaceuticals, personal care products, perfluorinated compounds (PFCs), pesticides, and industrial chemicals. Their complex molecular structures, environmental persistence, and occurrence at trace levels complicate monitoring and risk assessment efforts [34]. Conventional wastewater treatment often proves insufficient for their complete removal, leading to their introduction into aquatic environments through effluent discharge and the reuse of reclaimed water and sludge in agriculture [18] [35]. This continuous emission necessitates advanced analytical techniques capable of sensitive detection, confident identification, and accurate quantification to underpin effective risk management and policy development aligned with the SDGs [20] [36].

Advanced Analytical Techniques for Detection and Quantification

The complexity of environmental matrices and the trace nature of OMPs demand sophisticated analytical workflows. These methodologies progress from targeted analysis of specific compounds to comprehensive suspect and non-target screening (SNTS) for identifying unknown contaminants.

Sample Preparation and Separation Techniques

Efficient extraction and clean-up are critical for reliable OMP analysis. Recent advancements emphasize green analytical chemistry principles, such as the development of methods based on hydrophobic natural deep eutectic solvents (NADES). For instance, a formulation of thymol and menthol (4:1 molar ratio) has been successfully employed in dispersive liquid-liquid microextraction (DLLME) for compounds including benzotriazoles and UV filters, demonstrating recoveries of 82–108% in wastewater [36]. Alongside novel extraction protocols, advanced separation techniques like high-performance liquid chromatography (HPLC) coupled with high-resolution mass spectrometry (HRMS) form the backbone of OMP analysis, providing the necessary resolution for complex samples [36].

High-Resolution Mass Spectrometry and Ion Mobility Spectrometry

High-resolution mass spectrometry (HRMS) is indispensable for modern OMP analysis. Techniques such as Orbitrap and time-of-flight (TOF) mass analyzers provide accurate mass measurements, enabling the determination of elemental composition and the identification of previously unknown compounds and their transformation products (TPs) [36]. Liquid chromatography coupled to HRMS (LC-HRMS) is widely applied in wide-scope target screening and SNTS strategies. Ion mobility spectrometry (IMS), often coupled with HRMS (LC-IMS-HRMS), adds a further dimension of separation based on the ion's size, shape, and charge, which helps distinguish isobaric compounds and isobaric interferences and provides collision cross-section (CCS) values as a stable identifier for confident annotation [36].

The following workflow diagram illustrates a comprehensive analytical process for micropollutant monitoring, from sample preparation to data analysis and risk assessment.

Quantitative Data on Micropollutant Occurrence

Large-scale monitoring is essential to understand the scope of OMP contamination. A recent systematic review of reclaimed water in China, covering 24 provincial regions and 4 municipalities, detected 369 distinct OMPs from 11 chemical classes. The table below summarizes the key findings from this study, which utilized advanced analytical techniques like LC-HRMS for compound identification and quantification [34].

Table 1: Priority Organic Micropollutants in Reclaimed Water in China: A Summary of Key Monitoring Data [34]

Pollutant Category	Number of Candidate OMPs	Exemplary High-Priority Compounds	Maximum Concentrations	Primary Risks Identified
PAHs & PCBs	Not Specified	PCB 126, Benzo[a]Pyrene (BaP)	High	Significant ecological risk; high toxicity and carcinogenicity
Pesticides	171 (Medium Priority)	Various	Varies	Dominated medium-priority group
Perfluorinated Compounds (PFCs)	Not Specified	PFOA	High	High potential health risks, strong persistence and bioaccumulation
Other Industrial Chemicals	Not Specified	Various	High	Posed significant threats

The same study employed a multi-criteria investigation scoring method based on 12 indicators—including detection frequency, biodegradability, bioaccumulation, acute/chronic toxicity, carcinogenicity, and endocrine disruption potential—to classify the 369 detected compounds. This analysis identified 29 OMPs as high-priority, 171 as medium-priority, and 125 as low-priority substances, providing a targeted list for control efforts [34].

Experimental Protocols and Methodologies

Protocol for Suspect and Non-Target Screening (SNTS)

1. Sample Collection and Preparation: Collect water samples (e.g., wastewater influent/effluent) in pre-cleaned containers. Perform solid-phase extraction (SPE) using cartridges suitable for a broad polarity range (e.g., Oasis HLB). Alternatively, apply green techniques like NADES-DLLME [36]. 2. Instrumental Analysis: Analyze samples using LC-HRMS (e.g., Q-TOF or Orbitrap). Employ a chromatographic gradient capable of separating compounds of diverse polarities. Acquire data in both full-scan MS (for accurate mass) and data-dependent MS/MS modes (for fragmentation spectra) [36]. 3. Data Processing: For target screening, use an internal database of known compounds with exact masses, retention times, and fragmentation spectra for identification and quantification. For suspect screening, interrogate the accurate mass data against large digital databases (e.g., NORMAN) to generate a list of potential matches, which require confirmation with reference standards. For non-target screening, use software tools to mine the data for unknown features, derive molecular formulas, and interpret fragmentation spectra to propose structures de novo [36]. 4. Identification Confidence: Follow the confidence level scheme by Schymanski et al. (2014), where Level 1 is confirmed by reference standard, Level 2 is probable structure by library spectrum match, and Level 3 is tentative candidate(s) [37].

Protocol for Machine Learning Prediction of WWTP Removal

1. Data Compilation: Collate a dataset of micropollutant removal from full-scale conventional WWTPs with activated sludge and nitrifying-denitrifying steps. The target variable is median breakthrough, ( B = C{\text{Effluent}} / C{\text{Influent}} ) [37]. 2. Data Curation: Preprocess chemical structures (e.g., using Python libraries like RDKit). Apply curation criteria, such as excluding substances with breakthrough >120% or high sorption/volatility, to create a robust training set [37]. 3. Model Training: Use molecular substructure fingerprints (e.g., MACCS keys) as descriptors. Train a Random Forest model via nested cross-validation to capture non-linear relationships between chemical structure and breakthrough. The best-performing model used MACCS fingerprints and achieved more reliable predictions than established regulatory models (e.g., EPI Suite's STPWIN) [37]. 4. Model Application: The publicly available model (PEPPER) can predict breakthrough for over 14,000 commercial chemicals, aiding in alternatives assessment and safe-by-design chemical development [37].

The Scientist's Toolkit: Essential Research Reagents and Materials

Advanced OMP analysis requires a suite of specialized reagents, materials, and software. The following table details key components of the modern environmental chemist's toolkit.

Table 2: Research Reagent Solutions for Advanced Micropollutant Analysis

Tool/Reagent	Function/Application	Technical Specification & Purpose
Hydrophobic NADES	Green Sample Preparation	Thymol:Menthol (4:1 molar ratio); acts as an efficient, biodegradable extraction solvent in DLLME to isolate OMPs from water [36].
LC-HRMS System	Separation & Detection	Orbitrap or Q-TOF mass analyzer; provides high mass accuracy and resolution for identifying known/unknown compounds and TPs [36].
Ion Mobility Spectrometer	Additional Separation	Coupled with LC-HRMS (LC-IMS-HRMS); provides Collision Cross-Section (CCS) values as a stable identifier for confident compound annotation [36].
SPE Sorbents	Sample Clean-up & Pre-concentration	Oasis HLB or similar reversed-phase polymers; extract a wide range of OMPs from complex water matrices prior to analysis [36].
PEPPER Model	In-silico Prediction	A machine learning model (Random Forest) that predicts WWTP removal of chemicals directly from their molecular structure using MACCS fingerprints [37].

Integrated Risk Analysis and Prioritization Frameworks

Monitoring data alone is insufficient for management; it must be interpreted through a risk lens. A multi-criteria integrated scoring method effectively prioritizes OMPs by combining factors related to both exposure potential (e.g., detection frequency, concentration, environmental persistence, bioaccumulation) and hazard (e.g., acute/chronic toxicity, carcinogenicity, mutagenicity, endocrine disruption) [34]. This approach, which aligns with strategies in the EU Water Framework Directive, can highlight pollutants like PFCs that, despite low concentrations, are prioritized due to high persistence and bioaccumulation potential [34].

Engaging a broad range of stakeholders—from regulators and industry representatives to water associations—is critical for developing a holistic and accepted strategy, as demonstrated by Germany's multi-stakeholder dialogue for its Trace Substance Strategy [38]. This process led to the creation of a Committee for the Identification of Relevant Micropollutants and the use of roundtables to address emission reductions, moving beyond a purely technological focus to include input prevention [38].

The following diagram visualizes this multi-faceted strategy, which combines technological, preventive, and collaborative pillars to form a comprehensive management approach.

Addressing the global challenge of aquatic micropollutants requires a synergistic application of advanced analytical techniques, predictive computational models, and integrated risk assessment frameworks. The integration of tools such as LC-HRMS, IMS, and machine learning with green chemistry principles and multi-stakeholder governance provides a robust pathway for protecting water resources. This holistic approach is indispensable for achieving the targets of SDG 6, ensuring the safe reuse of reclaimed water, and fostering the development of safer chemicals and products in alignment with the tenets of sustainability and a circular economy.

The pervasive presence of organic micropollutants in global water resources represents a critical challenge for environmental chemistry and sustainable development implementation. These substances—including pharmaceuticals, personal care products, pesticides, and industrial chemicals—persist in aquatic environments at concentrations ranging from nanograms to micrograms per liter, posing significant risks to ecosystems and human health despite their trace levels [39]. Conventional wastewater treatment processes exhibit limited efficiency in removing many persistent compounds, with removal rates for pharmaceuticals like carbamazepine often below 10% [40]. This inadequacy has stimulated extensive research into advanced adsorption technologies that align with Sustainable Development Goal 6 (clean water and sanitation) through innovative material science and process engineering.

Among the various remediation strategies, adsorption technologies have emerged as particularly promising due to their operational simplicity, cost-effectiveness, and absence of harmful transformation by-products [40]. This technical guide comprehensively examines two pivotal approaches within this domain: the established application of granular activated carbon (GAC) and the emerging utilization of agricultural waste-derived adsorbents. By examining fundamental mechanisms, performance data, and implementation frameworks, this review provides researchers and environmental professionals with the technical foundation necessary to advance water treatment technologies in the context of increasingly constrained global water resources.

Granular Activated Carbon: Mechanisms and Advanced Modeling

Fundamental Adsorption Mechanisms

Granular activated carbon operates through multiple simultaneous mechanisms that facilitate the removal of diverse micropollutants from water matrices. The primary mechanism involves physical adsorption via van der Waals forces within the extensive porous structure of activated carbon, which typically exhibits specific surface areas ranging from 500 to 1500 m²/g [41]. Chemical adsorption occurs through specific interactions between contaminant molecules and surface functional groups, particularly evident in the removal of compounds with aromatic structures through π-π electron donor-acceptor interactions [42]. Additionally, electrostatic interactions play a crucial role for ionizable compounds, where the surface charge of the GAC (determined by its point of zero charge, pHₚ₂c) and the ionization state of the micropollutant (determined by its pKₐ) govern attraction or repulsion forces [40].

The efficiency of these mechanisms is influenced by several factors. For instance, the adsorption of ionizable pharmaceuticals like ibuprofen (pKₐ ≈ 4.9) is highly pH-dependent, existing primarily in its neutral form at pH < pKₐ and anionic form at pH > pKₐ, which significantly affects its electrostatic interaction with the adsorbent surface [40]. In contrast, the adsorption of non-ionizable compounds like carbamazepine (pKₐ ≈ 13.9) occurs primarily through non-electrostatic interactions such as hydrogen bonding and π-π interactions, with minimal pH dependence across environmentally relevant ranges [40].

Competitive Adsorption in Complex Matrices

In real wastewater scenarios, GAC filters rarely treat single contaminants but rather complex mixtures where competitive adsorption significantly impacts performance. Recent modeling approaches have successfully predicted competitive organic micropollutant adsorption in full-scale GAC filters using the ideal adsorbed solution theory in combination with the tracer model for competitive adsorption and the linear driving force model for surface diffusion [43]. These models have demonstrated accurate breakthrough curve predictions for OMPs whose removal is dominated by adsorption mechanisms (e.g., benzotriazole, carbamazepine), but they also reveal limitations for compounds like diclofenac, where implementation of biodegradation processes is essential for accurate prediction [43].

The presence of natural organic matter (NOM) in wastewater matrices creates significant competition for adsorption sites, potentially reducing micropollutant removal efficiency. However, studies using alternative adsorbents like granular zeolite filters have demonstrated that the effect of NOM on the adsorption of certain OMPs can be negligible, with less than 8% of dissolved organic carbon removed while achieving 70-100% removal for 8 of 10 target OMPs [44]. This highlights the importance of adsorbent selection based on water matrix composition.

Table 1: Performance of Granular Activated Carbon for Micropollutant Removal

Micropollutant	Adsorption Capacity (mg/g)	Key Removal Mechanisms	Factors Influencing Efficiency
Carbamazepine	6 (typical on commercial AC) [42]	π-π interactions, hydrogen bonding	Minimal pH dependence, high persistence
Bisphenol A	6 (typical on commercial AC) [42]	Hydrophobic interactions, π-π bonding	pH-dependent speciation, NOM competition
Rhodamine B	Varies with GAC type [41]	Electrostatic attraction, chemisorption	pH, initial concentration, GAC dose
Thiamphenicol	Varies with GAC type [41]	Chemisorption, surface complexation	pH, functional groups on GAC surface

Operational Considerations and Modeling Approaches

The practical implementation of GAC filtration systems involves several critical operational considerations. Empty bed contact time (EBCT) significantly influences removal efficiency, with shorter times potentially limiting diffusion into particle pores [43]. Filter backwashing has been shown to impact breakthrough curve behavior, with proper implementation significantly improving model predictions for full-scale GAC adsorbers [43]. Additionally, operation configuration plays a role, with serial GAC filter operation demonstrating greater efficiency compared to parallel filter operation [43].

Predictive modeling of micropollutant removal in fixed-bed adsorbers presents challenges in parameter estimation. Recent research has evaluated constant pattern models including: (1) irreversible isotherm with film and intraparticle diffusion, (2) irreversible isotherm with intraparticle diffusion only, and (3) Langmuir isotherm with intraparticle diffusion only [45]. For some systems, only models including both film and intraparticle diffusion resistances yielded quantitative agreement with experimental data, while in other cases, correlations underestimated intraparticle diffusion coefficients, requiring adjustment for accurate prediction [45].

Agricultural Waste-Derived Adsorbents: Sustainable Alternatives

Material Synthesis and Modification Techniques

Agricultural residues represent an abundant, renewable, and low-cost resource for adsorbent production, with global agricultural activity generating nearly 5 billion tons of waste annually [39]. The transformation of these wastes into efficient adsorbents typically involves thermal processing, with pyrolysis being the most common technique. Slow pyrolysis at temperatures of 300-400°C with heating rates of 5-7°C/min and prolonged residence times favors high biochar yields, while fast and flash pyrolysis prioritize bio-oil and gas production [39]. Emerging techniques like microwave-assisted pyrolysis (MAP) offer advantages through rapid, volumetric, and selective heating via direct electromagnetic radiation interaction [39].

Chemical modification techniques significantly enhance the adsorption performance of agricultural waste-derived materials. Iron and nitrogen co-doping has demonstrated remarkable improvements, with Fe/N-biochar exhibiting 10.8 times higher adsorption capacity than pristine biochar [42]. This enhancement is attributed to strengthened π-π electron donor-acceptor interactions between organics and the adsorbent, with graphitic N and Fe-Nₓ sites identified as primary adsorption centers [42]. Chemical activation using agents such as phosphoric acid (commonly used at weight ratios of 74.52% for olive fruit stones) creates developed porous structures with specific surface areas reaching up to 2500 m²/g in materials derived from coconut shells [39] [41].

Table 2: Agricultural Waste-Derived Adsorbents and Their Performance

Agricultural Waste Source	Modification Method	Target Micropollutant	Adsorption Capacity	Key Mechanisms
Sawdust	Fe/N co-doping	Bisphenol A	54 mg/g [42]	π-π EDA interactions, pore filling
Olive fruit stones	Chemical activation (H₃PO₄)	Rhodamine B, Thiamphenicol	Varies with conditions [41]	Chemisorption, electrostatic attraction
Sugarcane bagasse	Pyrolysis & activation	Pharmaceuticals	Varies with compound [39]	Hydrophobic interactions, hydrogen bonding
Rice husks	Thermal conversion	Various OMPs	Varies with compound [39]	π-π interactions, ion exchange

Adsorption Mechanisms and Performance

Agricultural waste-derived adsorbents remove micropollutants through multiple mechanisms that depend on both adsorbent properties and contaminant characteristics. The lignocellulosic composition of these materials—typically containing 35-50% cellulose, 20-35% hemicellulose, and 15-30% lignin—provides a complex matrix rich in functional groups (-OH, -COOH, -OCH₃) that enable diverse interactions with emerging contaminants [39]. The aromatic structure of lignin particularly favors π-π interactions with pharmaceutical compounds containing aromatic rings [39].

Research demonstrates that Fe/N-biochar exhibits enhanced adsorption performance for multiple common micropollutants including phenol, acetaminophen, sulfamethoxazole, ibuprofen, carbamazepine, tetracycline, naproxen, and ciprofloxacin [42]. Adsorption kinetics and isotherm studies typically show that micropollutant adsorption onto modified biochars follows pseudo-second-order kinetics, suggesting chemisorption as the rate-limiting step, with monolayer coverage observed according to Langmuir isotherm models [42] [41]. Thermodynamic studies further indicate that these adsorption processes are typically feasible and spontaneous [42].

Regeneration and Lifecycle Considerations

A critical advantage of adsorption technologies utilizing agricultural waste is the potential for adsorbent regeneration and reuse. Thermal regeneration through simple heat treatment can effectively restore the adsorption capacity of spent Fe/N-biochar that has reached adsorption equilibrium [42]. For GAC derived from agricultural sources, regeneration tests have demonstrated effectiveness over multiple cycles, with efficiencies of 62.39% for Rhodamine B and 59.6% for thiamphenicol maintained after three regeneration cycles [41].

Alternative regeneration methods include in-situ oxidative regeneration, as demonstrated in zeolite systems regenerated with gaseous ozone, allowing effective removal of 70-100% for 8 of 10 OMPs across multiple cycles [44]. This approach reduced ozone consumption by approximately 70% through optimization of pre-backwash duration from 30 minutes to 1 hour [44]. The sustainable lifecycle management of these adsorbents aligns with circular economy principles within SDG implementation frameworks, though challenges remain in managing spent adsorbents to fully close the lifecycle loop [40].

Experimental Methodologies and Protocols

Preparation of Optimized Granular Activated Carbon from Olive Fruit Stones

The production of optimized granular activated carbon (OGAC) from olive fruit stones follows a systematic protocol based on response surface methodology optimization [41]:

• Precursor Preparation: Clean and dry olive fruit stones, then grind to particle sizes of 0.5-2 mm.
• Chemical Activation: Prepare a 74.52% phosphoric acid (H₃PO₄) solution and mix with the precursor at a solid-liquid ratio of 1:2.
• Impregnation: Allow the mixture to stand for 24 hours to ensure complete impregnation.
• Carbonization: Transfer the impregnated material to a furnace and heat to 550°C at a heating rate of 10°C/min under inert atmosphere.
• Activation: Maintain the activation temperature of 550°C for 120 minutes.
• Washing and Drying: Thoroughly wash the activated material with distilled water until neutral pH is achieved, then dry at 105°C for 24 hours.

This optimized protocol produces OGAC with enhanced porosity and surface area specifically tailored for micropollutant removal.

Synthesis of Iron and Nitrogen Co-Doped Biochar (Fe/N-Biochar)

The preparation of Fe/N-biochar involves a simple pyrolysis method [42]:

• Precursor Preparation: Mix sawdust (or other agricultural residue) with iron precursor (FeCl₃·6H₂O) and nitrogen precursor (dicyandiamide, C₂H₄N₄).
• Homogenization: Stir the mixture thoroughly to ensure uniform distribution of iron and nitrogen precursors.
• Pyrolysis: Heat the mixture to 700°C under nitrogen atmosphere with a residence time of 2 hours.
• Cooling and Collection: Allow the material to cool naturally under inert atmosphere, then collect the resulting Fe/N-biochar.
• Post-Treatment: Wash the biochar with deionized water and ethanol to remove residual chemicals, then dry at 80°C for 12 hours.

The resulting material exhibits significantly enhanced adsorption capacity compared to pristine biochar, with maximum adsorption capacity for BPA of 54 mg/g, outperforming commercial graphene (19 mg/g) and activated carbon (6 mg/g) [42].

Encapsulation of Thermo-Plasma Expanded Graphite for Fixed-Bed Applications

The encapsulation of thermo-plasma expanded graphite (TPEG) in calcium alginate creates granular forms suitable for fixed-bed applications [46]:

• Alginate Solution Preparation: Dissolve 20 g of sodium alginate in 1 L of distilled water with stirring until a homogeneous gelatinous solution forms.
• TPEG Incorporation: Add TPEG (2.5-10% by total weight of sodium alginate) to the solution and stir for 24 hours to achieve homogeneous distribution.
• Cross-Linking: Transfer the solution to a separating funnel and drip into 1 L of 2% CaCl₂ solution under gentle stirring.
• Sphere Formation: Calcium ions cross-link alginate chains, forming insoluble spheres encapsulating TPEG.
• Recovery and Drying: Recover spheres by filtration and dry at 105°C for 24 hours.

This encapsulation method enables the use of light-weight exfoliated materials in fixed-bed configurations, with optimal performance observed at 5% TPEG incorporation [46].

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 3: Essential Research Reagents and Materials for Adsorption Studies

Reagent/Material	Specifications	Application Purpose	Key Considerations
Granular Activated Carbon	Derived from olive fruit stones, H₃PO₄ activation, 550°C [41]	Reference adsorbent for performance comparison	Surface chemistry, pore size distribution
Iron/Nitrogen Co-Doped Biochar	Sawdust precursor, FeCl₃·6H₂O and dicyandiamide doping, 700°C pyrolysis [42]	High-performance alternative to conventional AC	Fe/N ratio optimization, surface functionality
Sodium Alginate	High viscosity, pharmaceutical grade [46]	Encapsulation matrix for powder adsorbents	Viscosity control, cross-linking efficiency
Calcium Chloride	Anhydrous, ≥96% purity [46]	Cross-linking agent for alginate encapsulation	Solution concentration, contact time
Model Micropollutants	Carbamazepine, Bisphenol A, Sulfamethoxazole, etc. (purity >98%) [42] [46]	System performance evaluation	Stability in solution, analytical detection
Phosphoric Acid	85% purity, analytical grade [41]	Chemical activation of biomass	Concentration optimization, safety handling

Adsorption technologies utilizing granular activated carbon and agricultural waste-derived materials represent scientifically sound and implementation-ready approaches that directly support Sustainable Development Goal 6, which aims to ensure availability and sustainable management of water and sanitation for all. The integration of these technologies into water treatment infrastructure addresses the critical challenge of micropollutant removal while aligning with circular economy principles through the valorization of agricultural waste streams. Current research demonstrates that optimized GAC systems can effectively remove a broad spectrum of OMPs, with advanced modeling approaches enabling predictive performance evaluation under realistic conditions [43]. Simultaneously, modified agricultural waste-derived adsorbents offer sustainable alternatives with enhanced adsorption capacities, in some cases significantly outperforming conventional activated carbons for specific micropollutants [42].

Future development in this field should focus on several key areas: (1) enhancing the selectivity of adsorbents for target micropollutant groups through advanced functionalization strategies; (2) improving regeneration techniques to extend adsorbent lifespan and reduce operational costs; (3) developing accurate predictive models that incorporate competitive adsorption in complex wastewater matrices; and (4) scaling up production of optimized agricultural waste-derived adsorbents to enable widespread implementation. By addressing these priorities, adsorption technologies can play an increasingly vital role in achieving SDG targets while advancing the environmental chemistry of micropollutant remediation through scientifically rigorous and practically applicable solutions.

The pervasive contamination of water resources by micropollutants—a category encompassing heavy metals, pharmaceuticals, personal care products, pesticides, and industrial chemicals—represents a critical environmental and public health challenge on a global scale. These substances, often present at trace concentrations (ng/L to µg/L), evade conventional water treatment processes and pose significant risks due to their persistence, bioaccumulation potential, and toxicity [47]. Addressing this complex issue is imperative for achieving several United Nations Sustainable Development Goals (SDGs), particularly SDG 6 (Clean Water and Sanitation), SDG 3 (Good Health and Well-being), and SDG 14 (Life Below Water) [48] [49]. In this context, nanotechnology offers groundbreaking solutions, with magnetic nanoparticles (MNPs) emerging as a particularly advanced and versatile platform for environmental remediation.

MNPs, typically ranging from 1 to 100 nanometers in diameter, possess unique magnetic properties that differ dramatically from their bulk counterparts, a phenomenon known as "nanomagnetism" [50]. Iron-based MNPs, such as magnetite (Fe₃O₄) and maghemite (γ-Fe₂O₃), are especially favored for environmental applications due to their superparamagnetism, high surface-area-to-volume ratio, and the ability to be functionalized with various chemical groups [50] [51]. Their defining characteristic is the ability to be rapidly separated from treated water using an external magnetic field, overcoming a major limitation of other nanoscale adsorbents and catalysts, which are difficult to recover and can cause secondary pollution [47] [52]. This review details the latest breakthroughs in MNP technology, framing their development and application within the broader context of sustainable chemistry and SDG implementation.

Synthesis and Functionalization of Magnetic Nanoparticles

The efficacy of MNPs in micropollutant removal is fundamentally governed by their synthesis and functionalization, which dictate their size, morphology, stability, and surface chemistry.

Primary Synthesis Methods

A variety of physical, chemical, and biological methods are employed to synthesize MNPs with precise characteristics [51].

• Co-precipitation: This is the most common and straightforward chemical method, involving the simultaneous precipitation of Fe²⁺ and Fe³⁺ ions from an aqueous salt solution by adding a base. It is favored for its simplicity, low cost, and the production of nanoparticles in large quantities. The method allows for good control over size through parameters like pH, ionic strength, and temperature [51] [53]. A typical protocol involves dissolving ferrous and ferric chlorides in a 1:2 molar ratio in degassed water under a nitrogen atmosphere, followed by the dropwise addition of ammonium hydroxide to precipitate black magnetite nanoparticles [53].
• Thermal Decomposition: This method involves the high-temperature decomposition of organometallic precursors in high-boiling-point organic solvents. It produces MNPs with high crystallinity, excellent monodispersity, and well-defined shapes, making it ideal for applications requiring precise size control. However, the process is complex, energy-intensive, and often yields hydrophobic nanoparticles that require subsequent phase transfer for water treatment applications [51].
• Hydrothermal Synthesis: This process involves conducting reactions in a sealed vessel at elevated temperature and pressure. It offers milder reaction conditions compared to thermal decomposition and enables good control over particle size and crystallinity. While it avoids the need for strong chemicals, it can be sensitive to process parameters and often requires long reaction times [52].
• Green Synthesis: Aligning with the principles of green chemistry and SDG 12, there is a growing emphasis on using biological extracts (from plants, fungi, or bacteria) or biodegradable agents as reducing and stabilizing agents during synthesis. This approach minimizes the use of hazardous chemicals and reduces environmental impact [49].

Critical Functionalization Strategies

The native surface of MNPs often requires functionalization to enhance stability, prevent agglomeration, and introduce specific affinity for target micropollutants.

• Coating with Organic Polymers: Polymers like chitosan, polyethyleneimine, and alginate can be coated on MNP surfaces. These provide abundant functional groups (e.g., amine, hydroxyl) that act as binding sites for heavy metal ions and organic dyes through complexation and electrostatic interactions [47] [52].
• Inorganic Coatings: Silica (SiO₂) coating provides a robust, inert layer that improves chemical stability and prevents oxidation of the magnetic core. It also facilitates further functionalization with silane-coupling agents [50] [54].
• Carbon-Based Hybrids: Composites with graphene oxide, carbon nanotubes, or biochar combine the high adsorption capacity and π-π interaction capabilities of carbon materials with the magnetic separability of MNPs. For instance, magnetic graphene oxide composites are highly effective for adsorbing pharmaceutical residues and dyes [52] [53].
• Surface Modification with Specific Ligands: Ligands such as thiols (-SH) for heavy metals like Hg²⁺ and Pb²⁺, or antibodies for specific biological micropollutants, can be grafted onto MNPs to create highly selective capture platforms [47].

Table 1: Common Synthesis Methods for Magnetic Nanoparticles

Method	Principle	Key Advantages	Key Limitations
Co-precipitation [51] [53]	Precipitation of Fe²⁺/Fe³⁺ salts with a base	Simple, fast, cost-effective, scalable, aqueous-based	Broad size distribution, control of shape is difficult
Thermal Decomposition [51]	High-temp decomposition of organometallic precursors	Excellent size & shape control, high crystallinity, monodisperse	Complex procedure, high cost, organic solvents, hydrophobic NPs
Hydrothermal [52]	Reaction in aqueous solution at high T and P	Good crystallinity, control over morphology	Long reaction times, sensitive to parameters
Green Synthesis [49]	Use of biological extracts as reducing agents	Eco-friendly, sustainable, biocompatible	Standardization challenges, batch-to-batch variability

Mechanisms of Micropollutant Removal

MNPs remove micropollutants through multiple synergistic mechanisms, which can be categorized into adsorption and catalytic degradation.

Adsorption and Surface Complexation

This is the primary mechanism for the removal of heavy metals and inert organic compounds. The high surface area of MNPs provides numerous active sites. Functional groups on the MNP surface (e.g., -OH, -COOH, -NH₂) form strong complexes with metal ions. For organic micropollutants like dyes or antibiotics, interactions such as π-π stacking (on graphene-based composites), electrostatic attraction, and hydrogen bonding are dominant [47] [52]. The magnetic component enables subsequent recovery of the pollutant-laden adsorbent via a magnetic field [52].

Catalytic Degradation

For biodegradable organic micropollutants, MNPs can act as catalysts in Advanced Oxidation Processes (AOPs). In Fenton-like reactions, MNPs catalyze hydrogen peroxide (H₂O₂) or peroxymonosulfate (PMS) to generate highly reactive oxygen species (ROS), such as hydroxyl radicals (•OH) and sulfate radicals (SO₄•⁻). These radicals non-selectively oxidize and mineralize organic pollutants into less harmful end products like CO₂ and H₂O [47]. This adsorption-degradation synergy positions MNPs as versatile platforms beyond mere phase transfer agents [47].

Performance Metrics and Quantitative Data

The performance of various MNP composites has been extensively documented in the removal of diverse micropollutants. The following tables summarize key quantitative data from recent research.

Table 2: Performance of MNP Composites in Heavy Metal Removal

Magnetic Composite	Target Heavy Metal	Experimental Conditions	Adsorption Capacity	Removal Efficiency	Primary Mechanism
Chitosan-coated MNPs [47]	Cu(II)	Not Specified	149.25 mg/g	Not Specified	Surface complexation
Amino-functionalized CoFe₂O₄ Chitosan Beads (NH₂-CF-CB) [47]	Cu(II)	Not Specified	158.73 mg/g	Not Specified	Surface complexation
MnFe₂O₄–biochar composite [47]	Sb(III), Cd(II)	Aqueous solution	Not Specified	>90% (Sb), >85% (Cd)	Adsorption
Magnetic hemicellulose microspheres [47]	Cu(II)	Not Specified	Not Specified	Not Specified	Adsorption

Table 3: Performance of MNP Composites in Organic Micropollutant Removal

Magnetic Composite	Target Organic Pollutant	Experimental Conditions	Performance Metric	Primary Mechanism
Amino-functionalized CoFe₂O₄ Chitosan Beads (NH₂-CF-CB) [47]	Malachite Green (dye)	Not Specified	357.16 mg/g	Adsorption
Multifunctional Magnetic Biochar (MMBC-400) [47]	Malachite Green (dye)	With Peroxydisulfate	>85% degradation	Adsorption + Catalytic Degradation (ROS)
Magnetic Graphene Oxide with laccase [53]	Various dyes (e.g., Remazol Brilliant Blue R)	Enzyme-based nanobiocatalysis	High degradation, enhanced reusability	Enzymatic Degradation
Magnetic Carbon Nanotubes [52]	Dyes, Antibiotics	Not Specified	High adsorption capacity	Adsorption (π-π stacking)

Experimental Protocol: Synthesis and Application for Dye Removal

The following provides a detailed, step-by-step protocol for synthesizing magnetic graphene oxide (MGO) and applying it in the enzymatic degradation of organic dyes, representing a common nanobiocatalysis approach [53].

Synthesis of Magnetic Graphene Oxide (MGO) via Co-precipitation

Principle: Iron oxide nanoparticles (Fe₃O₄) are precipitated onto the surface of graphene oxide (GO) in an aqueous medium. The oxygen-containing functional groups on GO serve as nucleation sites, ensuring a uniform coating.

Materials:

• Graphene Oxide (GO) suspension: 5 mg/mL in deionized water.
• Iron Precursors: FeCl₃·6H₂O (Ferric Chloride Hexahydrate) and FeCl₂·4H₂O (Ferrous Chloride Tetrahydrate).
• Precipitating Agent: 25% Tetramethylammonium Hydroxide (TMAH) solution.
• Solvent: Deionized water, degassed with nitrogen for 30 minutes.
• Equipment: Three-neck round-bottom flask, mechanical stirrer, heating mantle with temperature control, nitrogen gas supply, magnetic separator, vacuum oven.

Procedure:

• Solution Preparation: In a three-neck flask, dissolve FeCl₃·6H₂O and FeCl₂·4H₂O in a 2:1 molar ratio in 100 mL of degassed water under vigorous stirring.
• GO Addition: Add 40 mL of the GO suspension (5 mg/mL) to the iron solution. Maintain a continuous nitrogen purge throughout the reaction to prevent oxidation of Fe²⁺.
• Heating: Heat the mixture to 80–85 °C with constant stirring.
• Precipitation: Using a dropping funnel, add 30 mL of the 25% TMAH solution dropwise to the reaction mixture over 15-20 minutes. Observe the formation of a black precipitate.
• Reaction Completion: Continue the reaction at 80–85 °C for 45–60 minutes.
• Sepection and Washing: Separate the black MGO composite using a strong neodymium magnet. Decant the supernatant. Re-disperse the particles in Milli-Q water and separate magnetically. Repeat this washing process three times.
• Drying: For long-term storage, transfer the wet MGO paste to a vacuum oven and dry at 45 °C for 12 hours to obtain a dry powder.

Enzyme Immobilization and Dye Degradation Experiment

Principle: The enzyme laccase is immobilized onto the MGO surface via physical adsorption or covalent binding, creating a magnetically recoverable nanobiocatalyst.

Materials:

• MGO composite (from step 5.1)
• Laccase enzyme from Trametes versicolor
• Dye Solution: Remazol Brilliant Blue R (50 mg/L in 0.1 M acetate buffer, pH 5.0)
• Binding Agent: (3-Aminopropyl)triethoxysilane (APTES) for covalent binding (optional)
• Equipment: Orbital shaker, spectrophotometer, magnets, acetate buffer.

Procedure:

• Immobilization (Physical Adsorption): Disperse 50 mg of MGO in 10 mL of acetate buffer (0.1 M, pH 5.0). Add 5 mg of laccase enzyme. Incubate the mixture on an orbital shaker at 4°C for 4-6 hours to allow the enzyme to bind to the MGO surface.
• Separation of Nanobiocatalyst: Recover the laccase-loaded MGO (MGO-Lac) using a magnet and wash the buffer twice to remove any unbound enzyme.
• Dye Degradation Assay:
  • Add the MGO-Lac nanobiocatalyst to 50 mL of the dye solution (50 mg/L).
  • Incubate at 30°C with continuous shaking (150 rpm).
  • At regular time intervals (e.g., 0, 15, 30, 60, 120 min), withdraw 3 mL aliquots.
  • Immediately separate the catalyst from the aliquot using a small magnet.
  • Measure the absorbance of the clear supernatant at 592 nm (λmax for Remazol Brilliant Blue R) using a spectrophotometer.
• Reusability Test: After the degradation cycle, recover the MGO-Lac magnetically, wash with acetate buffer, and reintroduce it into a fresh dye solution. Repeat the degradation assay for 4-5 cycles to assess catalyst stability and reusability.

The Scientist's Toolkit: Essential Research Reagents and Materials

The development and application of MNP-based remediation technologies rely on a suite of specialized reagents and materials.

Table 4: Essential Research Reagents for MNP Synthesis and Application

Reagent/Material	Function/Application	Key Characteristics
Ferric Chloride (FeCl₃·6H₂O) & Ferrous Chloride (FeCl₂·4H₂O) [53]	Iron precursors for co-precipitation synthesis of magnetite (Fe₃O₄) NPs.	High purity, oxygen-sensitive (especially Fe²⁺), typically used in a 2:1 Fe³⁺/Fe²⁺ molar ratio.
Ammonium Hydroxide (NH₄OH) / Tetramethylammonium Hydroxide (TMAH) [53]	Precipitating agent in co-precipitation synthesis. Provides OH⁻ ions to form iron oxides.	TMAH offers a metal-free alternative and can act as a surfactant.
Graphene Oxide (GO) [52] [53]	Carbon-based carrier to create high-surface-area composites. Enhances adsorption via π-π stacking.	Abundant oxygen-containing functional groups (-COOH, -OH) for binding NPs and pollutants.
Chitosan [47] [52]	Natural polymer coating for MNPs. Provides amino and hydroxyl groups for metal ion chelation.	Biodegradable, biocompatible, low cost, excellent film-forming ability.
(3-Aminopropyl)triethoxysilane (APTES) [53]	Silane-coupling agent for surface functionalization. Introduces primary amine (-NH₂) groups.	Enables covalent immobilization of enzymes and other biomolecules.
Laccase & Peroxidase Enzymes [53]	Oxidoreductases for nanobiocatalysis. Degrade phenolic and non-phenolic organic pollutants.	High specificity, operate under mild conditions, eco-friendly degradation pathway.
Hydrogen Peroxide (H₂O₂) & Peroxymonosulfate (PMS) [47]	Oxidants used in MNP-catalyzed Advanced Oxidation Processes (AOPs).	Source of reactive oxygen species (ROS) for the degradation of refractory organics.

Challenges, Environmental Considerations, and Future Outlook

Despite the significant promise of MNPs, their translation from laboratory innovation to widespread field-scale application faces several technical and environmental hurdles.

• Technical Challenges: Key issues include particle agglomeration and oxidative instability, which reduce reactivity over time. In complex, real-world matrices with multiple pollutants, MNPs can suffer from reduced efficacy and poor selectivity. Furthermore, scaling up synthesis while maintaining quality and functionality remains difficult [47] [54].
• Environmental and Toxicity Concerns: The full life cycle assessment of MNPs—from raw material extraction and energy-intensive synthesis to end-of-life disposal—reveals potential environmental impacts [50] [49]. Major uncertainties persist regarding the long-term fate, transport, and biocompatibility of MNPs in ecosystems, as well as their potential toxicity to human health and other biological systems [50] [55] [47].
• Economic and Commercial Barriers: The global MNP market, while growing at a CAGR of 10.4%, was valued at only US$74.2 million in 2022, indicating that commercial adoption is still in its early stages [50]. High production costs, concerns about reusability under harsh conditions, and the functionality of recovered MNPs present significant market hurdles [50].

Future progress depends on interdisciplinary collaboration focused on the rational design of stable, selective, and "intelligent" MNPs through advanced surface engineering. Research must prioritize green synthesis routes that use sustainable precursors and minimize energy consumption [52] [49]. A core objective for aligning with the SDGs must be to enhance the recovery and recyclability of MNPs to create closed-loop systems that minimize waste and secondary pollution [50] [49]. By integrating these considerations, magnetic nanotechnology can fully mature into a sustainable and powerful tool for ensuring water security and fulfilling the promise of the Sustainable Development Goals.

Machine Learning and QSAR Models for Predicting Micropollutant Removal in Wastewater Treatment

The pervasive presence of micropollutants in aquatic environments represents a significant challenge to achieving Sustainable Development Goal 6 (SDG 6), which aims to ensure availability and sustainable management of water and sanitation for all. Micropollutants—including pharmaceuticals, personal care products, pesticides, and industrial chemicals—persist in water sources at trace concentrations (ng/L to μg/L) and pose potential risks to aquatic ecosystems and human health despite conventional wastewater treatment processes [56]. The experimental determination of removal efficiency for each compound across diverse treatment technologies is prohibitively time-consuming and costly, creating a critical need for robust predictive modeling approaches [57].

Computational methods, particularly Quantitative Structure-Activity Relationship (QSAR) models and machine learning (ML) algorithms, have emerged as powerful tools for predicting the fate and removal of micropollutants in wastewater treatment systems. These approaches leverage molecular descriptors and operational parameters to establish complex relationships between chemical structure, treatment process conditions, and removal efficiency [58]. By providing accurate predictions for diverse compounds under varying conditions, these models enable researchers and engineers to optimize treatment strategies, prioritize contaminants of concern, and support the design of advanced treatment systems for water reuse applications—all essential components for addressing global water sustainability challenges.

Machine Learning Approaches for Membrane Process Optimization

Predictive Modeling for Forward and Reverse Osmosis

Membrane processes, particularly forward osmosis (FO) and reverse osmosis (RO), play a crucial role in advanced wastewater treatment for micropollutant removal. Recent research has established sophisticated machine learning models that accurately predict solute rejection by incorporating both conventional parameters and advanced molecular descriptors [57].

Table 1: Performance Comparison of Machine Learning Models for Membrane Processes

Model Type	Best-Performing Algorithm	R² Value	Key Predictive Variables	Interpretation Method
Forward Osmosis (FO)	Random Forest	0.85	Molecular length, water flux, hydrophobicity	SHAP analysis
Reverse Osmosis (RO)	Extreme Gradient Boosting (XGBoost)	0.92	Operating pressure, molecular length, ATSC2m descriptor, Balaban J, C=C double bond, carbonyl group	SHAP analysis
General Micropollutant Removal	Support Vector Machine (SVM)	79.1% accuracy	Abraham descriptors, log Kow	Cluster-then-predict approach

The integration of advanced variables such as molecular descriptors (MDs) and Morgan fingerprints (FPs) has significantly enhanced model performance, particularly for RO processes. These descriptors provide molecular-level information that concretizes rejection mechanisms by identifying specific functional groups relevant to each removal pathway [57]. For FO processes, more conventional parameters including molecular length, water flux, and hydrophobicity emerge as the most influential variables, reflecting the dominant role of size exclusion and hydrophobic interactions [57].

Experimental Protocol for Membrane Filtration Modeling

The development of robust ML models for membrane processes follows a systematic methodology:

• Data Collection and Curation: Rejection rates of organic pollutants are acquired from peer-reviewed literature (typically 22+ articles for FO and 32+ articles for RO). Only RO-specific data is included, as combining NF and RO data introduces bias by altering the ranking of input variables in feature importance analyses [57].

• Input Variable Selection: Four combinations of input variables are investigated: (1) physicochemical properties (PPs) + membrane characteristics and operating conditions (MOC), (2) PPs + MOC + fingerprints (FPs), (3) PPs + MOC + molecular descriptors (MDs), and (4) all variables combined [57].

• Model Training and Validation: Fourteen different ML algorithms are trained and evaluated using their default hyperparameters on the same training and testing datasets. The models are assessed based on their R² values and predictive accuracy [57].

• Mechanistic Interpretation: SHAP (Shapley Additive Explanations) analysis is applied to the best-performing models to identify the relative contribution of each input variable and provide insights into the underlying rejection mechanisms [57].

The resulting models offer a robust framework applicable to both scientific investigations for advancing mechanistic understanding and real-engineering scenarios to facilitate the design and optimization of FO and RO processes, enabling determination of optimal operational conditions with consideration of both pollutant rejection and energy consumption [57].

Membrane ML Workflow Diagram: This workflow illustrates the systematic approach for developing machine learning models to predict micropollutant removal in membrane processes, from data collection through model interpretation.

QSAR Modeling for Adsorption and Oxidation Processes

Predictive Frameworks for Adsorption Mechanisms

QSAR models have demonstrated particular utility in predicting the adsorption behavior of micropollutants onto various media, including ion-exchange resins. Recent research has established combined experimental-computational QSAR frameworks that explicitly incorporate concentration-dependent descriptors, significantly improving predictive accuracy [59].

Table 2: QSAR Model Performance for Anionic Micropollutant Adsorption

Model Characteristics	LFER-Based Model	COSMOtherm-Based Model
Training R²	> 0.93	> 0.93
External Validation R²	0.938	0.953
Standard Error (log units)	0.193	0.150
Key Descriptors	LFER parameters, log α	COSMOtherm descriptors, log α
Mechanistic Insights	Clear interpretability of molecular interactions	Effective capture of electronic and solvation effects

The incorporation of the activity degree of the ion (log α) as a concentration-dependent descriptor substantially improved model accuracy in both linear free energy relationship (LFER) and COSMOtherm-based approaches, reflecting the critical role of ionic strength and activity effects in adsorption processes [59]. Analysis of LFER descriptor contributions revealed that excess molar refractivity exerted a negative influence on adsorption, while polar interaction and hydrogen-bond basicity terms showed positive coefficients, indicating these interactions enhance adsorption affinity [59].

Oxidation Process Prediction Using Molecular Descriptors

For advanced oxidation processes (AOPs), QSAR models have been developed to predict the degradation kinetics of micropollutants based on their molecular characteristics. Studies focusing on phenolic compounds with different substituents have established multiple linear regression (MLR) equations demonstrating that degradation is significantly influenced by electronic, hydrophobic, topological, and steric properties [58].

These QSPR/QSAR models undergo strict internal and external statistical validation procedures and are trained to accurately predict experimental degradation rate constants in test sets, providing valuable tools for optimizing AOP systems without extensive experimental testing [58]. The models facilitate the identification of structural features that enhance or hinder degradation, guiding the selection of appropriate oxidation conditions for specific micropollutant classes.

Experimental Protocol for QSAR Model Development

The development of validated QSAR models for adsorption and oxidation processes follows a rigorous methodology:

• Experimental Data Generation: Systematic measurement of adsorption isotherms or degradation kinetics for a diverse set of compounds (e.g., 26 anionic compounds for adsorption studies) at multiple initial concentrations to create a robust dataset [59].

• Descriptor Calculation and Selection: Computation of molecular descriptors using specialized software. Two complementary descriptor sets are typically employed: (i) empirically derived LFER parameters and (ii) in silico-calculated COSMOtherm descriptors [59].

• Model Training: Development of regression models using appropriate algorithms (e.g., multiple linear regression for QSPR models) with careful attention to descriptor selection to avoid overfitting [58].

• Model Validation: Implementation of strict internal and external validation procedures, including training on a subset of compounds and testing on hold-out compounds to verify predictive accuracy [58] [59].

• Mechanistic Interpretation: Analysis of descriptor coefficients and contributions to extract meaningful insights about the underlying removal mechanisms and structure-activity relationships [59].

This approach establishes versatile frameworks for predictive evaluation of micropollutant removal, providing mechanistic insights and supporting preliminary assessment of treatment effectiveness for structurally novel or data-scarce pollutants [59].

Hybrid and Advanced Modeling Approaches

Treatment Train Prediction Frameworks

Beyond individual treatment processes, machine learning frameworks have been developed to predict micropollutant removal through entire wastewater and water reuse treatment trains. These approaches classify PPCPs based on their chemical properties and predict their removal patterns across multiple treatment stages [60].

One innovative approach evaluates two distinct clustering strategies: C1 (clustering based on the most efficient individual treatment process) and C2 (clustering based on the removal pattern of PPCPs across treatments) [60]. PPCPs are grouped based on their relative abundances by comparing peak areas measured via non-target profiling using ultra-performance liquid chromatography-tandem mass spectrometry through field-scale treatment trains. The resulting clusters are then classified using Abraham descriptors and log Kow as inputs to ML models including support vector machines (SVM), logistic regression, and random forest [60].

This approach has demonstrated a 58-75% overlap between ML clusters of PPCPs and clusters based on Abraham descriptor and log Kow similarity, indicating the potential of using these fundamental molecular properties to predict the fate of PPCPs through various treatment configurations [60].

Toxicity Prediction for Mixtures

A significant challenge in micropollutant management is predicting the toxicity of complex mixtures, as interactions between compounds can produce additive, synergistic, or antagonistic effects. Mathematical models, including concentration addition (CA) and independent action (IA) models, provide frameworks for mixture toxicity prediction, while QSAR and ML approaches offer promising alternatives to address limitations of traditional models [56].

The CA model, based on the Loewe additivity equation, assumes additive effects of each chemical at their respective concentrations and similar modes of action. For binary mixtures of compounds A and B, the equation is expressed as:

[ \frac{CA}{EC{yA}} + \frac{CB}{EC{yB}} = 1 ]

where (CA) and (CB) are specific concentrations of each compound resulting in effect y, and (EC{yA}) and (EC{yB}) denote the corresponding effect concentrations of each compound alone [56]. A sum <0.8 or >1.2 indicates synergistic or antagonistic deviation from the CA model, respectively.

Mixture Toxicity Models: This diagram outlines the computational approaches for predicting the toxicity of micropollutant mixtures, highlighting different interaction outcomes.

Table 3: Essential Research Tools for ML and QSAR Studies in Micropollutant Removal

Tool Category	Specific Tools/Reagents	Function and Application	Key Characteristics
Molecular Descriptors	Abraham descriptors, LFER parameters, Morgan fingerprints	Quantify structural and chemical properties for predictive modeling	Provide information on hydrophobicity, electronic properties, steric effects
Machine Learning Algorithms	Random Forest, XGBoost, SVM, ANN	Pattern recognition and prediction based on training data	Handle non-linear relationships, various performance characteristics
Validation Metrics	R², Q², RMSE, SHAP values	Model performance assessment and interpretation	Quantify predictive accuracy, feature importance
Experimental Materials	Amberjet 4200 resin, RO/FO membrane modules	Generate adsorption and rejection data for model training	Standardized materials for comparable results
Software and Databases	COSMOtherm, Danish QSAR database	Descriptor calculation and historical data access	Enable reproducible modeling approaches

Machine learning and QSAR modeling approaches represent transformative tools for predicting micropollutant removal in wastewater treatment systems, offering powerful alternatives to resource-intensive experimental methods. The integration of molecular descriptors with operational parameters enables accurate prediction of removal efficiency across diverse treatment technologies, including membrane processes, adsorption, and advanced oxidation. Furthermore, the application of interpretation methods such as SHAP analysis provides mechanistic insights that bridge the gap between black-box predictions and fundamental understanding of removal mechanisms.

These computational approaches directly support the achievement of water-related sustainability goals by enabling the design and optimization of treatment trains for efficient micropollutant removal, facilitating water reuse, and protecting aquatic ecosystems. As these models continue to evolve with improvements in data availability, algorithm sophistication, and mechanistic interpretability, they will play an increasingly vital role in addressing the complex challenges of micropollutant management in a water-constrained world.

The presence of persistent micropollutants, including pharmaceuticals, personal care products, and endocrine-disrupting chemicals, in water systems poses a significant challenge to global water security and environmental health. Conventional wastewater treatment plants are often inadequate for the complete removal of these complex organic compounds, allowing them to enter aquatic environments where they contribute to ecotoxicity and potential human health risks [61]. Within the framework of the United Nations Sustainable Development Goals (SDG), specifically SDG 6 (Clean Water and Sanitation), developing effective treatment strategies for these contaminants becomes paramount. Among the most investigated technologies for addressing this issue are Advanced Oxidation Processes (AOPs) and Bioremediation. AOPs are characterized by the generation of highly reactive oxygen species, primarily hydroxyl radicals (HO•), capable of mineralizing recalcitrant organic pollutants into water, carbon dioxide, and inorganic acids [61]. Bioremediation, conversely, leverages the metabolic capabilities of microorganisms (e.g., bacteria, fungi, algae) to degrade or transform environmental pollutants into less toxic forms [62] [63]. This technical guide provides a comprehensive comparison of these two technological families, evaluating their efficacy, mechanisms, and applications within the context of modern environmental chemistry and sustainable water management.

Advanced Oxidation Processes (AOPs): Mechanisms and Applications

Fundamental Principles and Variants

AOPs encompass a suite of chemical treatment techniques designed to remove organic and inorganic materials from water and wastewater through oxidation. The core mechanism involves the in-situ generation of highly reactive, non-selective hydroxyl radicals (HO•). The oxidative capacity of these radicals is second only to fluorine, making them effective against a wide spectrum of recalcitrant compounds [61]. The common feature of all AOPs is the production of HO•, which can be achieved through various methods involving ozone (O₃), hydrogen peroxide (H₂O₂), ultraviolet (UV) radiation, catalysts (e.g., titanium dioxide, TiO₂), and/or ferrous ions (Fe²⁺) [64].

Key AOP variants include:

• Fenton and Photo-Fenton Processes: The classical Fenton process uses Fe²⁺ and H₂O₂ to generate hydroxyl radicals. The Photo-Fenton process introduces UV/visible light to enhance the reaction rate by photoreducing Fe³⁺ back to Fe²⁺, facilitating a catalytic cycle [61] [65].
• UV/H₂O₂: Photolysis of H₂O₂ with UV light at 254 nm cleaves the peroxide bond, producing two HO• radicals.
• Ozonation (O₃ and O₃/UV): Ozone decomposes in water to yield HO•. The reaction is promoted by combining ozone with UV radiation or hydrogen peroxide.
• Heterogeneous Photocatalysis: Uses a solid semiconductor catalyst (e.g., TiO₂) irradiated with UV light to generate electron-hole pairs that subsequently produce HO• and other reactive species [64].

Experimental Protocols and Performance Evaluation

A systematic approach to evaluating AOPs at the laboratory scale is crucial for meaningful comparison and future scaling. The following protocol, adapted from a study on cosmetic wastewater treatment, outlines a standard procedure for assessing AOP efficacy [65].

Materials:

• Wastewater Sample: Real or synthetic wastewater containing the target pollutants.
• Chemical Reagents: Hydrogen peroxide (H₂O₂, 30%), ferrous sulfate heptahydrate (FeSO₄·7H₂O), ferric chloride hexahydrate (FeCl₃·6H₂O), sulfuric acid (H₂SO₄) for pH adjustment, sodium hydroxide (NaOH) for quenching.
• Equipment: Quartz batch reactor (to allow UV transmission), UV lamps (e.g., medium-pressure mercury lamps emitting at 254 nm), magnetic stirrer, pH meter, spectrophotometer or COD vials for analysis.

Experimental Procedure:

• Sample Preparation: Place 1 L of wastewater into the quartz reactor.
• pH Adjustment: Adjust the pH to the desired set-point (e.g., pH 3 for Fenton-based processes) using H₂SO₄ or NaOH.
• Reagent Addition: Add the required dosage of catalyst (e.g., Fe²⁺ or Fe³⁺) and oxidant (H₂O₂).
• Initiation: Start the reaction by turning on the UV lamps and the stirrer to ensure complete mixing.
• Reaction Monitoring: Conduct the experiment for a predetermined time (e.g., 40 minutes), collecting samples at regular intervals.
• Quenching: Immediately after sampling, quench the reaction by adding a small dose of NaOH to decompose residual H₂O₂ and raise the pH.
• Analysis: Filter samples (0.45 μm) and analyze for Chemical Oxygen Demand (COD), Biochemical Oxygen Demand (BOD₅), and specific pollutant concentration.

Performance Metrics:

• Removal Efficiency: Calculated as (1 - C_t / C_0) * 100%, where C₀ and C_t are the initial and time-t concentrations of the pollutant or COD.
• Biodegradability Enhancement: Measured by the increase in the BOD₅/COD ratio post-treatment.
• Kinetic Modeling: Data is often fitted to a pseudo-first-order kinetic model: -dC/dt = k_obs * C, where k_obs is the observed rate constant.
• Energy Consumption: Evaluated as specific energy consumption per unit of pollutant removed (e.g., kWh/g COD removed) [65].

Table 1: Performance Summary of Selected AOPs for Real Cosmetic Wastewater Treatment [65]

AOP Variant	Optimal Conditions	COD Removal (%)	Biodegradability Index (BOD₅/COD) Post-Treatment	Key Observations
UV Photolysis	pH 3, 40 min UV	Moderate	Improved to 0.5	Direct photolysis is less effective for complex matrices.
UV/H₂O₂	pH 3, 1 mL/L H₂O₂, 40 min	High	Improved to 0.65	Enhanced radical production improves degradation.
Photo-Fenton	pH 3, 0.75 g/L Fe²⁺, 1 mL/L H₂O₂, 40 min	95.5%	Improved from 0.28 to 0.8	Highest performance; synergistic effect of UV and Fenton.
Photo-Fenton Like	pH 3, 0.75 g/L Fe³⁺, 1 mL/L H₂O₂, 40 min	High	Improved to 0.75	Fe³⁺ is a viable alternative, though slightly less efficient than Fe²⁺.

Bioremediation: Mechanisms and Applications

Microbial Pathways and Technologies

Bioremediation is an environmentally sustainable, cost-effective technology that utilizes biological microorganisms to decompose, detoxify, or immobilize hazardous substances in the environment [62] [63]. Microorganisms, including aerobes and anaerobes, possess enzymatic pathways that allow them to utilize pollutants as a source of carbon, nitrogen, or energy, converting them to less toxic compounds like water, carbon dioxide, and biomass [62].

The main biological agents and systems include:

• Bacteria: Aerobic bacteria (e.g., Bacillus, Pseudomonas, Sphingomonas) degrade pesticides, alkanes, and polyaromatic compounds. Anaerobic bacteria are effective for polychlorinated biphenyls (PCBs) and chlorinated solvents [62].
• Fungi and Algae: Fungi (e.g., Aspergillus sydowii) can degrade organophosphate pesticides, while algae (e.g., Cymbella sp.) have been shown to detoxify pharmaceuticals like naproxen with high efficiency [62].
• Constructed Wetlands (CWs): Engineered systems that provide various micro-environments where physical, chemical, and biological processes synergistically remove pollutants [61].
• Membrane Bioreactors (MBRs): Combine biological degradation with membrane filtration, offering superior effluent quality and effective retention of slow-growing microorganisms [61].

Experimental Factors and Protocol Design

The success of microbial bioremediation is highly dependent on optimizing environmental and nutritional factors to support microbial growth and activity [62].

Key Factors Affecting Bioremediation:

• Biological Factors: Microbial population density, diversity, competition, and succession.
• Oxygen Availability: Determines whether aerobic or anaerobic metabolic pathways will dominate.
• Nutrients: A balanced Carbon:Nitrogen:Phosphorus (C:N:P) ratio is critical for microbial growth.
• Temperature: Affects the metabolic rate of enzymes involved in degradation.
• pH and Moisture Content: Must be within a suitable range for the specific microbial consortium [62].

General Protocol for Microbial Bioremediation:

• Microbial Selection: Isolate or select a pure strain or consortium known to degrade the target pollutant.
• Medium Preparation: Prepare a growth medium containing essential nutrients. For bioaugmentation, the medium may be a sample of the contaminated soil or water.
• Bioaugmentation/Biostimulation: Inoculate the contaminated matrix with the selected microbes (bioaugmentation) and/or add rate-limiting nutrients (biostimulation), such as nitrogen and phosphorus sources.
• Incubation: Incubate under controlled conditions (temperature, pH, aeration for aerobic processes) for a defined period.
• Monitoring: Periodically sample and analyze for pollutant concentration (e.g., via GC-MS, HPLC), microbial growth (e.g., plate count, optical density), and potential toxic intermediates.

Table 2: Examples of Microorganisms and Their Roles in Bioremediation

Microorganism	Type	Target Pollutant(s)	Mechanism/Remarks
Pseudomonas spp.	Aerobic Bacteria	Petroleum hydrocarbons, toluene, benzene	Utilizes pollutants as carbon source; often used in consortiums.
Aspergillus sydowii	Fungi	Organophosphate pesticides (e.g., chlorpyrifos)	Enzymatic degradation.
Cymbella sp.	Algae	Pharmaceutical (Naproxen)	Detoxification with reported 97.1% efficiency.
Sulfate-Reducing Bacteria	Anaerobic Bacteria	Chlorinated solvents, heavy metals	Reduction and precipitation under anaerobic conditions.

Comparative Analysis: Efficacy, Economics, and Implementation

Direct Comparison of AOPs and Bioremediation

A critical review of the literature reveals a complementary relationship between AOPs and bioremediation, with each having distinct advantages and limitations.

Table 3: Comparative Overview of AOPs vs. Bioremediation [61] [62] [63]

Parameter	Advanced Oxidation Processes (AOPs)	Bioremediation
Mechanism	Chemical destruction via reactive oxygen species (e.g., HO•).	Biological transformation/degradation by microbial enzymes.
Treatment Speed	Very fast (minutes to hours).	Slow (days to weeks).
Scope of Applicability	Broad spectrum of recalcitrant and non-biodegradable compounds.	Effective for biodegradable pollutants; limited for recalcitrant compounds.
Mineralization	Capable of complete mineralization to CO₂ and H₂O.	Can lead to complete mineralization, but may also produce transformation products.
Operating Cost	High (energy, chemical reagents).	Low (eco-friendly and cost-effective).
By-product Formation	Potential formation of unknown or toxic oxidation by-products.	Generally produces non-toxic by-products (e.g., H₂O, CO₂, biomass).
Environmental Friendliness	Can be energy-intensive and involve chemicals.	Considered a green and sustainable technology.
Sensitivity to Toxicity	Effective even in toxic conditions.	Can be inhibited by high pollutant toxicity.

The Hybrid AOP-Biological System

Recognizing the limitations of standalone processes, the hybrid AOP-Biological system has emerged as a highly promising strategy. In this configuration, AOPs serve as a pre-treatment step to break down complex, recalcitrant molecules into more readily biodegradable intermediates. This reduces the overall toxicity of the effluent and enhances its biodegradability index (BOD₅/COD), making it more amenable for subsequent biological polishing [61]. This approach offers significant advantages:

• Economic Viability: Reduces the operational cost of AOPs by minimizing the required reaction time and energy input for near-complete mineralization.
• Efficiency and Completeness: Ensures more complete degradation of pollutant mixtures, addressing the parent compounds via AOP and the intermediates via biological treatment.
• Reduction of Toxic By-products: The biological step can degrade oxidation by-products that might otherwise persist in the environment [61].

The following diagram illustrates the workflow and logical relationship within a hybrid AOP-Bioremediation system:

Diagram 1: Hybrid AOP-Bioremediation System Workflow. The decision loop ensures sufficient pre-treatment before biological polishing.

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 4: Key Research Reagent Solutions for AOP and Bioremediation Studies [62] [65]

Reagent/Material	Function	Typical Use-case
Hydrogen Peroxide (H₂O₂)	Source of hydroxyl radicals in AOPs (e.g., UV/H₂O₂, Fenton).	Oxidant in homogenous AOP systems.
Ferrous Sulfate (FeSO₄·7H₂O)	Catalyst in Fenton and Photo-Fenton processes.	Provides Fe²⁺ ions to decompose H₂O₂ into HO•.
UV Lamps (Low/Medium Pressure)	Light source for photolytic and photocatalytic AOPs.	Used in UV/H₂O₂, UV/O₃, Photo-Fenton, and photocatalysis.
Titanium Dioxide (TiO₂)	Semiconductor photocatalyst.	Used in heterogeneous photocatalysis (e.g., UV/TiO₂).
Defined Microbial Consortia	Biological agents for degradation.	Bioaugmentation studies for specific pollutants (e.g., hydrocarbons).
Nutrient Broths (N, P sources)	Biostimulation to enhance microbial growth.	Providing essential nutrients (Nitrogen, Phosphorus) in bioremediation.

Both Advanced Oxidation Processes and Bioremediation present powerful tools for addressing the global challenge of micropollutant contamination in water systems, a core concern in achieving SDG 6. AOPs offer a rapid, potent chemical solution for destroying a wide array of recalcitrant compounds but are often hampered by high operational costs and the potential for generating transformation products. Bioremediation, while more economical and environmentally benign, is inherently slower and may be ineffective against highly persistent pollutants. The future of efficient and sustainable wastewater treatment appears to lie not in choosing one over the other, but in their intelligent integration. The hybrid AOP/Biological system leverages the strengths of both—using AOPs as a pre-treatment to convert recalcitrant molecules into biodegradable intermediates, which are then efficiently and completely removed by a subsequent biological process. This synergistic approach represents a technologically and economically viable path forward for the complete degradation of pharmaceuticals and other emerging contaminants, aligning environmental remediation goals with the principles of sustainable development.

Green Chemistry and Process Optimization: Designing Safer, Sustainable Chemical Pathways

Implementing the 12 Principles of Green Chemistry in Pharmaceutical Development

The pharmaceutical industry faces a critical juncture, balancing the urgent need for new medicines with the significant environmental footprint of traditional drug manufacturing. The synthesis of active pharmaceutical ingredients (APIs) has been notoriously resource-intensive and wasteful, with the industry's carbon emissions surpassing those of the automotive sector by up to 55% [66]. Historically, pharmaceutical processes have exhibited excessively high E-Factors—the ratio of waste to product—often ranging from 25 to over 100, meaning for every kilogram of API produced, more than 100 kilograms of waste is generated [66]. This environmental burden extends to water pollution, with approximately 10 billion kilograms of waste generated annually from the production of 65 to 100 million kilograms of APIs, and the pharmaceutical sector is responsible for 17% of global carbon emissions, half of which derives from API manufacturing [67].

The 12 Principles of Green Chemistry, established by Paul Anastas and John Warner in 1998, provide a transformative framework for addressing these challenges [67] [68]. This technical guide explores the implementation of these principles within pharmaceutical development, framed against the pressing environmental context of micropollutant pollution and the global pursuit of Sustainable Development Goals (SDGs), particularly SDG 6 (clean water and sanitation) [69]. As emerging pharmaceutical micropollutants—including antibiotics, analgesics, and endocrine disruptors—increasingly contaminate aquatic ecosystems at concentrations of μg/L to ng/L, the adoption of green chemistry becomes not merely an environmental consideration but a strategic imperative for sustainable drug development [70] [71].

Green Chemistry Principles and Pharmaceutical Applications

The 12 Principles of Green Chemistry form a comprehensive design philosophy that shifts pharmaceutical manufacturing from waste management to waste prevention at the molecular level [66]. When systematically applied throughout drug development and production, these principles create cascading benefits across operational efficiency, environmental performance, and economic outcomes.

Table 1: The 12 Principles of Green Chemistry and Their Implementation in Pharmaceutical Development

Principle	Technical Implementation in Pharma	Quantitative Benefits
1. Prevent Waste	Design processes to minimize by-products; optimize reaction stoichiometry [66].	PMI reductions up to tenfold reported; Pfizer achieved 50% waste reduction [66] [68].
2. Atom Economy	Maximize incorporation of starting materials into final API; redesign synthetic pathways [66].	Higher atom economy directly reduces raw material consumption and waste generation [66].
3. Less Hazardous Syntheses	Replace toxic reagents with safer alternatives; avoid hazardous intermediates [68] [66].	Reduces costs for specialized handling, containment, PPE, and insurance [66].
4. Design Safer Chemicals	While API structure is fixed for generics, design safer intermediates, reagents, and solvents [66].	Minimizes formation of genotoxic impurities that complicate regulatory approval [66].
5. Safer Solvents & Auxiliaries	Replace dichloromethane, benzene with water, ethanol, or supercritical CO₂ [68] [66].	Solvents often account for majority of process mass intensity; switching reduces waste and toxicity [66].
6. Energy Efficiency	Use microwave-assisted synthesis; conduct reactions at ambient temperature/pressure [67] [68].	Microwave synthesis reduces reaction time from hours to minutes with significant energy savings [67].
7. Renewable Feedstocks	Transition from petrochemical-derived to bio-based precursors from sugars, plant oils, algae [68] [66].	Enhances supply chain resilience against petroleum price volatility [66].
8. Reduce Derivatives	Minimize protecting groups; streamline synthesis using biocatalysis [66].	Each protection/deprotection step adds reagents, time, and waste; reduction improves efficiency [66].
9. Catalysis	Implement biocatalysts, enzymatic processes, and catalytic over stoichiometric reactions [68] [66].	Catalysts used in small amounts, reusable, and reduce waste by orders of magnitude [66].
10. Design for Degradation	Design APIs and process chemicals to break down into innocuous substances after use [68].	Reduces persistence of pharmaceutical micropollutants in aquatic environments [70] [5].
11. Real-time Analysis	Implement Process Analytical Technology (PAT) for in-process monitoring and control [68] [66].	Prevents runaway reactions, optimizes yield, aligns with FDA Quality by Design initiatives [66].
12. Inherently Safer Chemistry	Choose substances and process conditions to minimize accident potential [68] [66].	Integrates principles 3, 5, and 9 to reduce risks of releases, explosions, and fires [66].

Environmental Context: Pharmaceutical Micropollutants

Conventional pharmaceutical manufacturing contributes significantly to the burden of emerging micropollutants in aquatic ecosystems. These contaminants include active pharmaceutical ingredients, intermediates, and metabolites that persist through wastewater treatment processes and enter water bodies, where they can exert biological effects at minute concentrations (μg/L to ng/L) [70]. Specific pharmaceutical micropollutants of concern include erythromycin, ibuprofen, and triclocarban, which have been identified as primary micropollutants originating from pharmaceutical industry effluents [70].

These micropollutants pose significant risks to aquatic ecosystems, including endocrine disruption in fish, reduced reproduction in daphnids, and inhibited growth in algae [71]. A recent risk assessment in southeastern Spain identified citalopram and irbesartan as presenting high human risk quotients (HRQ > 1) in babies exposed to reclaimed water, while irbesartan and clarithromycin showed significant ecological risks to fish and algae respectively [71]. The environmental persistence of these substances is compounded by their ability to interact with other pollutants; microplastics can act as vectors for pharmaceutical contaminants, forming complex "plastisphere" communities that may enhance viral stability and facilitate the spread of antibiotic resistance genes [5].

Experimental Protocols for Green Chemistry Implementation

Protocol: Continuous Flow Synthesis for API Manufacturing

Objective: Implement continuous flow synthesis to enhance reaction control, improve safety, and reduce waste generation compared to batch processing [67].

Methodology:

• Reactor Setup: Utilize specialized continuous flow equipment with precisely controlled temperature zones, pressure regulation, and mixing parameters.
• Process Optimization: Employ Design of Experiments (DoE) methodologies to optimize residence time, temperature, and reagent stoichiometry.
• Integration with PAT: Implement real-time monitoring using inline spectroscopy (FTIR, Raman) to track reaction progression and intermediate formation.
• Workup Integration: Direct coupling with continuous separation units (membrane separators, liquid-liquid extractors) for immediate product isolation.

Key Advantages:

• Superior heat and mass transfer enables more precise control of exothermic reactions [67].
• Reduced reactor volume and increased safety profile for hazardous chemistries.
• Enhanced reproducibility and simpler scale-up from laboratory to production.

Protocol: Biocatalysis for Stereoselective Synthesis

Objective: Employ enzyme-mediated transformations to achieve high stereoselectivity under mild conditions, reducing protection/deprotection steps and hazardous reagents [68] [66].

Methodology:

• Enzyme Selection: Screen commercial enzyme libraries or engineer custom biocatalysts for specific transformation requirements.
• Reaction Optimization: Systematically vary parameters including pH, temperature, co-solvents, and co-factor recycling systems.
• Process Development: Establish substrate loading limits, enzyme stability profiles, and product inhibition thresholds.
• Product Isolation: Develop efficient isolation protocols leveraging differences in solubility between product and enzyme.

Key Advantages:

• High selectivity reduces or eliminates protecting groups (Principle 8) [66].
• Mild reaction conditions (ambient temperature, neutral pH) reduce energy consumption (Principle 6) [68].
• Aqueous reaction media replaces hazardous organic solvents (Principle 5) [68].

Table 2: Research Reagent Solutions for Green Chemistry Implementation

Reagent/Catalyst	Function	Green Chemistry Advantage
Immobilized Enzymes	Biocatalysis for selective transformations	Reusable, work in aqueous media, high selectivity reduces derivatives [68] [66].
Metallocatalysts	Facilitate catalytic versus stoichiometric reactions	Reduce metal waste; enable atom-economic transformations [66].
Bio-derived Solvents	(e.g., Cyrene, 2-MeTHF)	Renewable feedstocks; lower toxicity than traditional solvents [68] [66].
Water as Reaction Medium	Solvent for aqueous-phase chemistry	Non-toxic, non-flammable, eliminates VOC emissions [68].
Microwave Reactors	Energy-efficient reaction heating	Rapid, selective heating reduces energy consumption and reaction times [67].
Continuous Flow Systems	Enhanced process control and safety	Improved heat/mass transfer; smaller environmental footprint [67].

Analytical Methodologies for Green Process Development

Protocol: Process Mass Intensity (PMI) Assessment

Objective: Quantify the environmental efficiency of pharmaceutical processes using PMI as a key metric for comparing and optimizing synthetic routes [66].

Methodology:

• Material Inventory: Document the mass of all input materials (reagents, solvents, catalysts) for each process step.
• PMI Calculation: Apply the formula PMI = Total mass of inputs (kg) / Mass of API (kg).
• Component Analysis: Break down PMI into contributions from solvents, reagents, water, and other materials.
• Benchmarking: Compare PMI values against industry benchmarks and identify improvement opportunities.

Interpretation: PMI provides a comprehensive assessment of resource efficiency, directly linking to Principles 1 (Waste Prevention) and 2 (Atom Economy). Industry leaders have achieved PMI values below 50 for optimized processes, representing significant improvements over traditional syntheses with PMI > 100 [66].

Advanced Analytical Techniques for Micropollutant Detection

Monitoring pharmaceutical micropollutants requires sophisticated analytical methods capable of detecting trace concentrations in complex matrices. The primary analytical methods for detecting micropollutants involve hybrid techniques that integrate chromatography with mass spectrometry [70]. These include:

• Liquid Chromatography-Mass Spectrometry (LC-MS/MS): Provides high sensitivity and selectivity for polar pharmaceutical compounds and their metabolites.
• Gas Chromatography-Mass Spectrometry (GC-MS): Suitable for volatile and semi-volatile organic compounds.
• High-Performance Liquid Chromatography (HPLC) with UV/fluorescence detection: Conventional technique for routine monitoring of specific compound classes.

These analytical methods are essential for assessing the environmental fate of pharmaceutical residues and evaluating the effectiveness of green chemistry approaches in reducing micropollutant emissions [70].

Regulatory and Strategic Framework

Alignment with Global Sustainability Initiatives

The implementation of green chemistry in pharmaceutical development aligns with several critical regulatory and sustainability frameworks:

• European Green Deal: Pushes for carbon neutrality by 2050 across the European Union and affects packaging and transparency regarding ecosystem impacts [67].
• Urban Wastewater Treatment Directive (UWWTD): Establishes stringent requirements including an 80% reduction in micropollutants and mandatory quaternary treatments for larger wastewater treatment plants [71].
• REACH Regulation: Provides a framework for ensuring safer chemical utilization and protecting human health and the environment from hazardous substances [67].
• Sustainable Development Goal 6: Aims to ensure availability and sustainable management of water and sanitation for all, with specific targets on water quality and wastewater treatment [69].

The implementation of the 12 Principles of Green Chemistry represents a fundamental shift in pharmaceutical development—from a traditional focus solely on cost and yield to a holistic approach that balances economic, environmental, and social considerations. As the industry faces increasing regulatory pressure and stakeholder expectations regarding its environmental footprint, green chemistry transitions from an optional initiative to a core strategic priority.

The technical protocols and methodologies outlined in this guide provide a roadmap for researchers and drug development professionals to systematically integrate green chemistry principles throughout the pharmaceutical lifecycle. Through the adoption of continuous manufacturing, biocatalysis, solvent alternative assessment, and rigorous metrics like PMI, the pharmaceutical industry can significantly reduce its contribution to micropollutant pollution while simultaneously improving process efficiency and economic performance.

This approach aligns pharmaceutical innovation with global sustainability frameworks, particularly SDG 6, creating a pathway toward a circular economy for pharmaceuticals where waste is minimized, resources are conserved, and environmental impacts are substantially reduced. The continued development and implementation of green chemistry methodologies will be essential for creating a sustainable future for pharmaceutical manufacturing that delivers essential medicines while protecting ecosystem and human health.

The pharmaceutical industry faces a critical challenge: balancing the delivery of life-saving medicines with the responsibility to minimize environmental impact. Pharmaceutical residues from production, use, and disposal increasingly contaminate aquatic and terrestrial ecosystems, posing risks such as antimicrobial resistance (AMR) and endocrine disruption in wildlife [72]. With AMR linked to 4.7 million deaths in 2021, the environmental release of active pharmaceutical ingredients (APIs) is not just an ecological issue but a pressing public health crisis [72]. Sustainable drug design represents a paradigm shift, integrating green chemistry principles and environmental risk assessment directly into the drug development lifecycle to prevent pollution at its source. This approach aligns with the United Nations Sustainable Development Goals (SDGs), particularly SDG 3 (Good Health and Well-being), SDG 6 (Clean Water and Sanitation), SDG 9 (Industry, Innovation and Infrastructure), and SDG 12 (Responsible Consumption and Production) [73]. By designing pharmaceuticals for reduced environmental persistence and enhanced degradability, while maintaining efficacy and safety, the industry can mitigate its ecological footprint and contribute to a sustainable healthcare system.

Drug Lifecycle Analysis and Environmental Impact Vectors

The environmental impact of pharmaceuticals occurs across their entire lifecycle, from synthesis to patient use and eventual disposal. Understanding these impact vectors is essential for targeting intervention strategies effectively. In the manufacturing phase, emissions are often tied to energy-intensive processes and solvent use, contributing significantly to the carbon footprint [74]. The research and discovery phase, while complex and decentralized, generates substantial plastic waste from pipette tips and assay plates, which often cannot be recycled due to contamination and must be incinerated [74]. During patient use, APIs and their metabolites are excreted and enter wastewater systems, while improper disposal of unused medications adds to the environmental burden [72]. The One Health approach recognizes the interconnectedness of human, animal, and environmental health, emphasizing that comprehensive strategies must address all these sectors [72].

Table 1: Environmental Impact Vectors Across the Pharmaceutical Lifecycle

Lifecycle Stage	Primary Environmental Impacts	Key Contributing Factors
API Synthesis & Manufacturing	Greenhouse gas emissions, solvent waste, energy consumption [75]	Energy-intensive processes, resource-inefficient synthetic routes [74]
Research & Discovery	Plastic waste, solvent consumption, energy use [74]	Single-use lab plastics, low-efficiency screening methods, virgin plastic use [74]
Packaging & Distribution	Material waste, carbon emissions from transport [75]	Non-recyclable materials, excessive packaging, unsustainable sourcing [75]
Patient Use & End-of-Life	Aquatic pollution, antimicrobial resistance, ecosystem toxicity [72]	Excretion of APIs, improper disposal of unused medicines [72]

Notably, the environmental release of pharmaceuticals has substantial financial implications, including costs related to waste management and wastewater treatment [72]. A comprehensive lifecycle assessment (LCA) approach, as adopted by industry leaders, is crucial for quantifying these impacts and identifying hotspots for intervention. Companies like AstraZeneca are implementing Product Sustainability Index (PSI) programs to measure environmental performance and establish improvement plans, with 71% of launched products assessed against this index by the end of 2024 [75].

Core Strategies in Sustainable Formulation Design

Green Chemistry and Manufacturing Efficiency

Integrating green chemistry principles at the molecular design stage represents the most proactive approach to sustainable drug development. The pharmaceutical industry employs Process Mass Intensity (PMI) as a key metric to assess the sustainability of manufacturing processes, with leading companies setting targets for 90% of total syntheses to meet resource efficiency targets at launch by 2025 [75]. This focus on atom economy and waste minimization is fundamental to reducing environmental impact at the source. Practical implementation includes adopting acoustic dispensing technologies to reduce solvent volumes and employing higher plate formats to minimize plastic waste in screening operations [74]. Furthermore, Design of Experiment (DoE) methodologies enable researchers to embed sustainability into assay design, systematically reducing waste and eliminating harmful reagents from the outset [74]. As one industry expert notes, "Using design of experiment as a technology... it's a way of thinking about running processes with a focus on sustainability as the endpoint" [74]. These approaches not only reduce environmental impact but also improve operational efficiency and cost-effectiveness.

Advanced Materials and Delivery Systems

Innovative materials and delivery technologies offer promising pathways to reduce the environmental footprint of pharmaceutical products. The development of advanced materials for drug delivery can enhance bioavailability, potentially reducing required dosages and subsequent environmental loading. For respiratory medicines, which have traditionally used propellants with high global warming potential, the transition to next-generation propellants (NGPs) represents a breakthrough. For instance, the propellant HFO-1234ze(E) has a near-zero Global Warming Potential (GWP)—99.9% lower than those currently used in most respiratory medicines [75]. In May 2025, a world-first approval was granted in the UK for an inhaled respiratory medicine using this next-generation propellant, with regulatory filings submitted in the EU and China as well [75]. This transition exemplifies how reformulation can dramatically reduce climate impact without compromising therapeutic efficacy. Additionally, nanotechnology-based delivery systems show potential for targeted release and reduced API requirements, though their own environmental safety must be thoroughly assessed.

Packaging Innovation and Circular Economy Models

Redesigning pharmaceutical packaging through circular economy principles presents significant opportunities for reducing waste and resource consumption. Leading companies have established targets to ensure that 95% of paper-based product packaging materials are supplied from sustainable sources [75]. Beyond material sourcing, innovative approaches include right-sized packaging to minimize material use, redesigning for recyclability, and exploring reusable container systems for certain medication classes. Furthermore, sustainable procurement practices are emerging as a key strategy, including buying in smaller, more precise quantities, using medicines with longer shelf lives, reducing packaging volume, and opting for sustainable packaging materials [72]. These initiatives are part of a broader shift toward circular business practices that prioritize resource efficiency across the product lifecycle, from design to end-of-life management.

Analytical and Remediation Technologies for Micropollutants

Detection and Analysis Methods

Accurate detection and monitoring of pharmaceutical micropollutants in environmental matrices is fundamental to risk assessment and mitigation. Advanced analytical techniques are essential for identifying and quantifying trace levels of emerging contaminants. Mass spectrometry remains the gold standard, with sessions at recent environmental conferences dedicated to "Advanced Mass Spectrometry Techniques" for monitoring pesticides and organic micropollutants across food, water, soil, and air media [76]. The development of the "European Laboratory Network for Chemical Exposure Assessment" represents a coordinated effort to standardize and enhance monitoring capabilities across regions [76]. These analytical advances enable more comprehensive environmental risk assessment of pharmaceuticals throughout their lifecycle, informing both regulatory decisions and sustainable design choices.

Adsorption-Based Removal Technologies

While source reduction is paramount, effective removal technologies for pharmaceutical residues in wastewater are essential. Adsorption-based approaches using innovative materials have shown significant promise for addressing persistent micropollutants. Metallic and metal oxide nanomaterials offer particularly attractive solutions due to their high surface area-to-volume ratios and tunable surface chemistry [77]. These materials can be engineered for selective adsorption of specific pharmaceutical classes, providing a low-cost, effective alternative to traditional wastewater treatment technologies like advanced oxidation processes (AOPs), which can be expensive and sophisticated [77]. The synthesis methods for these nanoparticles—including chemical, physical, and biological techniques—each present distinct advantages and challenges, with growing interest in green synthesis approaches that minimize secondary environmental impacts [77]. The integration of magnetic properties into these nanomaterials further enhances their utility by enabling efficient recovery and regeneration after use, promoting more sustainable treatment systems [77].

Table 2: Performance Comparison of Nanomaterial Adsorbents for Pharmaceutical Removal

Nanomaterial Type	Target Pharmaceuticals	Reported Efficiency	Key Advantages
Metal Oxide Nanoparticles	Antibiotics, Psychoactive drugs [77]	High removal for specific compound classes [77]	High surface area, tunable functionality [77]
Metallic Nanostructures	Hormones, Analgesics [77]	Variable based on functionalization [77]	Plasmonic properties, recyclability [77]
Magnetic Nanocomposites	Mixed pharmaceutical classes [77]	High with recovery capability [77]	Easy separation, reusability [77]
Bio-synthesized Nanoparticles	Emerging micropollutants [77]	Promising, requires more research [77]	Reduced environmental impact of synthesis [77]

Experimental Framework and Methodology

Sustainable Synthesis and Formulation Protocol

The following protocol provides a methodology for developing sustainable drug formulations with reduced environmental impact, integrating green chemistry principles and environmental safety assessments.

Materials and Reagents:

• Bio-based or green solvents: Cyclopentyl methyl ether (CPME), 2-Methyltetrahydrofuran (2-MeTHF)
• Catalysts: Immobilized enzymes, heterogeneous metal catalysts
• Analytical standards: Pharmaceutical compounds and known metabolites
• Environmental simulants: Natural water samples, buffered solutions at various pH levels

Procedure:

• Design Phase: Employ in silico tools to predict environmental persistence, bioaccumulation potential, and toxicity of candidate molecules and their major metabolites.
• Synthetic Route Selection: Apply green chemistry metrics, particularly Process Mass Intensity (PMI), to evaluate and optimize synthetic pathways for atom economy and reduced waste generation [75].
• Solvent System Optimization: Utilize automated screening platforms with acoustic dispensing technology to identify minimal solvent volumes necessary for reactions and purifications [74].
• Degradation Studies: Conduct simulated environmental degradation testing under controlled conditions:
  • Prepare aqueous solutions of the API at environmentally relevant concentrations (ng/L to μg/L)
  • Expose to photolytic conditions (UV light at 254 nm and 365 nm) to assess photodegradation
  • Monitor degradation kinetics via LC-MS/MS, identifying major transformation products
  • Evaluate biodegradability using standard OECD screening tests
• Formulation Development: Design delivery systems that maximize bioavailability while minimizing environmental persistence, considering prodrug approaches or controlled-release mechanisms that reduce dosing frequency.

Environmental Risk Assessment Protocol

A standardized environmental risk assessment (ERA) is essential for evaluating the potential impact of new pharmaceutical formulations.

Materials:

• Test organisms: Algae (Pseudokirchneriella subcapitata), Daphnia (Daphnia magna), fish embryos (Danio rerio)
• Culture media: Standardized growth media for each test species
• Analytical equipment: LC-MS/MS system, dissolved oxygen meter, pH meter

Procedure:

• Problem Formulation: Define assessment endpoints and conceptual models outlining potential exposure pathways.
• Exposure Assessment:
  • Determine predicted environmental concentrations (PEC) based on usage patterns, metabolism, and removal in wastewater treatment
  • Measure physicochemical properties (log P, water solubility, pKa) that influence environmental fate
• Effects Assessment:
  • Conduct acute toxicity tests with algae, Daphnia, and fish according to OECD guidelines
  • Perform chronic toxicity testing at environmentally relevant concentrations
  • Include endocrine disruption screening assays where structurally indicated
• Risk Characterization: Calculate risk quotients (PEC/PNEC) for different environmental compartments, identifying need for additional testing or risk management measures.

Research Reagent Solutions for Environmental Testing

Table 3: Essential Research Reagents for Pharmaceutical Environmental Impact Assessment

Reagent/Material	Specifications	Application in Sustainable Drug Design
LC-MS/MS Standards	Pharmaceutical compounds and known metabolites, purity >95%	Quantification of parent compounds and transformation products in environmental matrices [77]
Test Organisms	Algae (P. subcapitata), Daphnia (D. magna), Fish embryos (D. rerio)	Standardized ecotoxicity testing according to OECD guidelines for environmental risk assessment
Metal Oxide Nanoparticles	TiO₂, Fe₃O₄, ZnO; various surface functionalizations	Adsorption studies and development of removal technologies for wastewater treatment [77]
Green Solvents	CPME, 2-MeTHF, Ethyl Lactate; bio-based sources	Replacement of traditional hazardous solvents in API synthesis to reduce environmental footprint [74]
Environmental Simulants	Natural water samples, varying pH/hardness	Assessment of pharmaceutical degradation under environmentally relevant conditions [77]

Regulatory Frameworks and Global Policy Alignment

The regulatory landscape for pharmaceutical environmental impact is evolving rapidly, with increasing emphasis on prevention at source as a core strategy. International organizations are driving this shift through coordinated policy initiatives. The World Health Organization (WHO) has published global guidance on the safe management of pharmaceutical waste from healthcare facilities, emphasizing prevention and minimization of waste at its source as the most effective approach [72]. Similarly, the World Organisation for Animal Health (WOAH) has implemented standards for the prudent and responsible use of antimicrobials in animals, explicitly excluding the use of antimicrobials for growth promotion [72]. These policy frameworks align with the One Health approach, recognizing the interconnectedness of human, animal, and environmental health. At the manufacturing level, extended producer responsibility concepts are gaining traction, encouraging pharmaceutical companies to consider the entire lifecycle of their products. The industry is also moving toward standardized Life Cycle Assessment (LCA) methodologies, with collaborations between companies, healthcare systems, and standards organizations like the British Standards Institution (BSI) to develop a unified approach to measuring and reporting the environmental impact of medicines [75]. These policy developments create both obligations and opportunities for integrating sustainable design principles into pharmaceutical development.

Sustainable drug design represents an essential evolution in pharmaceutical development, balancing therapeutic innovation with environmental responsibility. By integrating green chemistry principles, advanced formulation strategies, and comprehensive environmental risk assessments throughout the drug development lifecycle, the industry can significantly reduce its ecological footprint. The approaches outlined—from molecular design choices that enhance degradability to the adoption of circular economy models in packaging—demonstrate that prevention at source is both technically feasible and environmentally imperative. The transition to next-generation propellants in inhalers exemplifies how systematic reformulation can achieve dramatic reductions in environmental impact while maintaining therapeutic efficacy [75]. Furthermore, advances in adsorption technologies using metallic and metal oxide nanomaterials offer promising solutions for removing persistent micropollutants from wastewater [77]. As the industry moves forward, collaboration across sectors—including pharmaceutical companies, regulatory agencies, healthcare providers, and academia—will be crucial to standardize assessment methods, share best practices, and drive continuous improvement. With only five years remaining to achieve the 2030 Sustainable Development Goals, accelerating the adoption of sustainable drug design is not merely an environmental consideration but an ethical obligation for the pharmaceutical industry [73].

The escalating crisis of environmental micropollutants and the urgent need to combat climate change, as outlined in United Nations Sustainable Development Goal (SDG) 13: Climate Action, demand transformative approaches in chemical synthesis and environmental remediation [78] [79]. Micropollutants—including pharmaceuticals, endocrine-disrupting chemicals, pesticides, and personal care products—persist in aquatic environments at trace concentrations (ng/L to μg/L), posing significant threats to ecosystems and human health due to their biological activity and persistence [80]. Traditional chemical manufacturing and water treatment processes often generate substantial waste, require hazardous reagents, and consume excessive energy, contributing to the very environmental challenges they aim to solve [80] [81].

Catalysis and biocatalysis represent paradigm-shifting strategies for developing efficient, low-waste synthesis routes that align with the principles of green chemistry and sustainable development. By harnessing the remarkable specificity and catalytic efficiency of biological and bio-inspired systems, these approaches minimize energy consumption, reduce hazardous by-product formation, and operate under mild environmental conditions [82] [81]. The integration of advanced catalytic technologies addresses both pollution mitigation and climate action by converting harmful contaminants into benign substances while simultaneously reducing the carbon footprint of chemical processes [83] [79]. This technical review examines cutting-edge developments in catalysis and biocatalysis, focusing on their application within the context of environmental chemistry and SDG implementation, with particular emphasis on quantitative performance metrics, experimental methodologies, and practical implementation frameworks.

Advanced Catalytic and Biocatalytic Systems

Enzyme-Based Biocatalysts

Microbial enzymes constitute a diverse class of biocatalysts with exceptional capabilities for environmental remediation and green synthesis. Oxidoreductases, including laccases (EC 1.10.3.2), peroxidases, tyrosinases, and oxygenases, demonstrate remarkable efficacy in oxidizing a broad spectrum of organic micropollutants through electron transfer reactions [82]. These multi-copper enzymes harbor three distinct copper centers (T1, T2, T3) that facilitate electron acceptance from substrates and subsequent oxygen reduction to water [82]. For recalcitrant compounds with high redox potentials, laccases utilize mediator molecules such as 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) or 1-hydroxybenzotriazole (HBT) as electron shuttles to enhance degradation efficiency [82].

Hydrolases (esterases, lipases, cutinases, PETases, dehalogenases) perform nucleophilic catalysis on electrophilic functional groups, enabling efficient degradation of pesticides and plastic pollutants [82]. Their inherent biodegradability, substrate specificity, and catalytic potency under ambient conditions position enzyme biocatalysts as powerful tools for sustainable chemistry. However, practical applications face challenges related to enzyme stability, recovery, and reusability in continuous flow systems [82].

Immobilized Enzyme Systems

Enzyme immobilization techniques significantly enhance stability, activity, and operational longevity by anchoring enzymes to solid supports, creating protected microenvironments that minimize degradation in fluctuating environmental conditions [82]. Multiple immobilization strategies exist, each with distinct advantages:

• Adsorption: Physical attachment to supports via hydrophobic interactions, hydrogen bonding, or van der Waals forces
• Covalent binding: Formation of stable covalent bonds between enzyme functional groups and activated supports
• Cross-linking: Intermolecular connection via bifunctional reagents
• Encapsulation: Confinement within porous matrices or membranes
• Affinity-based immobilization: Specific biointeractions promoting optimal enzyme orientation [82]

These immobilized systems demonstrate improved pollutant degradation efficiency and cost-effectiveness through multiple reusability cycles, making them particularly valuable for continuous flow wastewater treatment applications [82].

Nanobiohybrid Materials

Nanobiohybrids represent cutting-edge composites created by interfacing nanomaterials with biological systems, merging the advantages of both components [83]. Synthesis strategies encompass:

• Enzyme nanobiohybrids: Integration of enzymes with reticular frameworks, semiconductor nanoparticles, or single-walled carbon nanotubes
• Cell nanobiohybrids: Combination of whole cells with nanomaterials for enhanced CO₂ conversion to value-added chemicals
• Plant nanobiohybrids: Incorporation of nanomaterials into living plants for in-situ environmental sensing [83]

These hybrid systems demonstrate exceptional performance for micropollutant removal, carbon dioxide conversion, and real-time monitoring of toxic metal ions and organic contaminants, functioning as eco-friendly, efficient, and cost-effective environmental technologies [83].

Nanozymes

Nanozymes—nanomaterials with intrinsic enzyme-like characteristics—represent a revolutionary expansion of biocatalytic systems beyond traditional protein- and nucleic acid-based enzymes [84]. Since the 2007 discovery that Fe₃O₄ nanoparticles exhibit peroxidase-like activity, thousands of nanomaterials including metal oxides, noble metals, carbon materials, and metal-organic frameworks have demonstrated diverse biocatalytic capabilities [84]. These materials possess multiple nanostructure-confined active sites that provide interfaces for substrate interactions, enabling oxidoreductase-like (peroxidase, catalase, oxidase, superoxide dismutase), hydrolase-like (phosphatase, protease, glycosidase), lyase-like, and isomerase-like activities [84].

Natural biogenic nanozymes, including magnetosomes, ferritin iron cores, and amyloid protein assemblies, perform physiological biocatalytic functions and may contribute to disease pathogenesis, suggesting their potential roles in primordial biocatalysis under extreme early Earth conditions [84]. The unique structural stability, designability, and multifunctionality of nanozymes enable applications surpassing the limitations of conventional enzymes, particularly in biomedical and environmental fields [84].

Quantitative Performance Metrics for Catalytic Systems

Table 1: Performance Metrics of Advanced Catalytic and Biocatalytic Systems

Catalytic System	Target Pollutants/Applications	Key Performance Metrics	Operational Advantages	Limitations/Challenges
Microbial Enzymes (Laccases, Peroxidases, Hydrolases)	Pharmaceuticals, dyes, pesticides, phenolic compounds [82]	High degradation efficiency for specific compound classes; Function under mild conditions (pH 4-7, 20-40°C) [82]	Biodegradability; High substrate specificity; Renewable sourcing [82]	Limited stability; Challenges in recovery/reuse; Susceptibility to inhibition [82]
Immobilized Enzymes	Multipollutant mixtures; Continuous flow systems [82]	Enhanced stability (2-10x improvement); Reusability (5-20 cycles); Retention of >70% initial activity after extended use [82]	Protection from denaturation; Easy separation from reaction mixture; Continuous process capability [82]	Potential activity loss during immobilization; Additional material costs; Mass transfer limitations [82]
Powdered Activated Carbon (PAC)	Pharmaceuticals, personal care products, pesticides [85]	70-93% removal efficiency at doses of 10-20 mg/L with 15-30 min contact time [85]	Strong adsorption performance; Mild reaction conditions; Technical maturity [85]	High operational costs at scale; Formation of concentrated residues; Requires additional separation [80] [85]
Advanced Oxidation Processes (AOPs)	Refractory organic compounds; Pharmaceutical residues [80]	>80% removal for PAHs, pesticides, corrosion inhibitors within minutes to hours [86]	Rapid reaction kinetics; Broad-spectrum effectiveness; No concentrated waste streams [80]	Energy intensive; Potential toxic by-product formation; pH dependence [80]
Nature-Based Solutions (Biofilters, Constructed Wetlands)	Mixed organic micropollutants in stormwater [86]	>80% removal for most hydrophobic OMPs; 60%+ for many hydrophilic compounds [86]	Low energy requirements; Multiple ecosystem services; Aesthetic benefits [86]	Land intensive; Variable performance; Limited for emerging refractory pollutants [86]
Nanozymes	Diverse environmental contaminants; Biomedical applications [84]	High catalytic efficiency under extreme conditions; Multifunctional capabilities; Tunable activity [84]	Extraordinary stability; Designable properties; Integration with unique nanoscale phenomena [84]	Complex characterization; Potential nanotoxicity concerns; Regulatory uncertainty [84]

Table 2: Correlation Between Pollutant Characteristics and Removal Efficiency in Nature-Based Solutions

Pollutant Characteristic	Impact on Removal Efficiency	Dominant Removal Mechanism	System Optimization Strategy
Hydrophobicity (log Kₒw)	Significant positive correlation with removal (p < 0.05) [86]	Adsorption to organic matter and biofilms [86]	Media selection with high organic content; Extended hydraulic retention time
Biodegradability	Variable impact based on molecular structure	Microbial degradation [86]	Bioaugmentation with specialized strains; Biofilm support materials
Chemical Functionality	Determines susceptibility to specific enzymes	Enzymatic transformation [82]	Amendment with specific immobilized enzymes; Redox condition manipulation
Molecular Size/Charge	Influences adsorption and membrane passage	Size exclusion; Electrostatic interactions [85]	Tunable membrane materials; Charged media amendments

Experimental Protocols and Methodologies

Immobilized Enzyme Preparation and Evaluation

Protocol: Covalent Immobilization of Laccase for Micropollutant Degradation

Materials Required:

• Purified laccase from Trametes versicolor or recombinant source
• Functionalized support material (e.g., chitosan beads, silica nanoparticles, MOFs)
• Coupling reagents: glutaraldehyde (2.5% v/v), EDC/NHS for carboxyl groups
• Buffer solutions: acetate buffer (pH 4.5-5.0), phosphate buffer (pH 6.0-7.0)
• Model pollutants: carbamazepine, diclofenac, bisphenol-A, or target compounds
• Analytical equipment: HPLC-MS/MS, spectrophotometer [82]

Immobilization Procedure:

• Support Activation: Incubate functionalized support material with 2.5% glutaraldehyde in acetate buffer (0.1 M, pH 5.0) for 2 hours at 25°C with gentle agitation
• Washing: Remove excess cross-linker by repeated centrifugation and washing with coupling buffer
• Enzyme Coupling: Incubate activated support with laccase solution (1-5 mg/mL in coupling buffer) for 12-16 hours at 4°C
• Quenching: Block remaining active sites with 1 M ethanolamine (pH 8.0) for 1 hour
• Final Wash: Remove non-covalently bound enzyme by washing with high-ionic-strength buffer (1 M NaCl) followed by storage buffer [82]

Activity Assessment:

• Free Enzyme Control: Determine specific activity of free laccase using 0.5 mM ABTS in acetate buffer by monitoring A₄₂₀ (ε₄₂₀ = 36,000 M⁻¹cm⁻¹)
• Immobilized Enzyme Activity: Measure activity of immobilized preparation under identical conditions
• Calculation: Determine immobilization yield, activity recovery, and expressed activity using standard formulas [82]

Reusability Testing:

• Conduct batch reactions for 1-hour cycles with fresh substrate solution
• Separate immobilized enzyme by filtration or centrifugation between cycles
• Measure residual activity relative to initial activity over multiple cycles [82]

Powdered Activated Carbon (PAC) Treatment Optimization

Protocol: PAC-Based Micropollutant Removal with Sludge Recirculation

Materials:

• Powdered activated carbon (Norit SAE Super, Donau Carbon)
• Coagulant: FeCl₃ (1-5 mg/L)
• Flocculant: cationic polymer (0.5-1.0 mg/L)
• Synthetic or real wastewater spiked with target micropollutants
• Jar test apparatus with multiple stirring stations
• Analytical equipment: HPLC-MS/MS, TOC analyzer, turbidimeter [85]

Batch Optimization:

• PAC Screening: Test different PAC types at doses of 10, 20, 30, 40 mg/L with 30-minute contact time
• Coagulant/Flocculant Addition: Evaluate FeCl₃ (1-5 mg/L) and polymer (0.5-1.0 mg/L) effects on removal efficiency
• Water Hardness Effects: Assess impact of Ca²⁺ and Mg²⁺ (50-200 mg/L as CaCO₃) on system performance
• Kinetic Studies: Determine adsorption rates with time-series sampling over 5-120 minutes [85]

Pilot-Scale Implementation:

• System Configuration: Set up continuous flow system with contact reactor, lamella separator, sedimentation tank, and recirculation loop
• PAC Recirculation: Implement sludge return ratio of 2-10% to maximize PAC utilization
• Performance Monitoring: Measure micropollutant removal, turbidity, and DOC at various points in the treatment train
• Optimization: Adjust PAC dose (10-20 mg/L), contact time (15-30 min), and recirculation rate based on real-time performance data [85]

Nanozyme Synthesis and Characterization

Protocol: Preparation and Evaluation of Peroxidase-Mimetic Nanozymes

Materials:

• Precursors: FeCl₃·6H₂O, FeCl₂·4H₂O, ammonium hydroxide
• Stabilizers: citrate, PEG, or other surface modifiers
• Substrates: TMB (3,3',5,5'-tetramethylbenzidine), H₂O₂, ABTS
• Buffer solutions: acetate (pH 3.0-5.5), phosphate (pH 6.0-8.0)
• Characterization equipment: TEM, XRD, FTIR, UV-Vis spectrophotometer [84]

Synthesis Procedure:

• Co-precipitation Method:
  • Dissolve Fe³⁺ and Fe²⁺ salts in deoxygenated water at 2:1 molar ratio
  • Add ammonium hydroxide under vigorous stirring to precipitate nanoparticles
  • Heat mixture to 70-90°C for 30-60 minutes with constant stirring
  • Wash nanoparticles repeatedly with deionized water and collect via magnetic separation
  • Redisperse in appropriate buffer for storage [84]

Activity Characterization:

• Steady-State Kinetics:
  • Measure initial reaction rates with varying substrate concentrations
  • Use TMB (0.1-2.0 mM) and H₂O₂ (1-100 mM) in acetate buffer (pH 4.0)
  • Monitor absorbance at 652 nm (ε₆₅₂ = 39,000 M⁻¹cm⁻¹ for oxidized TMB)
  • Determine kinetic parameters (Kₘ, Vₘₐₓ) using Michaelis-Menten analysis [84]

• pH and Temperature Stability:
  • Assess activity across pH range (3.0-9.0) and temperature range (20-80°C)
  • Compare with native horseradish peroxidase under identical conditions [84]

Implementation Framework and SDG Alignment

The strategic implementation of advanced catalytic and biocatalytic systems directly supports achievement of multiple SDG 13 (Climate Action) targets through:

Target 13.2: Climate Change Integration into Policies

• Transforming chemical manufacturing and wastewater treatment sectors toward low-carbon processes
• Reducing greenhouse gas emissions through energy-efficient catalytic routes compared to conventional thermal processes [78] [79]

Target 13.3: Climate Change Education and Awareness

• Building technical capacity for green chemistry implementation across industrial, academic, and governmental sectors
• Mainstreaming sustainable development concepts into chemical education and professional training [78]

Synergies with Other SDGs:

• SDG 3 (Good Health): Reducing toxic micropollutant exposure
• SDG 6 (Clean Water): Improving water quality through advanced treatment
• SDG 9 (Industry/Innovation): Sustainable industrialization through green chemistry
• SDG 12 (Responsible Consumption): Sustainable chemical production and waste minimization [79]

Urban implementation initiatives, such as the Los Angeles Green New Deal, demonstrate how local climate action plans can integrate advanced catalytic technologies for pollution mitigation while creating green job opportunities in sustainable chemistry [87].

Visualization of Catalytic Systems and Workflows

Catalytic Technologies for Environmental Remediation

Enzyme Immobilization Strategies and Benefits

SDG Integration Framework for Catalytic Technologies

Research Reagent Solutions Toolkit

Table 3: Essential Research Reagents for Catalysis and Biocatalysis Studies

Reagent/Material	Function/Application	Key Characteristics	Representative Examples
Microbial Enzymes	Biocatalytic degradation of pollutants	High specificity, biodegradable, renewable	Laccases from Trametes versicolor, Peroxidases from Bacillus species [82]
Immobilization Supports	Enzyme stabilization and reuse	High surface area, functionalizable, stable	Chitosan beads, silica nanoparticles, metal-organic frameworks (MOFs) [82]
Nanomaterials	Nanozyme development, nanobiohybrids	Intrinsic catalytic activity, tunable properties	Fe₃O₄ nanoparticles, gold nanoparticles, carbon nanotubes [83] [84]
Activated Carbons	Adsorptive pollutant removal	High surface area, porous structure, modifiable surface	Powdered Activated Carbon (Norit, Donau) [85]
Advanced Oxidation Reagents	Radical-mediated degradation	Powerful oxidizing capacity, broad applicability	Hydrogen peroxide, ozone, persulfate activators [80]
Mediator Compounds	Electron shuttles for enzyme systems	Redox-active, low molecular weight	ABTS, HBT, syringaldazine for laccase systems [82]
Analytical Standards	Quantification of micropollutants	High purity, stable isotopically labeled	Pharmaceutical compounds, pesticide standards, internal standards [80] [85]

Catalysis and biocatalysis represent transformative approaches for developing efficient, low-waste synthesis routes that directly address the interconnected challenges of micropollutant contamination and climate change. The integration of enzyme technologies, advanced materials, and process innovations creates powerful synergies that advance multiple Sustainable Development Goals, particularly SDG 13 (Climate Action) through reduced energy consumption, minimized waste generation, and sustainable resource utilization.

Future research priorities should focus on:

• Advanced Material Development: Designing next-generation nanozymes and nanobiohybrids with enhanced specificity and activity under environmentally relevant conditions
• Process Intensification: Optimizing hybrid systems that combine biological and chemical catalysis for maximum efficiency and minimal environmental footprint
• Machine Learning Integration: Utilizing predictive modeling for enzyme design, reaction optimization, and system performance forecasting
• Circular Economy Applications: Developing catalytic processes that transform waste streams into value-added products, closing material loops
• Policy Implementation Frameworks: Creating technical guidelines and regulatory pathways to accelerate adoption of sustainable catalytic technologies

The continued advancement and implementation of these technologies will be essential for achieving global sustainability targets and creating a circular, low-carbon economy that effectively addresses the pressing challenges of environmental pollution and climate change.

The pharmaceutical industry stands at a critical juncture, facing the dual challenge of maintaining global health while addressing its significant environmental footprint. Pharmaceutically active micropollutants (PhAMPs) have emerged as a concerning class of environmental contaminants, detected in surface waters, groundwater, and even drinking water supplies at concentrations ranging from ng/L to μg/L [7]. These persistent compounds, designed to elicit biological responses, circumvent conventional wastewater treatment systems and pose threats to aquatic ecosystems and human health through bioaccumulation and potential antibiotic resistance development [7] [1].

The circular economy framework presents a transformative approach to these challenges, seeking to redefine waste as a resource and close material loops throughout the pharmaceutical value chain. This paradigm shift encompasses both waste valorization strategies that extract value from by-products and the transition to renewable feedstocks that reduce dependence on finite fossil resources. When implemented effectively, these approaches directly support multiple United Nations Sustainable Development Goals (SDGs), including SDG 3 (Good Health and Well-being), SDG 6 (Clean Water and Sanitation), SDG 9 (Industry, Innovation and Infrastructure), SDG 12 (Responsible Consumption and Production), and SDG 13 (Climate Action) [88].

This technical guide examines current practices, methodologies, and implementation frameworks for integrating circular economy principles into pharmaceutical research, development, and manufacturing, with particular emphasis on their role in mitigating the environmental impact of pharmaceutical micropollutants.

Waste Valorization: From Linear Disposal to Circular Resource

The Scope of Pharmaceutical Waste

Pharmaceutical waste encompasses a heterogeneous stream including expired medications, manufacturing by-products, solvents, and contaminated packaging materials. The World Health Organization classifies this waste into multiple categories: pathological, pharmaceutical, cytotoxic, sharps, infectious, non-hazardous, and radioactive [89]. Notably, only approximately 15% of pharmaceutical waste is classified as hazardous, while the remaining 85% constitutes general waste, though this distinction varies by compound and concentration [89].

The environmental persistence of pharmaceuticals stems from their inherent design properties: they are engineered for structural stability to maintain efficacy during storage, possess lipophilic characteristics to cross biological membranes, and demonstrate resistance to enzymatic degradation and low pH environments [7]. These same properties complicate degradation in natural environments and conventional treatment systems, leading to their classification as persistent, mobile compounds in aquatic systems [1].

Current Industry Practices and Performance

Leading pharmaceutical companies have established ambitious targets and implemented various waste valorization strategies. The table below summarizes key performance data and initiatives from industry leaders.

Table 1: Pharmaceutical Industry Waste Valorization Initiatives and Performance Metrics

Company/Initiative	Valorization Strategy	Key Performance Metrics	Technical Process
Sanofi [90]	Solvent regeneration and reuse	58% of solvents regenerated and reintroduced into industrial processes (2024)	On-site treatment and purification of used solvents
Sanofi [90]	Biowaste methanization	>99% of heparin production biowaste converted to biomethane	Anaerobic digestion of pig mucosa waste
Sanofi [90]	Industrial symbiosis	89% of operational waste reused, recycled, or recovered (2024)	Categorization, segregation, and specialized treatment
AstraZeneca [91]	Silica waste repurposing	~80% landfill reduction at Coppell, Texas site	Wastewater treatment with silica separation for construction materials
AstraZeneca [91]	Heat recovery from wastewater	5 GWh annual energy savings (Södertälje, Sweden)	Heat pumps extracting thermal energy from wastewater
Cross-company (Returpen) [90]	Medical device recycling	5.2 million injection pens annually in Denmark	Reverse logistics through pharmacy collection points

Analytical Framework for Waste Valorization Potential

The selection of appropriate valorization pathways requires systematic evaluation of waste streams. The following diagram illustrates the decision framework for prioritizing pharmaceutical waste valorization opportunities.

Waste Valorization Decision Framework

Experimental Protocol: Biowaste to Biomethane Conversion

The conversion of biological waste streams to biomethane represents a promising valorization pathway for fermentation-derived pharmaceuticals and vaccine production.

Objective: Convert heparin production waste (pig mucosa) to biomethane through anaerobic digestion.

Materials:

• Anaerobic digester system: 5L laboratory-scale bioreactor with gas collection
• Inoculum: Anaerobically digested sewage sludge (1.5L)
• Substrate: Heparin production waste (pig mucosa) - homogenized
• Anaerobic chamber: For maintaining oxygen-free environment
• Gas chromatography system: For biogas composition analysis
• pH and temperature monitoring system

Methodology:

• Substrate Preparation: Homogenize pig mucosa waste using a laboratory blender. Determine total solids (TS) and volatile solids (VS) content according to Standard Methods 2540B and 2540E.
• Inoculum Acclimation: Mix inoculum with substrate at 1:3 ratio (based on VS) and maintain at 35±1°C for 14 days to acclimate microorganisms.
• Batch Assembly: Combine acclimated inoculum (400mL) with substrate (100mL based on VS) in 1L digestion bottles. Maintain substrate to inoculum ratio of 0.5 based on VS.
• Process Controls: Set up controls containing only inoculum and distilled water to account for background gas production.
• Anaerobic Conditions: Flush headspace with nitrogen gas (N₂) for 3 minutes to establish anaerobic conditions.
• Incubation: Place bottles in temperature-controlled shaker (35±1°C, 100 rpm) for 45 days.
• Monitoring: Measure biogas production daily by water displacement method. Analyze biogas composition via gas chromatography twice weekly.
• Parameter Analysis: Monitor pH, volatile fatty acids (VFA), and chemical oxygen demand (COD) weekly.

Data Analysis: Calculate biomethane potential (BMP) using the formula:

This protocol can be adapted for various biological waste streams, including vaccine production waste and fermentation residues [90].

Renewable Feedstocks: Transitioning from Fossil to Bio-Based

The Renewable Feedstock Imperative

The transition to renewable feedstocks represents a fundamental shift from petrochemical-based pharmaceutical synthesis to bio-based production routes. Lignocellulosic biomass, comprising approximately 70% of all annually produced land biomass (170-200 × 10⁹ tons yr⁻¹), offers a promising non-edible feedstock source that avoids competition with food production [92]. Unlike fossil resources that require functionalization, biomass feedstocks are already highly functionalized, containing oxygen-rich functional groups that provide synthetic handles for transformation into valuable pharmaceutical intermediates.

The compositional complexity of biomass necessitates novel processing approaches compared to traditional petrochemical refining. Where fossil feedstocks are typically processed in the gas phase at elevated temperatures, biorefining operations predominantly occur in liquid phase, frequently in polar solvents like water, at moderate temperatures to preserve the functionality of thermally labile biomolecules [92].

Catalytic Transformation Platforms

The selective defunctionalization of biomass components presents significant catalytic challenges. The table below summarizes key catalytic platforms for transforming renewable feedstocks into pharmaceutical intermediates.

Table 2: Catalytic Platforms for Renewable Feedstock Transformation

Catalytic Platform	Target Transformation	Exemplary Catalyst Systems	Key Pharmaceutical Intermediates
Hydrodeoxygenation	Selective oxygen removal from polyols	Ir-ReOₓ/SiO₂, Pt/CoAl₂O₄, Ru/C with HZSM-5	n-Hexane (from cellulose), Linear alkanes
Hydrogenolysis	C-O bond cleavage in sugar alcohols	Supported metal catalysts (Pt, Pd, Ru) with acidic/basic sites	Ethylene glycol, Propylene glycol
Ring-Opening Hydrogenation	Furanics to diols	Pd-doped Ir-ReOₓ/SiO₂, Pd/ZrPO₄, Ru/C with Ir-ReOₓ/SiO₂	1,5-Pentanediol (from furfural), 1,6-Hexanediol (from HMF)
Deoxydehydration	Simultaneous removal of two OH groups	Homogeneous Mo-based complexes, ReOₓ-based systems	Conjugated dienes from sugar alcohols
Biocatalysis	Selective functional group interconversion	Engineered enzymes, whole-cell systems	Chiral alcohols, amines, pharmaceutical building blocks

Experimental Protocol: Continuous Flow Transformation of HMF

5-Hydroxymethylfurfural (HMF) represents a key biomass-derived platform chemical with numerous pharmaceutical applications. This protocol details its transformation in continuous flow systems for enhanced efficiency.

Objective: Convert HMF to 2,5-bis(hydroxymethyl)furan (BHMF) via continuous flow hydrogenation.

Materials:

• Continuous flow reactor system: Micronit MR-560 with temperature control
• Catalyst: Ru/C (5 wt% Ru) packed in reactor (50 μL bed volume)
• Substrate solution: 0.1 M HMF in ethanol
• High-pressure syringe pumps: For precise reagent delivery
• Back-pressure regulator: Maintain system pressure at 20 bar
• HPLC system: For reaction monitoring and product quantification
• Hydrogen gas: 99.99% purity

Methodology:

• Catalyst Packing: Pack Ru/C catalyst into reactor module using slurry packing method with ethanol as suspension medium.
• System Assembly: Connect reactor to syringe pumps, back-pressure regulator, and product collection vessel. Pressure-test system with ethanol at 30 bar.
• Catalyst Activation: Flow hydrogen gas (50 mL/min) through reactor at 150°C and atmospheric pressure for 2 hours to reduce catalyst.
• Reaction Conditions: Set reactor temperature to 80°C and system pressure to 20 bar using back-pressure regulator.
• Reagent Delivery: Deliver substrate solution (0.1 mL/min) and hydrogen gas (5 mL/min) to reactor using T-mixer.
• Process Optimization: Systematically vary parameters (temperature: 60-120°C, pressure: 10-30 bar, residence time: 1-10 minutes) to optimize conversion and selectivity.
• Product Collection: Collect liquid effluent in cooled collection vessel and analyze by HPLC at 30-minute intervals.
• Long-term Stability: Operate continuously for 24+ hours to assess catalyst deactivation.

Analytical Methods:

• HPLC Analysis: C18 column, mobile phase: water/acetonitrile gradient, detection: UV at 280 nm
• Product Identification: NMR spectroscopy for structural confirmation
• Turnover Frequency (TOF) Calculation: moles BHMF produced / (moles surface Ru × time)

This continuous flow approach typically achieves >95% HMF conversion with >90% selectivity to BHMF at optimized conditions, demonstrating advantages over batch processes in mass transfer and scalability [93] [92].

Advanced Separation Strategies for Biomass-Derived Compounds

The separation of target molecules from complex biomass-derived reaction mixtures presents distinct challenges. Traditional distillation is often unsuitable for thermally labile oxygenated compounds, necessitating alternative approaches:

Membrane Separation: Polymeric nanofiltration membranes with molecular weight cut-offs of 200-400 Da effectively separate HMF from sugar substrates in aqueous media.

Adsorption Processes: Functionalized resins with controlled hydrophobicity selectively recover fermentation-derived products like succinic acid from broth.

Aqueous Biphasic Systems: Smart systems using stimuli-responsive polymers or switchable solvents enable energy-efficient product recovery.

The integration of advanced separation early in process development is critical for viable renewable feedstock utilization [92].

Integrated Circular Pharmaceutical Supply Chain

Systems Approach to Circularity

Achieving meaningful circularity in the pharmaceutical sector requires a systems perspective that integrates multiple stakeholders and circular strategies. The following diagram maps the interconnected pathways of a circular pharmaceutical supply chain.

Circular Pharmaceutical Supply Chain Framework

Multi-Stakeholder Implementation Framework

Successful implementation of circular economy principles requires coordinated action across multiple stakeholders:

Government & Regulatory Bodies:

• Establish extended producer responsibility (EPR) schemes for pharmaceutical waste
• Implement green procurement policies favoring circular products
• Develop standards for recycled content in pharmaceutical packaging
• Fund research on advanced recycling technologies for complex materials

Healthcare Providers & Pharmacies:

• Implement medication take-back programs (e.g., Returpen in Denmark, RECYPEN in France) [90]
• Optimize inventory management to reduce expiration
• Educate patients on proper medication disposal
• Participate in reverse logistics for medical devices

Pharmaceutical Manufacturers:

• Integrate green chemistry principles into R&D (e.g., Evonik's flow chemistry and surfactant technologies) [93]
• Design products for disassembly and recyclability
• Implement industrial symbiosis partnerships
• Develop closed-loop solvent recovery systems

Research Institutions:

• Advance catalytic systems for biomass conversion
• Develop analytical methods for micropollutant detection
• Engineer biodegradable pharmaceutical compounds
• Create assessment frameworks for circularity metrics

The Scientist's Toolkit: Research Reagents for Circular Pharma

Table 3: Essential Research Reagents and Materials for Circular Pharmaceutical Research

Reagent/Material	Function	Application Examples	Sustainability Considerations
Supported Metal Catalysts (Ru/C, Pt/Al₂O₃, Pd/C)	Hydrogenation, hydrodeoxygenation	Biomass upgrading, solvent recycling	Recovery and regeneration potential
Enzyme Preparations (Lipases, peroxidases, cytochrome P450s)	Biocatalysis	Selective synthesis, pollutant degradation	Biodegradability, mild reaction conditions
Ionic Liquids (Imidazolium, cholinium-based)	Green solvents, catalysis	Biomass dissolution, reaction media	Recyclability, toxicity profile
Functionalized Adsorbents (Molecularly imprinted polymers, activated carbon)	Selective separation	Micropollutant removal, product recovery	Regeneration capacity, selectivity
Metagenomic Libraries	Enzyme discovery	Novel biocatalyst identification	Access to uncultured microbial diversity
Switchable Solvents (CO₂-triggered polarity changes)	Tunable separation	Product isolation, catalyst recycling	Energy efficiency, reusability
Continuous Flow Reactors (Microreactors, packed beds)	Process intensification	Safe handling of intermediates, improved efficiency	Reduced footprint, enhanced safety

The integration of circular economy principles through waste valorization and renewable feedstocks represents a transformative pathway for reducing the pharmaceutical industry's environmental impact, particularly regarding pharmaceutical micropollutants. The methodologies and frameworks presented in this guide provide researchers and industry professionals with practical approaches for implementing these strategies.

Significant research challenges remain, including:

• Advanced Analytical Methods: Developing more sensitive detection methods for pharmaceutical micropollutants at environmentally relevant concentrations (ng/L) [7] [1]
• Catalytic Innovation: Designing multifunctional catalysts for selective transformations of complex biomass components [92]
• Biodegradable Pharmaceuticals: Engineering pharmaceutical compounds with reduced environmental persistence while maintaining therapeutic efficacy [7]
• Circular Design Principles: Establishing guidelines for designing pharmaceutical products and processes with inherent circularity [90] [91]
• Policy Integration: Aligning regulatory frameworks with circular economy objectives to create enabling environments for innovation [94] [88]

As the pharmaceutical industry advances along this circular trajectory, the integration of green chemistry, renewable feedstocks, and waste valorization strategies will be essential for achieving sustainable healthcare systems that deliver both human and environmental health benefits.

The transition to green processes is a critical component of achieving the United Nations Sustainable Development Goals (SDGs), particularly in specialized fields such as environmental chemistry and pharmaceutical development. This whitepaper provides a comprehensive analysis of the technical and economic barriers hindering the widespread adoption of these sustainable methodologies. By synthesizing current research and presenting structured frameworks, quantitative data, and experimental protocols, we offer researchers and drug development professionals actionable strategies for implementing green processes in micropollutant management and medicinal chemistry. The integration of technological innovation with systemic policy approaches emerges as a critical pathway for overcoming implementation challenges and accelerating progress toward sustainability targets.

Green processes represent transformative methodologies designed to achieve better environmental performance than conventional counterparts, directly supporting the transition to a sustainable future [95]. Within environmental chemistry, particularly concerning micropollutants and pharmaceutical contaminants, these processes fulfill three essential functions: mitigating adverse production effects on ecosystems, recuperating damaged environments, and decontaminating polluted systems while recovering valuable materials [95]. The strategic implementation of green processes aligns with multiple SDGs, including Clean Water and Sanitation (SDG 6), Good Health and Well-being (SDG 3), Responsible Consumption and Production (SDG 12), and Life Below Water (SDG 14) [6] [96].

The pharmaceutical industry and environmental chemistry research face a critical juncture in addressing Contaminants of Emerging Concern (CECs), which include pharmaceutical residues, personal care products, and engineered nanomaterials [6]. These substances pose significant ecotoxicological threats through mechanisms such as bioaccumulation and antibiotic resistance development, with current research efforts hampered by global data imbalances that favor Global North perspectives [6]. Overcoming these challenges requires both technical innovation and economic restructuring, framed within a holistic understanding of sustainability that balances ecological preservation with societal well-being [95].

Technical Barriers and Advanced Solutions

Analytical and Process Design Challenges

The development of effective green processes for micropollutant management faces significant technical hurdles, primarily stemming from the complex nature of environmental matrices and the limitations of existing treatment methodologies. Contaminants of Emerging Concern (CECs) exhibit diverse chemical structures and persistence, requiring sophisticated analytical approaches for detection and removal [6]. A critical global challenge is the data imbalance in CEC research, with approximately 75% of studies focused on North America and Europe despite the majority of the global population residing in Asia and Africa [6]. This geographical bias leads to technological solutions that may be inappropriate for regions with different pollution profiles, ecosystems, and infrastructure capabilities.

The detection and analysis of micropollutants requires advanced instrumentation and method development to address the wide concentration ranges and matrix effects in environmental samples. Research indicates that analytical methodologies must be adapted to specific regional contexts to account for varying contamination profiles and environmental conditions [6]. For example, studies have identified that pharmaceutical pollutants can have drastically different impacts on ecosystems based on local species and environmental factors, necessitating customized approaches rather than one-size-fits-all solutions [6].

Technological Implementation Frameworks

Implementing green processes at scale requires systematic approaches to technology adoption and optimization. Research demonstrates that successful implementation follows a technology adoption framework that evaluates multiple technical parameters, including emission profiles, waste stream management, supply chain risks, and life cycle environmental impacts [97]. These factors must be assessed holistically rather than in isolation to avoid unintended consequences or suboptimal environmental outcomes.

Table 1: Technical Barrier Assessment Framework for Green Processes

Barrier Category	Specific Parameters	Assessment Method	Mitigation Strategies
Analytical Capabilities	Detection limits, Matrix effects, Method sensitivity	Method validation using reference materials	Hyphenated techniques, Advanced mass spectrometry, Sample pre-concentration
Process Efficiency	Conversion rates, Energy consumption, Byproduct formation	Techno-economic analysis, Life cycle assessment	Catalyst development, Process intensification, Reactor design optimization
Environmental Impact	Emissions to air/water, Waste generation, Ecotoxicity	Life cycle assessment, Environmental risk assessment	Green chemistry principles, Waste valorization, Circular economy integration
Scale-up Challenges	Mass/heat transfer, Mixing efficiency, Separation performance	Pilot plant studies, Computational modeling	Modular design, Continuous processing, Advanced process control

A promising case study in overcoming technical barriers is the enzymatic recycling of polyethylene terephthalate (PET), which employs biological catalysts to depolymerize plastic waste into reusable monomers [97]. This process represents a green alternative to conventional plastic recycling, operating at moderate temperatures and avoiding hazardous solvents. The technology successfully addresses multiple technical challenges through enzyme engineering to improve stability and activity, process optimization to enhance reaction rates, and product purification to obtain materials suitable for repolymerization [97].

Economic Challenges and Adoption Barriers

Financial and Market Implementation Hurdles

The adoption of green processes faces significant economic challenges that often deter organizations from transitioning from conventional methods. Comprehensive analyses identify high initial investment costs as a primary barrier, particularly for advanced technologies requiring specialized equipment or infrastructure modifications [98] [99]. Additionally, longer project timelines for implementation and limited access to financing further constrain adoption, especially for small and medium enterprises [98]. These financial barriers create a perceived conflict between economic and environmental objectives, despite evidence that green processes can yield long-term economic benefits through efficiency gains and resource conservation [99].

Economic modeling reveals that technology adoption follows complex adaptive dynamics influenced by increasing returns to scale and network effects [100]. This creates a tendency for markets to become locked into established brown technologies even when superior green alternatives exist, due to accumulated infrastructure, knowledge, and supply chain development around conventional processes [100]. Breaking this path dependency requires targeted policy interventions that reshape economic incentives and reduce perceived risks for early adopters.

Table 2: Economic Barriers to Green Process Adoption

Barrier Category	Specific Challenges	Impact Metrics	Exemplary Data
Financial Constraints	High upfront costs, Limited financing access, Longer payback periods	Capital expenditure, Return on investment, Project timelines	Solar installations: 18-25% cost increase due to tariffs [101]
Market Structure	Established competitors, Supply chain limitations, Customer resistance	Market share, Adoption rate, Production capacity	EV price increases of 15% post-tariffs slow consumer adoption [101]
Regulatory Compliance	Permitting complexity, Emission standards, Waste disposal regulations	Compliance costs, Timeline delays, Administrative burden	10.5 GW of planned U.S. solar installations cancelled due to trade barriers [101]
Innovation Investment	R&D funding gaps, Demonstration scale-up risks, Intellectual property issues	R&D expenditure, Patent filings, Pilot projects	35-40% decline in clean tech R&D investment with trade barriers [101]

Policy and Behavioral Economics

Overcoming economic barriers requires understanding the behavioral and systemic factors that influence technology adoption decisions. Research integrating the Theory of Planned Behavior (TPB) and Diffusion of Innovations Theory (DIT) demonstrates that successful adoption depends on both individual factors (attitudes, perceived control, subjective norms) and systemic enablers (government support, regulatory frameworks, market infrastructure) [99]. This integrated approach reveals that government policies play a crucial role in reshaping organizational beliefs and overcoming initial resistance based on past experiences with conventional technologies [99].

Trade policies and international relations significantly impact the economic viability of green processes, as evidenced by recent tariff implementations. Protectionist trade measures have been shown to increase costs for critical clean technology components by 18-25% for steel mounting systems and 20% for solar cells, while electric vehicle prices rose by an average of 15% following tariff implementation [101]. These cost increases directly threaten emission reduction targets by slowing the deployment of renewable energy and clean transportation alternatives [101].

Integrated Methodologies and Experimental Approaches

Assessment Protocols and Workflows

Implementing green processes requires systematic assessment methodologies that evaluate both technical performance and sustainability metrics. The following workflow illustrates the integrated approach necessary for comprehensive technology evaluation:

Technology Assessment Workflow

The experimental protocol for evaluating green processes incorporates both laboratory-scale validation and system-level assessment:

• Technology Screening and Selection: Identify candidate processes based on green chemistry principles and SDG alignment [95] [96]. Prioritize technologies addressing specific environmental challenges, such as micropollutant removal or waste valorization.

• Barrier Assessment Implementation: Apply a comprehensive framework evaluating air pollutant emissions, wastewater and solid waste streams, production costs, economic impacts, life cycle environmental effects, and supply chain risks [97]. Assign numerical values to each barrier based on comparison with regulatory requirements, existing technologies, and sustainability benchmarks.

• Techno-economic Analysis (TEA): Conduct detailed cost assessment including capital expenditure, operating costs, sensitivity analysis, and break-even analysis [97]. For enzymatic recycling case studies, analyze at multiple scales (e.g., 50,000 and 100,000 metric tons/year) to evaluate economies of scale [97].

• Life Cycle Assessment (LCA): Quantify environmental impacts across the entire value chain using established methodologies (e.g., ISO 14040/14044) [97]. Include categories such as global warming potential, resource depletion, ecotoxicity, and human health impacts.

• Adoption Rate Modeling: Utilize Bass diffusion curves and other quantitative models to estimate technology adoption rates based on barrier strength and market conditions [97]. Identify specific barriers that most significantly impact adoption potential.

Research Reagent Solutions for Micropollutant Analysis

Table 3: Essential Research Reagents for Green Process Development

Reagent/Material	Function and Application	Technical Specifications	Sustainability Considerations
Enzymatic Catalysts	Biocatalysis for polymerization/depolymerization	PET-depolymerizing enzymes (IC), optimized activity (>500 U/mg)	Biodegradable, renewable production hosts [97]
Advanced Oxidation Materials	Photocatalytic micropollutant degradation	TiO₂-based catalysts, specific surface area >100 m²/g	Minimal secondary waste generation [6]
Molecularly Imprinted Polymers	Selective contaminant recognition and removal	High binding capacity (>50 mg/g), specificity coefficients	Reusability (>100 cycles), regeneration capacity [6]
Green Solvents	Alternative reaction media for synthesis	Bio-based solvents, ionic liquids, supercritical CO₂	Low toxicity, renewable feedstocks, biodegradable [96]
Analytical Reference Standards	Contaminant quantification and method validation	Certified reference materials for CECs (purity >98%)	Minimal hazardous solvent use in analysis [6]

Strategic Implementation Framework

Policy Integration and Global Collaboration

Effective implementation of green processes requires policy frameworks that address both technical and economic dimensions. Research indicates that optimal temporal patterns for subsidies follow a decreasing trajectory, providing strong initial support that phases out as technologies achieve market competitiveness [100]. Additionally, Pigouvian taxes on conventional processes must be carefully calibrated to avoid unintended consequences, as they may conflict with clean technology adoption in certain market conditions [100].

Addressing the global data imbalance in contaminant research requires explicit acknowledgement of resource inequalities and colonial legacies that shape current research priorities [6]. Actionable recommendations include developing equitable research collaborations that respect Indigenous knowledge systems, adapting sampling and analysis protocols to local contexts, ensuring fair funding mechanisms, and employing sensitive language that challenges capitalist and colonial narratives [6]. These approaches are essential for developing globally relevant solutions to micropollutant challenges.

The following strategic framework illustrates the interconnected components required for successful green process implementation:

Strategic Implementation Framework

Pathway Forward and Research Priorities

Accelerating the adoption of green processes in environmental chemistry and pharmaceutical development requires focused attention on key research priorities and implementation strategies. Critical areas for further investigation include:

• Advanced Analytical Methodologies: Development of sensitive, selective, and accessible techniques for monitoring micropollutants across diverse environmental contexts, with particular emphasis on addressing data gaps in Global South regions [6].

• Circular Economy Integration: Designing processes that not only eliminate contaminants but also recover valuable resources, creating economic incentives while addressing pollution challenges [95] [97].

• Decision Support Tools: Creating comprehensive frameworks that integrate technical, economic, and social dimensions to guide policymakers, investors, and researchers in prioritizing green process investments [97] [99].

• Equitable Knowledge Co-production: Establishing research paradigms that respectfully integrate Indigenous knowledge systems and local community perspectives, particularly in regions disproportionately affected by contaminant pollution [6].

The successful implementation of green processes will require unprecedented collaboration across disciplines, sectors, and geographic boundaries. By addressing both technical and economic barriers through integrated approaches that align environmental and social objectives with economic viability, the scientific community can accelerate progress toward achieving the Sustainable Development Goals while addressing the pressing challenge of micropollutant contamination.

Policy, Validation, and Comparative Analysis: Frameworks for Safe and Sustainable Implementation

The EU Chemical Strategy and Safe and Sustainable by Design (SSbD) Framework

The European Union's Chemicals Strategy for Sustainability (CSS) represents a foundational pillar of the European Green Deal, establishing an ambitious pathway toward a toxic-free environment. This strategy directly confronts the critical challenge that the planetary boundary for chemical pollution has been exceeded, driven by the growing volume and diversity of chemicals in use [102]. As the second-largest chemical producer globally by sales value, the EU's production and consumption patterns have significant implications for human health and environmental integrity both within and beyond Europe [102]. The CSS outlines over 80 specific actions to fundamentally transform chemical risk management through two complementary approaches: strengthening regulatory frameworks and promoting voluntary innovation initiatives [103].

Central to this transformative agenda is the Safe and Sustainable by Design (SSbD) Framework, a voluntary approach announced in December 2022 through a Commission Recommendation [104] [105]. This framework serves as a decision support tool to steer innovation toward safer and more sustainable chemicals and materials, benefiting users and consumers alike while strengthening industrial competitiveness [106]. The SSbD framework embodies the strategic principle that addressing chemical impacts most effectively requires intervention at the earliest stages of product conception and design, rather than managing consequences after market introduction. By integrating safety and sustainability considerations throughout the innovation process, the framework aims to substitute or minimize the production and use of substances of concern beyond regulatory obligations, while simultaneously minimizing impacts on health, climate, and environment throughout the chemical lifecycle [104].

The SSbD Framework: Structure and Operational Components

Core Framework Architecture

The SSbD framework is architecturally structured around iterative design and assessment phases applied throughout the innovation lifecycle. The (re-)design phase involves applying guiding principles to steer development processes, while the assessment phase comprises a multi-step evaluation that becomes increasingly refined as data availability improves throughout innovation maturity stages [104]. This structure accommodates different stages of innovation maturity, from early research to commercial development, making it particularly valuable for assessing innovations at low Technology Readiness Levels [106].

The framework follows life cycle thinking principles with assessment components organized into five iterative steps:

• Step 1: Hazard Assessment – Evaluation of intrinsic properties of the chemical or material
• Step 2: Human Health and Safety in Production – Assessment of worker exposure during production and processing
• Step 3: Safety in Application – Evaluation of exposure and risks during the use phase
• Step 4: Environmental Sustainability – Life cycle environmental impact assessment
• Step 5: Socio-Economic Sustainability – Analysis of broader societal and economic impacts [105]

A crucial starting point is the Scoping Analysis, which contextualizes the assessment by defining the chemical or material under consideration, its lifecycle, function, redesign parameters, and innovation maturity aspects. This scoping provides the necessary foundation for conducting context-specific SSbD assessments with clearly defined boundaries [105].

Recent Framework Evolution

The SSbD framework has undergone substantial refinement through a comprehensive two-year testing period involving over 80 case studies, stakeholder workshops, and feedback rounds [106]. In July 2025, the European Commission launched a public consultation on a revised version of the SSbD Framework, with the survey open until September 15, 2025 [106]. This revision introduces several new elements, including a streamlined 'Scoping Analysis' to guide innovators, a unified safety assessment approach, and an Environmental Sustainability Assessment benchmark [106]. The revised framework is expected to serve as the foundation for a Commission Recommendation later in 2025, further bolstering the EU's leadership in safe, sustainable, and competitive innovation [106].

Table 1: Core Components of the SSbD Framework

Component	Description	Key Innovations in 2025 Revision
Scoping Analysis	Defines assessment boundaries, innovation maturity, and lifecycle parameters	Unified approach to guide innovators
Safety Assessment	Integrated evaluation of hazard, exposure, and risk across lifecycle	Combined hazard and exposure assessment approach
Environmental Sustainability	Lifecycle environmental impact evaluation	Benchmarking system for assessment
Socio-Economic Assessment	Analysis of broader societal impacts	Enhanced practicality focus
Iterative Application	Framework applicable across technology readiness levels	Improved guidance for early-stage innovation

Interfacing with Micropollutant Challenges: Policy and Technical Dimensions

Micropollutants as a Test Case for SSbD Implementation

The management of micropollutants represents a critical test case for the practical implementation of both the CSS and SSbD Framework. Micropollutants encompass diverse compounds including pharmaceuticals, personal care products, pesticides, and industrial chemicals that persist in aquatic environments at concentrations ranging from micrograms to nanograms per liter [2]. These substances pose significant challenges due to their persistence, bioaccumulation potential, and capacity for endocrine disruption in aquatic organisms [107] [2]. A large-scale 2024 study screening rivers across 22 European countries detected 504 harmful substances—175 of them pharmaceuticals like painkillers and antidepressants—demonstrating the pervasive nature of this contamination [107].

The revised Urban Wastewater Treatment Directive represents a crucial regulatory response that interfaces directly with the SSbD approach. This directive, effective from January 2025, mandates that wastewater treatment plants serving more than 150,000 people implement advanced "quaternary" treatment technologies—such as ozonation and activated carbon filtration—between 2027 and 2045 [107]. These advanced treatments are designed to reduce micropollutant levels by at least 50%, representing a significant advancement over conventional treatment methods that are largely ineffective against many persistent and mobile substances [107] [108].

The Polluter-Pays Principle and Industry Response

A particularly innovative aspect of the wastewater directive is its application of the polluter-pays principle, requiring the pharmaceutical and cosmetics industries to cover 80% of the construction and operating costs of advanced treatment systems [107]. This approach has generated significant opposition from industry groups, who have filed numerous complaints with the European Court of Justice and are lobbying for alternative cost-sharing models [107]. Industry representatives argue that focusing solely on two sectors fails to incentivize greener product development across all polluters and could potentially limit access to essential medicines [107].

This regulatory tension highlights the critical importance of the SSbD Framework's preventive approach. By encouraging the design of chemicals that break down into harmless molecules or can be effectively removed through conventional treatment processes, the framework addresses contamination at its source rather than relying solely on end-of-pipe solutions [107] [102]. Environmental economists and water utilities argue that the polluter-pays model creates essential market incentives for manufacturers to develop safer alternatives, whereas alternative funding models would eliminate this crucial incentive signal [107].

Table 2: Key Micropollutants of Concern and Their Impacts

Micropollutant Category	Example Compounds	Primary Environmental Concerns	Evidence from Studies
Pharmaceuticals	Diclofenac, Metformin, Ibuprofen	Kidney damage in fish; sex changes in aquatic organisms; increased mortality	Diclofenac found in 75% of German surface water samples [107]
Personal Care Products	Triclocarban, Alkyl-hydroxybenzoates	Endocrine disruption; estrogenic effects	Estrogenic impacts in rats; weak estrogenic activities observed [2]
Per- and Polyfluoroalkyl Substances (PFAS)	Short-chained PFAS	High mobility and persistence; contamination of drinking water sources	Particularly prone to escape conventional wastewater treatment [108]
Industrial Chemicals	Bisphenol A, 2-OH-benzothiazole	Hormonal effects; increased cancer risk	Elevated breast cancer risk in humans [2]

Methodological Guide: SSbD Assessment Protocols and Experimental Approaches

SSbD Assessment Workflow

The SSbD assessment follows a systematic workflow that integrates safety and sustainability considerations throughout the innovation process. The diagram below illustrates this iterative assessment workflow:

Analytical Methods for Micropollutant Assessment

The experimental protocols for assessing micropollutant impacts within the SSbD framework involve sophisticated analytical techniques capable of detecting contaminants at minute concentrations. The primary methodologies include:

• Chromatography-Spectroscopy Hybrid Techniques: These represent the gold standard for micropollutant detection, typically combining high-performance liquid chromatography (HPLC) with mass spectrometry (LC-MS/MS) or tandem mass spectrometry (MS/MS) to achieve the required sensitivity and selectivity for complex environmental matrices [2].

• Sample Preparation Protocols: Solid-phase extraction (SPE) is routinely employed to concentrate samples and remove matrix interferences, significantly enhancing detection limits for trace-level contaminants. This is particularly crucial for detecting pharmaceuticals and personal care products in wastewater effluents, where concentrations typically range from ng/L to μg/L [2].

• Bioanalytical Methods: Cell-based bioassays and whole-organism toxicity testing provide critical information on biological effects that complement chemical analytics. These include estrogen receptor activation assays for endocrine disruptors and fish embryo toxicity tests, which are increasingly used as standardized screening tools [107] [2].

• Non-Target Screening Approaches: High-resolution mass spectrometry (HRMS) enables the detection and identification of unknown contaminants through suspect screening and non-target analysis, addressing the critical challenge of "unknown unknowns" in chemical assessment [108].

Table 3: Essential Research Reagents and Materials for SSbD-Compliant Micropollutant Assessment

Reagent/Material	Technical Function	Application Context
LC-MS/MS Grade Solvents	Mobile phase for chromatographic separation with minimal background interference	HPLC separation prior to mass spectrometric detection
Solid-Phase Extraction Cartridges	Concentration and cleanup of aqueous samples to enhance analytical sensitivity	Pre-concentration of micropollutants from wastewater samples
Certified Reference Standards	Quantitative calibration and method validation using substances of known purity	Identification and quantification of target micropollutants
Bioassay Kits	Assessment of biological activity and toxicological endpoints	Screening for endocrine disruption and other mechanistic effects
Passive Sampling Devices	Time-integrated monitoring of contaminant presence in water bodies	Field deployment for monitoring wastewater treatment efficacy

Alignment with Sustainable Development Goals and Strategic Integration

Direct Contributions to SDG Implementation

The SSbD Framework and the broader Chemicals Strategy for Sustainability make direct and substantive contributions to the United Nations Sustainable Development Goals (SDGs), particularly SDG 3 (Good Health and Well-being), SDG 6 (Clean Water and Sanitation), SDG 9 (Industry, Innovation and Infrastructure), SDG 12 (Responsible Consumption and Production), and SDG 13 (Climate Action) [78]. The framework's emphasis on preventing chemical pollution at source directly supports SDG 6.3, which aims to reduce pollution, eliminate dumping, and minimize the release of hazardous chemicals and materials by 2030.

For SDG 13 (Climate Action), the chemical sector's transition is particularly significant. While the EU chemical sector has reduced its direct greenhouse gas emissions by 55% between 1990 and 2019, it remains energy-intensive, accounting for 22% of total final energy consumption in industry [102]. The SSbD Framework's emphasis on sustainable material design and resource efficiency contributes directly to climate mitigation efforts. According to recent SDG monitoring data, global climate finance flows reached an annual average of $1.3 trillion in 2021-2022, representing a 63% increase from 2019-2020, with sustainable transport (96% increase) and clean energy (53% increase) seeing the largest rises [78].

The "One Substance, One Assessment" Paradigm

A key innovation in the EU's chemical management approach is the move toward "One Substance, One Assessment," which aims to improve the effectiveness, efficiency, and coherence of chemical safety evaluations across different legislative domains [103]. This initiative establishes a coordination mechanism involving Member States and EU agencies to harmonize safety assessments and includes the development of a common open data portal on chemicals and a repository of health-based limit values [103]. This paradigm directly supports the SSbD Framework by ensuring that data generated during the innovation process can efficiently support regulatory compliance, while regulatory data and methodologies can inform SSbD assessments, creating a reciprocal information flow between innovation and regulation [105].

The relationship between different components of the EU's chemical management ecosystem can be visualized as follows:

Implementation Challenges and Research Frontiers

Barriers to Widespread SSbD Adoption

Despite its promising framework, several significant challenges impede the widespread adoption of SSbD principles. The voluntary nature of the current framework creates uncertainty regarding participation levels, particularly among smaller enterprises with limited resources for comprehensive safety and sustainability assessments [105] [109]. Additionally, the application of SSbD assessment to innovations at low Technology Readiness Levels presents methodological challenges due to data limitations and uncertainty in forecasting environmental impacts at early development stages [106].

The chemical industry's deep integration with fossil fuel systems creates substantial carbon lock-in effects that resist transition. Petrochemicals serve as both feedstock and energy source for chemical production, with just seven basic petrochemicals feeding more than 90% of downstream organic chemical production globally [102]. This dependency creates significant path dependencies that complicate the transition to safer and more sustainable alternatives, particularly for high-volume basic chemicals that form the foundation of the chemical industry's product portfolio.

Emerging Research Priorities

The implementation of the SSbD Framework has identified several critical research priorities essential for its continued evolution:

• Alternative Assessment Methodologies: Developing streamlined assessment approaches suitable for early innovation stages when data is limited, including predictive toxicology and read-across methods for hazard evaluation and high-throughput life cycle assessment for environmental impacts [109].

• Mixture Toxicity Assessment: Advancing methodologies to address combination effects of chemical mixtures, which represents a significant challenge beyond traditional single-substance risk assessment approaches [103]. The European Commission is currently assessing how to introduce mixture assessment factors into chemical safety assessments under the REACH regulation revision [103].

• Green and Sustainable Chemistry Innovation: Accelerating research on alternative chemical synthesis pathways, bio-based feedstocks, and design principles that inherently minimize hazard and environmental impact while maintaining functionality [102] [109].

• Circular Economy Integration: Addressing the technical challenges presented by substances of concern that impede clean recycling, including development of safe-by-design materials compatible with circular economy systems [102] [103].

The continued refinement of the SSbD Framework through ongoing stakeholder consultation and scientific advancement positions it as a critical tool for achieving the EU's ambitious dual objectives of environmental protection and economic innovation in the chemicals sector. As noted in recent scientific assessment, "The voluntary EC SSbD Framework has an added value, and it fosters synergies between innovation of chemicals and materials and safety and sustainability provisions of relevant legislation" [105].

In Silico and In Vitro Tools for Hazard Screening and Prioritizing Risky Micropollutants

The pervasive presence of organic micropollutants in aquatic environments represents a significant challenge for environmental chemists and public health professionals. These substances, which include pharmaceuticals, personal care products, pesticides, and industrial chemicals, are detected at concentrations ranging from nanograms to micrograms per liter in water bodies worldwide [110] [111]. Despite their low concentrations, micropollutants can elicit adverse effects on aquatic organisms and human health through chronic exposure and complex mixture interactions [112]. The task of identifying and prioritizing the most hazardous compounds among the thousands detected requires sophisticated approaches that integrate computational predictions with biological validation.

This technical guide examines established and emerging methodologies for screening and prioritizing hazardous micropollutants, with particular emphasis on the integration of in silico and in vitro tools. These approaches provide a mechanistic basis for environmental risk assessment while supporting the implementation of several United Nations Sustainable Development Goals (SDGs), especially SDG 3 (Good Health and Well-Being), SDG 6 (Clean Water and Sanitation), and SDG 12 (Responsible Consumption and Production) [20] [113]. The environmentally sound management of chemicals throughout their life cycle, as targeted in SDG 12.4, depends fundamentally on robust scientific methods for risk assessment and prioritization [113].

In Silico Screening Tools and Methodologies

Quantitative Structure-Activity Relationship ((Q)SAR) Tools

(Q)SAR models predict the biological activity and environmental fate of chemicals from their molecular structures using mathematically derived relationships. These computational tools generate large datasets of predicted properties while minimizing experimental costs [114] [110].

Table 1: Common (Q)SAR Tools and Their Primary Applications in Micropollutant Screening

Tool Name	Developer	Key Endpoints	Regulatory Acceptance
EPI Suite	US EPA	Persistence, bioaccumulation, toxicity	High; used in REACH assessments
OECD QSAR Toolbox	OECD	Chemical hazard, PBT assessment	High; international regulatory use
OPERA	US EPA	Physicochemical properties, environmental fate parameters	Growing; open-access resource
VEGA	Mario Negri Institute	Toxicity, mutagenicity, endocrine disruption	Medium; research applications
TEST	US EPA	Acute and chronic toxicity endpoints	Medium; academic and research use

The application of (Q)SAR tools enables the prediction of multiple hazardous properties, including environmental persistence, bioaccumulation potential, ecotoxicity, and specific human health effects such as mutagenicity and endocrine disruption [114] [110]. For example, a recent study prioritizing 245 pharmaceutical and personal care products (PPCPs) utilized these tools to identify 16 substances as highest concern based on their persistent, mobile, and toxic (PMT) or persistent, bioaccumulative, and toxic (PBT) characteristics [110].

Experimental Protocol for (Q)SAR-Based Screening

A standardized workflow for in silico hazard screening involves the following steps:

• Chemical Structure Standardization: Obtain or draw molecular structures in standardized formats (SMILES, InChI, or SDF). Verify structural accuracy through cross-referencing with chemical databases [110].

• Endpoint Selection: Define the specific hazardous properties relevant to the assessment. Common endpoints include:

  • Persistence: Biodegradation half-life in water and soil
  • Bioaccumulation: Bioconcentration factor (BCF)
  • Toxicity: Acute and chronic toxicity to aquatic organisms (algae, daphnia, fish)
  • Human Health Effects: Mutagenicity, carcinogenicity, endocrine disruption [114] [110]

• Multi-Tool Prediction: Run predictions across multiple (Q)SAR platforms to increase reliability. Cross-tool verification enhances confidence in results when predictions converge [110].

• Data Integration and Quality Assessment: Compile predictions into a unified database. Apply quality indices to exclude low-confidence predictions, particularly for compounds with structural features outside the model's applicability domain [110].

• Hazard Classification: Compare predicted values against regulatory thresholds (e.g., REACH criteria for PBT substances: P: t½ > 40 days in water; B: BCF > 2000; T: chronic NOEC < 0.01 mg/L) to identify chemicals of concern [110].

In Vitro Bioanalytical Tools for Effect-Based Screening

Reporter Gene Assays for Endocrine Activity

In vitro bioassays measure the biological activity of environmental samples directly, capturing mixture effects that cannot be predicted from chemical analysis alone [112]. These tools are particularly valuable for detecting endocrine-disrupting compounds.

Table 2: Common Bioanalytical Tools for Detecting Endocrine-Active Micropollutants

Assay Type	Molecular Target	Detected Activity	Sensitivity (Typical EC50)
ERα-CALUX	Estrogen receptor α	Estrogenicity	0.1-1 pM E2 equivalents
AR-CALUX	Androgen receptor	Androgenicity	10-100 pM DHT equivalents
GR-CALUX	Glucocorticoid receptor	Glucocorticoid activity	0.1-1 nM Dex equivalents
PR-CALUX	Progesterone receptor	Progestogenic activity	1-10 pM progesterone equivalents
PPARγ-CALUX	Peroxisome proliferator-activated receptor γ	Lipid metabolism disruption	Varies by compound

A study of the Ganga River demonstrated the utility of these assays, detecting estrogenicity at levels equivalent to 10 ng/L 17β-estradiol at sites receiving urban drain discharges - concentrations sufficient to cause reproductive effects in fish [112]. The same study found high levels of glucocorticoid and peroxisome proliferator-like activity in drain-impacted areas, indicating the presence of complex mixtures of biologically active compounds [112].

Experimental Protocol for Effect-Directed Analysis

Effect-directed analysis (EDA) integrates biological testing with chemical analytical techniques to identify causative agents of toxicity in complex mixtures:

• Sample Collection and Preparation:

  • Collect water samples using approved protocols (e.g., grab or composite sampling)
  • Solid-phase extraction (SPE) using Oasis HLB cartridges (200 mg, 6 mL) or similar
  • Elute with LC-MS grade solvents (methanol, acetonitrile) and evaporate to dryness
  • Reconstitute in DMSO for biotesting or appropriate solvent for chemical analysis [114] [112]

• Bioassay Testing:

  • Expose reporter gene cell lines to serial dilutions of sample extracts
  • Incubate for predetermined exposure periods (typically 24-72 hours)
  • Measure luminescence or fluorescence as indicator of receptor activation
  • Include positive controls (receptor-specific agonists) and negative controls (vehicle-only) [112]

• Bioassay-Driven Fractionation:

  • Separate active extracts using HPLC with fraction collection
  • Test fractions for biological activity to isolate active components
  • Perform chemical analysis on active fractions using LC-QTOF MS or similar high-resolution techniques [114]

• Compound Identification:

  • Use accurate mass measurements and fragmentation patterns for tentative identification
  • Confirm identities with analytical standards when available
  • Apply identification confidence levels (Level 1: confirmed standard; Level 2: probable structure; Level 3: tentative candidate) [114]

Integrated Prioritization Frameworks

Multi-Criteria Decision Analysis

The integration of multiple data streams requires sophisticated prioritization frameworks. Multi-criteria decision analysis (MCDA) methods combine various hazard and exposure parameters to generate comprehensive risk rankings [114] [34]. A hybrid approach combining fuzzy Analytical Hierarchy Process (AHP) with the ELimination and Choice Expressing REality (ELECTRE) method has demonstrated utility in addressing the complexity of comparing micropollutants across multiple endpoints [114].

In one groundwater study, fuzzy AHP indicated the greatest importance of mutagenicity among eight evaluated indicators, while ELECTRE results highlighted thiamethoxam and carbendazim as the most dangerous pesticides for the environment [114]. This approach effectively weights the relative importance of different endpoints while classifying compounds based on their comprehensive environmental risk assessment.

Priority Index Calculation

A comprehensive prioritization scheme for micropollutants in Chinese wastewater treatment plant effluents calculated a Priority Index (PI) based on both exposure potential (EP) and hazard potential (HP) [111]. The methodology involved:

Exposure Potential (EP) = f(measured concentration, detection frequency) Hazard Potential (HP) = f(persistence, bioaccumulation, in vitro toxicity, in vivo toxicity) Priority Index (PI) = EP × HP

This approach identified 15 priority pollutants from 216 detected micropollutants, including regulated persistent organic pollutants like perfluorooctanoic acid and their alternatives such as perfluorobutane sulfonate, along with emerging contaminants not currently regulated [111].

Table 3: Multi-Criteria Prioritization Framework for Micropollutants

Criteria Category	Specific Parameters	Data Sources	Weighting Approach
Exposure Potential	Detection frequency, Median concentration, Maximum concentration	LC-MS/MS monitoring, Literature data	Statistical distribution analysis
Hazard Characteristics	Persistence (half-life), Bioaccumulation (BCF), Acute toxicity (EC50), Chronic toxicity (NOEC)	QSAR predictions, Experimental data	Multivariate analysis
Human Health Effects	Carcinogenicity, Mutagenicity, Reproductive toxicity, Endocrine disruption	QSAR, ToxCast, Experimental studies	Fuzzy AHP weighting
Environmental Fate	Plant uptake potential, Soil adsorption, Hydrolysis rate	EPI Suite, QSAR Toolbox	Regulatory thresholds

The Researcher's Toolkit: Essential Reagents and Materials

Table 4: Essential Research Reagents and Materials for Micropollutant Screening

Item	Specifications	Application	Key Function
Oasis HLB Cartridges	200 mg, 6 mL capacity	Solid-phase extraction	Broad-spectrum retention of polar and non-polar micropollutants
LC-MS Grade Solvents	Acetonitrile, Methanol, Water (18.2 MΩ·cm)	Sample preparation, Mobile phases	Minimize background interference in analysis
Analytical Standards	Purity >95.9%	Compound identification and quantification	Reference for accurate chemical identification
Reporter Gene Cell Lines	ERα, AR, GR, PR transfected lines	Bioassay testing	Specific detection of endocrine activity
Luciferase Assay Kits	Commercial kits with substrates	Bioassay endpoint measurement	Quantification of receptor activation
LC-QTOF MS System	High resolution (>25,000), Accurate mass (<5 ppm)	Chemical screening and identification	Tentative identification without standards

Connection to Sustainable Development Goals

The methodologies described in this guide directly support the achievement of several Sustainable Development Goals. SDG 6 (Clean Water and Sanitation) specifically targets improving water quality by reducing pollution from hazardous chemicals [20] [113]. The monitoring and prioritization approaches enable evidence-based management of water resources by identifying the most hazardous micropollutants requiring control.

Similarly, SDG 3 (Good Health and Well-Being) aims to substantially reduce deaths and illnesses from hazardous chemicals and pollution [113]. The tools described here allow for early identification of potentially harmful substances before they cause widespread human health impacts. SDG 12 (Responsible Consumption and Production) specifically includes target 12.4, aiming for environmentally sound management of chemicals throughout their life cycle [20] [113].

Research into SDGs has grown exponentially, with studies on SDG 13 (Climate Action), SDG 3 (Good Health and Well-Being), and SDG 11 (Sustainable Cities and Communities) accounting for 36.45% of mapped studies [115]. However, more research is needed to address the interconnections between micropollutant management and all relevant SDGs.

The integration of in silico and in vitro tools provides a powerful framework for screening and prioritizing hazardous micropollutants. (Q)SAR predictions enable efficient evaluation of numerous chemicals for multiple hazardous properties, while bioanalytical tools capture the complex mixture effects often present in environmental samples. The combination of these approaches through multi-criteria decision analysis supports informed risk management and regulatory decisions.

As chemical production continues to grow globally, these methodologies will become increasingly essential for protecting human health and aquatic ecosystems. Future development should focus on improving the predictive accuracy of computational models, expanding the scope of bioanalytical tools to cover additional toxicity pathways, and refining integrated prioritization frameworks that can adapt to emerging contaminants and evolving regulatory needs.

In the face of increasing global environmental challenges, the scientific community requires robust, quantitative tools to assess the full scope of human impacts on natural systems. Life Cycle Assessment (LCA) has emerged as the premier methodological framework for evaluating the environmental burdens associated with products, processes, or services throughout their entire existence—from raw material extraction to final disposal [116]. When applied specifically to the domain of chemical emissions and their effects, this approach crystallizes into the specialized concept of the "Chemical Footprint," which quantifies the impact of chemical substances on ecosystems and human health.

The relevance of these assessment frameworks is particularly acute in the context of micropollutants—chemical substances detected in the environment at trace concentrations (typically μg/L to ng/L) but which pose significant threats due to their persistence, bioaccumulation potential, and biological activity [70]. These pollutants, including pharmaceuticals, personal care products, and endocrine-disrupting compounds, represent a formidable challenge for sustainable development, directly impacting the achievement of Sustainable Development Goal (SDG) 14, which aims to "conserve and sustainably use the oceans, seas and marine resources" [117].

This technical guide provides researchers and drug development professionals with a comprehensive overview of LCA methodology and chemical footprint concepts within the specific context of micropollutant environmental chemistry and SDG implementation.

Life Cycle Assessment: A Methodological Framework

Definition and Standardization

Life Cycle Assessment is a systematic, scientific method for evaluating the environmental impacts associated with all stages of a product's life cycle, encompassing raw material extraction, material processing, manufacturing, distribution, use, repair, maintenance, and end-of-life disposal or recycling [116] [118]. Recognized internationally through the ISO 14040 and 14044 standards, LCA provides a structured framework for quantifying resource consumption, energy use, and emissions across the entire value chain [116] [119].

The fundamental purpose of LCA is to provide data-driven insights that support more informed sustainability decisions, enabling researchers and product developers to identify environmental "hotspots" and prioritize opportunities for improvement [116] [119]. Rather than relying on assumptions about environmental preferability, LCA offers empirical evidence for comparing different materials, processes, or product systems.

The Four Phases of LCA

According to ISO standards, a comprehensive LCA consists of four interrelated phases that ensure methodological rigor and comprehensiveness [116] [119].

Phase 1: Goal and Scope Definition

This initial phase establishes the purpose, intended application, and audience for the LCA study. Critically, it defines the system boundaries—determining which life cycle stages and processes will be included—and specifies the functional unit, which provides a standardized basis for comparing systems (e.g., "per kilogram of product" or "per unit of service delivered") [119]. This stage also selects relevant impact categories (e.g., global warming potential, water consumption, toxicity) that will be the focus of the assessment.

Phase 2: Life Cycle Inventory (LCI)

The LCI phase involves compiling and quantifying inputs (energy, water, materials) and outputs (emissions to air, water, land, waste) for each process within the defined system boundaries [118]. This data-intensive stage requires detailed information about resource extraction, manufacturing processes, transportation logistics, use patterns, and end-of-life management, creating a comprehensive inventory of all mass and energy flows associated with the product system.

Phase 3: Life Cycle Impact Assessment (LCIA)

In the LCIA phase, inventory data is translated into potential environmental impacts using scientifically-established characterization models. This involves classifying inventory flows into selected impact categories (e.g., classifying greenhouse gases according to their global warming potential) and modeling their contributions to each category [118]. Common impact categories relevant to micropollutants include:

• Global warming potential
• Water use and pollution
• Human toxicity
• Ecotoxicity
• Eutrophication
• Resource depletion

Phase 4: Interpretation

The final phase involves critically evaluating the results from both the inventory and impact assessment to draw conclusions, explain limitations, and provide recommendations to decision-makers [119]. This stage identifies significant environmental issues, checks the completeness and sensitivity of the data, and enables evidence-based decisions for improving environmental performance.

Table 1: Core Impact Categories in Life Cycle Impact Assessment (LCIA)

Impact Category	Indicator	Unit	Relevance to Micropollutants
Global Warming	Global Warming Potential (GWP)	kg CO₂ equivalent	Energy consumption in production/ treatment
Ecotoxicity	Comparative Toxic Unit (CTU)	CTUe	Direct effects of chemical emissions on ecosystems
Human Toxicity	Comparative Toxic Unit (CTU)	CTUhh	Human health effects from exposure to toxic substances
Eutrophication	Eutrophication Potential (EP)	kg PO₄ equivalent	Nutrient pollution from agricultural runoff
Water Consumption	Water Use	m³	Water resource depletion in processes

LCA Models and System Boundaries

Depending on the study goals and data availability, different LCA modeling approaches can be applied, each with distinct system boundaries [119]:

• Cradle-to-Grave: Comprehensive assessment from resource extraction through disposal
• Cradle-to-Gate: Partial assessment from resource extraction to factory gate
• Cradle-to-Cradle: Assessment that incorporates recycling and reuse of materials
• Gate-to-Gate: Assessment focused on a single manufacturing process

For chemical footprint calculations, the cradle-to-gate approach is frequently employed, particularly for chemical products and intermediates that will undergo further processing [120].

Diagram 1: LCA Methodological Framework

Chemical Footprints and Micropollutants

The Micropollutant Challenge

Micropollutants represent a diverse array of chemical substances that persist in the environment at trace concentrations yet exert disproportionate effects on ecosystems and human health. Major categories include pharmaceuticals, personal care products, steroid hormones, antibiotics, pesticides, endocrine disruptors, and industrial chemicals [70]. These compounds enter the environment through multiple pathways, including industrial effluents, wastewater treatment plants, agricultural runoff, and atmospheric deposition [70].

The environmental persistence of micropollutants is particularly concerning. Studies have identified specific compounds such as erythromycin (antibiotic), ibuprofen (analgesic), and triclocarban (antibacterial) as primary micropollutants of concern due to their widespread detection and potential ecological impacts [70]. These substances can interfere with endocrine systems in aquatic organisms, cause reproductive and developmental abnormalities, bioaccumulate in food webs, and contribute to antimicrobial resistance [70].

Of particular concern is the interaction between different classes of micropollutants. Recent research indicates that microplastics (MPs) can act as vectors for other organic micropollutants, accumulating in aquatic organisms and propagating through the food chain [5]. Furthermore, viruses can adsorb onto MPs, including binding to bacterial biofilms that form the "plastisphere," potentially enhancing viral stability and prolonging pathogen persistence in aquatic environments [5].

Chemical Footprint within LCA

The chemical footprint can be understood as a specialized application of LCA methodology focused specifically on quantifying the impacts of chemical emissions throughout a product's life cycle. Within the LCIA phase, the chemical footprint typically addresses impact categories such as:

• Ecotoxicity - impacts on aquatic and terrestrial ecosystems
• Human toxicity - carcinogenic and non-carcinogenic effects on human health
• Acidification - acidifying effects on soils and water bodies
• Eutrophication - nutrient over-enrichment of ecosystems

Calculating a chemical footprint requires specific characterization models that translate chemical emissions into potential ecological and health impacts. These models consider the substance-specific fate, exposure, and effects in environmental compartments (air, water, soil) and within human populations.

Table 2: Analytical Methods for Micropollutant Detection

Analytical Technique	Target Micropollutants	Detection Limits	Key Applications
Liquid Chromatography-Mass Spectrometry (LC-MS/MS)	Pharmaceuticals, Polar Pesticides	ng/L range	Quantitative analysis of multiple classes in water
Gas Chromatography-Mass Spectrometry (GC-MS)	Semi-volatile Compounds, PCBs	ng/L to μg/L	Industrial chemicals, persistent organic pollutants
High-Performance Liquid Chromatography (HPLC)	Antibiotics, Steroid Hormones	μg/L range	Screening and quantification of specific compound classes
Immunoassay Methods	Pesticides, Toxins	Compound-dependent	Rapid screening for specific compound groups

Methodologies and Experimental Protocols

LCA Applied to Micropollutant Management

Conducting an LCA for chemical products, particularly those that may become micropollutants, requires specialized methodological considerations. The following protocol outlines a standardized approach for assessing the chemical footprint of pharmaceutical products:

Phase 1: Goal and Scope Definition

• Functional Unit Definition: Define a quantifiable unit that describes the primary function of the system (e.g., "treatment of one patient for 30 days").
• System Boundaries: Establish cradle-to-gate or cradle-to-grave boundaries, including API synthesis, formulation, packaging, distribution, use, and disposal.
• Impact Categories Selection: Prioritize human toxicity, ecotoxicity, and resource depletion categories relevant to pharmaceutical impacts.

Phase 2: Life Cycle Inventory

• Data Collection: Gather primary data from manufacturing processes (solvent use, energy consumption, waste streams) and secondary data for upstream processes.
• Emission Quantification: Document direct emissions from manufacturing and potential post-use environmental releases based on metabolism studies and removal rates in wastewater treatment.
• Data Quality Assessment: Document uncertainty, temporal, and geographical representativeness of all data sources.

Phase 3: Life Cycle Impact Assessment

• Characterization Modeling: Apply fate, exposure, and effect models to translate emissions into impact scores (USEtox model recommended for toxicity impacts).
• Normalization and Weighting: Optionally compare results to reference systems to contextualize significance of impacts.

Phase 4: Interpretation

• Hotspot Identification: Identify processes contributing most significantly to overall impacts.
• Uncertainty Analysis: Quantify uncertainty in inventory data and impact assessment results.
• Improvement Assessment: Evaluate opportunities for reducing impacts through process modifications, alternative chemistries, or waste treatment technologies.

Advanced Analytical Detection Methods

Monitoring micropollutants in environmental compartments requires sophisticated analytical techniques capable of detecting trace concentrations in complex matrices. The following experimental protocols represent state-of-the-art approaches:

Protocol 1: Solid-Phase Extraction (SPE) Coupled with LC-MS/MS

• Sample Preparation: Filter water samples (100-1000 mL) through glass fiber filters (0.7 μm) to remove particulate matter.
• Extraction: Use hydrophilic-lipophilic balanced (HLB) SPE cartridges for compound extraction. Condition cartridges with methanol and ultrapure water before sample loading.
• Elution: Elute analytes using 6-10 mL of methanol or acetonitrile. Evaporate eluent under gentle nitrogen stream and reconstitute in appropriate mobile phase.
• Analysis: Perform separation using C18 reverse-phase column with gradient elution (water and methanol, both with 0.1% formic acid). Use tandem mass spectrometry in multiple reaction monitoring (MRM) mode for detection and quantification.
• Quality Control: Include procedural blanks, matrix spikes, and internal standards (isotope-labeled analogs) for quantification.

Protocol 2: Passive Sampling Techniques

• Sampler Deployment: Deploy polar organic chemical integrative samplers (POCIS) or ceramic dosimeters in water bodies for 14-28 days.
• Extraction: Disassemble samplers and extract sorbents using appropriate solvents via ultrasound-assisted extraction or pressurized liquid extraction.
• Analysis: Analyze extracts using LC-MS/MS or GC-MS depending on target analytes.
• Calibration: Use performance reference compounds to calculate time-weighted average concentrations.

Source-Control Approaches for Micropollutant Mitigation

Implementing source-control technologies represents a critical strategy for reducing chemical footprints at the emission stage. Experimental approaches include:

Advanced Oxidation Processes (AOPs)

• Protocol: Apply ozone (O₃), hydrogen peroxide (H₂O₂), ultraviolet (UV) radiation, or combinations (O₃/UV, H₂O₂/UV) to wastewater streams.
• Operation: Optimize oxidant doses, pH, and reaction time based on target compound reactivity.
• Analysis: Monitor parent compound degradation and transformation product formation using LC-MS/MS.
• Toxicity Assessment: Evaluate toxicity changes during treatment using bioassays (e.g., Vibrio fischeri).

Membrane Filtration

• Protocol: Employ nanofiltration (NF) or reverse osmosis (RO) membranes with molecular weight cut-offs <300-400 Da.
• Operation: Optimize pressure, cross-flow velocity, and recovery rate to balance removal efficiency and operational costs.
• Fouling Control: Implement pre-treatment and membrane cleaning protocols to maintain performance.
• Analysis: Quantify micropollutant rejection rates and monitor membrane integrity.

Diagram 2: Chemical Footprint Framework

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 3: Essential Research Reagents for Micropollutant Analysis

Reagent/Material	Function	Application Notes
HLB SPE Cartridges	Extraction of diverse polar and non-polar analytes from water samples	Hydrophilic-Lipophilic Balanced copolymer; suitable for broad-spectrum micropollutant extraction
Isotope-Labeled Internal Standards	Quantification correction for matrix effects and recovery losses	¹³C or ²H-labeled analogs of target analytes; essential for precise LC-MS/MS quantification
LC-MS Grade Solvents	Mobile phase preparation and sample extraction	High purity solvents (methanol, acetonitrile, water) with minimal background contamination
C18 Reverse-Phase Columns	Chromatographic separation of analytes	2.1-4.6 mm ID, 1.7-5 μm particle size; provides optimal resolution for complex environmental samples
Passive Sampling Devices (POCIS)	Time-integrated monitoring of water concentrations	Polar Organic Chemical Integrative Samplers; capture time-weighted average concentrations
Bioassay Kits (Vibrio fischeri)	Toxicity screening of samples and transformation products	Luminescent bacteria-based assay; provides rapid toxicity assessment
Certified Reference Materials	Method validation and quality assurance	Certified concentrations of target analytes in appropriate matrices

LCA and Chemical Footprints in SDG Implementation

The application of LCA and chemical footprint methodologies directly supports the implementation of several Sustainable Development Goals, particularly SDG 14 (Life Below Water). Marine pollution has reached critical levels, with over 17 million metric tons of plastic waste entering the ocean in 2021 alone—a figure projected to double or triple by 2040 [117]. Additionally, ocean acidification has increased approximately 30% since pre-industrial times, threatening marine ecosystems and food webs [117].

LCA enables evidence-based policies for marine protection by quantifying the impacts of land-based activities on aquatic ecosystems. The methodology helps identify priority intervention points throughout product life cycles where modifications can most effectively prevent pollutants from reaching marine environments [121]. This aligns with SDG Target 14.1, which aims to "prevent and significantly reduce marine pollution of all kinds, particularly from land-based activities, including marine debris and nutrient pollution by 2025" [117].

Internationally, organizations like the United Nations Environment Programme are working to integrate LCA data into digital product information systems and passports, creating transparency across global value chains [121]. This harmonization of environmental assessment methods enables more effective international cooperation on marine protection, particularly for areas beyond national jurisdiction.

Life Cycle Assessment provides an essential methodological framework for quantifying the environmental impacts of products and processes, with specialized application to chemical footprints and micropollutant management. As global challenges of chemical pollution intensify—particularly in marine environments—the rigorous, scientific approach offered by LCA becomes increasingly vital for researchers, regulatory bodies, and industry professionals.

The standardized protocols, analytical methods, and assessment frameworks detailed in this technical guide offer researchers and drug development professionals the tools necessary to comprehensively evaluate and mitigate the environmental impacts of chemical substances. By integrating these methodologies into research, development, and policy-making, the scientific community can make substantive contributions to achieving SDG 14 and related sustainability targets, ensuring the protection of aquatic ecosystems for future generations.

Future developments in LCA methodology will likely focus on enhancing spatial and temporal resolution of impact assessments, improving characterization factors for emerging contaminants, and integrating high-throughput screening data into chemical footprint calculations. Additionally, the ongoing harmonization of LCA databases and methods through initiatives like the Global LCA Platform will facilitate more consistent and comparable assessments across sectors and geographic boundaries [121].

Comparative Analysis of Regulatory Landscapes and International Guidelines

The pervasive issue of micropollutant contamination in global water resources represents a critical challenge at the intersection of environmental chemistry, regulatory science, and sustainable development. Emerging micropollutants (EMPs), including pharmaceuticals, personal care products, pesticides, and per- and polyfluoroalkyl substances (PFAS), are increasingly detected in aquatic environments where they pose significant threats due to their persistence, bioaccumulation potential, and intrinsic toxicity [122]. The environmental chemistry of these compounds necessitates sophisticated analytical and remediation approaches, while their transboundary nature demands coordinated international regulatory responses aligned with the United Nations Sustainable Development Goals (SDGs), particularly SDG 6 (Clean Water and Sanitation) [123] [124].

This technical guide provides a comparative analysis of the regulatory frameworks and international guidelines governing micropollutants, contextualized within the broader implementation of SDGs. It examines the technical methodologies enabling detection and monitoring, evaluates treatment technologies, and explores the evolving policy landscapes that collectively form the foundation for effective environmental management of chemical contaminants.

Global Regulatory Frameworks for Micropollutants

Comparative Analysis of Major Regulatory Systems

Diverse regulatory philosophies and implementation mechanisms characterize the global approach to micropollutant management. The following table summarizes key features of major frameworks:

Table 1: Comparison of Major Regulatory Frameworks for Micropollutants

Region/System	Key Regulatory Instrument	Scope & Focus	Key Micropollutant Categories Addressed	Enforcement Mechanism
European Union	REACH Regulation [125]	Registration, Evaluation, Authorisation and Restriction of Chemicals; "No data, no market" principle	Substances of Very High Concern (SVHCs); persistent, bioaccumulative and toxic (PBT) substances; very persistent and very bioaccumulative (vPvB)	Mandatory registration for substances >1 tonne/year; Authorisation required for SVHC use
United States	Executive Orders & EPA Policy (2025) [126]	Focus on cooperative federalism, permitting reform, and regulatory cost-cutting; revisiting NEPA, ESA implementations	Prioritized based on economic impact assessments; shifting focus from previous environmental justice emphases	Temporary pause and review of existing litigation and consent decrees; 10:1 deregulation requirement for new rules
International Finance	World Bank Group EHS Guidelines [127]	Technical guidance for projects in chemicals processing, manufacturing, and related sectors	Pesticides manufacturing, large-volume organic chemicals, pharmaceuticals, petroleum refining	Project financing conditionality; not legally binding but integrated into loan agreements
UN SDG Framework	SDG Indicator 6.3.1 & 6.3.2 [123]	Ambient water quality and proportion of wastewater safely treated; global monitoring	Hazardous chemicals, materials, and nutrients; focus on waterbody impacts	Voluntary national reporting; peer pressure and global benchmarking

Recent Policy Developments and Shifts

The regulatory landscape is dynamic, with significant recent developments influencing micropollutant governance:

• US Regulatory Reform (2025): The current administration has implemented a "temporary pause" on federal environmental litigation and new grant programs for review, rescinded prior environmental justice policies, and instituted a requirement that for every new regulation proposed, agencies must identify at least ten existing regulations for repeal [126]. This represents a significant shift from precaution-based approaches toward cost-benefit analysis using the 2003 version of OMB Circular A-4, which excludes global climate effects.
• EU REACH Evolution: The European Chemicals Agency (ECHA) maintains a rigorous process for evaluating registered substances, with authorization requirements aiming to ensure SVHCs are progressively replaced by suitable alternatives where economically and technically feasible [125]. The focus remains on hazard-based rather than risk-based assessment for priority compounds.
• Transboundary Water Monitoring: Initiatives like the Itaipu Binacional partnership for monitoring micropollutants in the hydrographic basin of the Itaipu Reservoir demonstrate the importance of cross-border cooperation in water quality management, directly supporting SDG Target 6.5 on integrated water resources management [123].

Analytical Methodologies for Micropollutant Detection

Experimental Workflow for Micropollutant Analysis

The following diagram illustrates the comprehensive workflow for detecting, identifying, and quantifying micropollutants in environmental samples:

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 2: Key Research Reagents and Materials for Micropollutant Analysis

Reagent/Material	Function & Application	Technical Specifications
Solid Phase Extraction (SPE) Cartridges	Extraction and preconcentration of micropollutants from water samples	Various sorbents (C18, HLB, WCX, WAX); selected based on analyte polarity and pKa; critical for achieving low detection limits
Isotopically Labeled Internal Standards	Quantification accuracy via correction for matrix effects and recovery variations	(^{13}\mathrm{C})-, (^{15}\mathrm{N})-, or (^{2}\mathrm{H})-labeled analogs of target analytes; essential for isotope dilution mass spectrometry
LC-MS/MS Mobile Phase Additives	Chromatographic separation and ionization efficiency enhancement	Ammonium formate/acetate, formic/acetic acid; MS-grade purity to minimize background contamination and signal suppression
Granular Activated Carbon (GAC)	Adsorption studies for treatment efficiency evaluation	Specific surface area >500 m²/g; used in batch isotherm experiments and column studies for breakthrough curve analysis
HPLC Columns	Chromatographic separation prior to mass spectrometric detection	C18 stationary phases (1.7-2.2 μm particle size); 50-100 mm length; capable of separating complex environmental mixtures
Certified Reference Materials	Method validation and quality assurance	Matrix-matched certified materials with known concentrations of target micropollutants; essential for analytical accuracy verification

Treatment Technologies for Micropollutant Removal

Performance Comparison of Advanced Treatment Methods

Various technologies have been developed for mitigating organic micropollutants (OMPs) in drinking water and wastewater, each with distinct mechanisms, advantages, and limitations [128]:

Table 3: Comparison of Micropollutant Treatment Technologies

Technology	Mechanism	Key Target Compounds	Efficiency & Limitations	Operational Considerations
Granular Activated Carbon (GAC)	Physical adsorption onto porous carbon surface	Non-polar OMPs, pharmaceuticals, some pesticides	Inefficient for very polar metabolites (e.g., DMS); requires frequent regeneration; cost-effective for certain compound classes	Empty bed contact time critical; frequent media replacement increases operational costs
Advanced Oxidation Processes (AOPs)	Chemical oxidation via hydroxyl radicals	Broad-spectrum degradation of OMPs	Formation of transformation products and by-products (nitrite, nitrosamines); may require post-treatment	UV/H₂O₂ optimization needed for specific matrices; energy-intensive
Membrane Filtration (NF/RO)	Size exclusion and charge repulsion	Wide range of OMPs based on molecular size	High rejection rates for most OMPs; produces concentrate stream requiring disposal; water loss concerns	Permitting for concentrate discharge; operational pressure affects efficiency
Biological Treatment	Microbial degradation in sand filters or bioreactors	Biodegradable OMPs under specific redox conditions	Insufficient for persistent pesticide metabolites (e.g., desphenyl-chloridazone); sustainable retrofit option	Hydraulic retention time and biomass adaptation critical; low environmental impact

Adsorption-Based Magnetic Nanotechnology

Adsorption via metallic and metal oxide nanomaterials presents an attractive alternative to conventional treatment methods, offering high surface area-to-volume ratios and tunable surface chemistry [122]. Magnetic nanoparticles functionalized with specific ligands can target particular micropollutant classes while enabling separation and recovery via magnetic fields, addressing challenges of nanoparticle retention in treatment systems. Synthesis approaches include:

• Chemical Methods: Co-precipitation, thermal decomposition, and microemulsion techniques offering precise size and morphology control but potentially involving hazardous chemicals.
• Physical Methods: Laser ablation and electron beam lithography providing high purity but requiring sophisticated equipment.
• Green Synthesis: Using biological extracts (plant, microbial) for reduction and stabilization, aligning with green chemistry principles but offering less control over particle characteristics.

The regeneration and reuse potential of these nanomaterials is critical for developing sustainable water treatment systems that align with SDG 12 (Responsible Consumption and Production) by reducing material consumption and waste generation [122].

Sustainable Development Goals Integration

Wastewater Treatment Contributions to SDG Achievement

Wastewater management and micropollutant control directly contribute to achieving multiple Sustainable Development Goals, extending far beyond the immediate targets of SDG 6 (Clean Water and Sanitation) [124]:

Table 4: Wastewater Treatment Contributions to SDG Implementation

Sustainable Development Goal	Contribution Pathway	Relevance to Micropollutant Management
SDG 1: No Poverty	New income sources for smallholders from waste recovery	Resource recovery from treatment processes creates economic opportunities
SDG 2: Zero Hunger	Increased water availability for agricultural irrigation	Treated wastewater provides alternative water source; reduces contaminant uptake in crops
SDG 3: Good Health & Well-being	Reduced human exposure to hazardous chemicals	Removal of endocrine disruptors, carcinogens, and toxic compounds from water supplies
SDG 6: Clean Water & Sanitation	Improved water quality through pollution reduction	Direct reduction of hazardous chemical discharge into water bodies (Target 6.3)
SDG 7: Affordable & Clean Energy	Energy generation from wastewater biogas	Anaerobic digestion of treatment sludges produces renewable energy
SDG 11: Sustainable Cities	Reduced environmental impact of urban wastewater discharges	Protection of urban water resources from chemical contamination
SDG 12: Responsible Consumption	Waste-to-resource approaches and reduced chemical release	Proper management of chemicals and waste throughout their life cycle (Target 12.4)
SDG 14: Life Below Water	Minimized release of land-based pollutants into marine environments	Reduced nutrient and hazardous substance inputs to coastal waters

The implementation of monitoring programs, such as the Itaipu Binacional initiative in the hydrographic basin of the Itaipu Reservoir, demonstrates how data-driven water management supports multiple SDGs by informing conservation actions, guiding land use decisions, and advising basin committees on water quality standards compatible with multiple water uses [123].

Environmental Justice Considerations in Regulatory Implementation

The rescission of environmental justice policies and programs in the U.S. represents a significant shift in regulatory approach to chemical management [126]. This contrasts with the UN's SDG framework which emphasizes equitable access to safe and affordable drinking water for all (Target 6.1) and specifically calls attention to the needs of vulnerable populations [123]. The differential impact of regulatory changes on communities disproportionately affected by micropollutant contamination highlights the intersection between environmental chemistry and social equity in regulatory implementation.

The comparative analysis of regulatory landscapes reveals a complex, evolving patchwork of approaches to micropollutant management, with significant divergence in philosophical foundations, implementation mechanisms, and enforcement strategies. The EU's precautionary REACH framework contrasts with the U.S.'s current cost-benefit oriented approach, while international EHS guidelines and the voluntary SDG framework provide additional layers of governance.

From a technical perspective, advanced analytical methodologies enable increasingly sophisticated detection and characterization of micropollutants in environmental matrices, while adsorption-based nanotechnologies and other treatment advances offer promising removal solutions. However, the persistent detection of new compounds and transformation products underscores the dynamic nature of the challenge.

Successful navigation of this landscape requires integrating robust environmental chemistry with thoughtful regulatory analysis and SDG-aligned implementation strategies. Future approaches must balance technical efficacy with economic feasibility, environmental sustainability, and social equity to comprehensively address the global challenge of micropollutant contamination.

The global challenge of chemical micropollution necessitates a paradigm shift in how chemical innovations are developed and implemented. Industry-academia collaboration has emerged as a critical engine for driving this transition, combining fundamental research excellence with industrial scalability and market relevance. Within the framework of the United Nations Sustainable Development Goals (SDGs), particularly SDG 6 (Clean Water and Sanitation), SDG 9 (Industry, Innovation, and Infrastructure), and SDG 12 (Responsible Consumption and Production), these partnerships are developing transformative solutions to mitigate the environmental impact of micropollutants [129]. This whitepaper examines contemporary collaborative models through detailed technical case studies, providing researchers and drug development professionals with validated frameworks, experimental protocols, and analytical tools for advancing sustainable chemistry in the context of micropollutant management.

Case Study 1: The PLANTED ETN – A Multidisciplinary Training Network

The European Training Network (ETN) PLANTED exemplifies a structured consortium designed to address organic contaminants of emerging concern through multidisciplinary cooperation. The network coordinates expertise from three universities—Comenius University Bratislava (CUB), Ghent University (UGENT), and the University of Tartu (UT)—alongside multiple industrial stakeholders from the wastewater treatment sector [130]. The primary scientific objectives focus on two innovative fronts: developing advanced plasma-based water treatment technologies and exploring the potential for nitrogen fixation to enable water reuse in agriculture [130].

Table: PLANTED Project Participant Roles and Expertise

Participant Institution	Specialized Expertise	Contribution to Project Goals
University of Tartu	Plasma Physics, Environmental Chemistry	Project coordination; plasma process development
Ghent University	Green Chemistry & Technology, Applied Physics	Biological treatment integration; process scaling
Comenius University Bratislava	Environmental Physics, Biology, Inorganic Chemistry	Mechanistic biological impact studies; material synthesis
External Partners (e.g., Tartu Waterworks)	Wastewater Treatment Technology & Operations	Real-world validation; technology piloting & market insight

This collaborative model is strengthened by its commitment to educating new experts through specialized training schools, short-term scientific missions (STSMs), and the development of shared learning resources like MOOCs (Massive Open Online Courses) [130].

Experimental Protocol: Plasma-Based Water Treatment Screening

The following workflow provides a generalized protocol for evaluating plasma-based treatment systems, reflecting the integrated approach within PLANTED.

Workflow Overview: A collaborative experimental workflow for plasma-based water treatment.

Step-by-Step Methodology:

• Sample Preparation & Characterization: Source real wastewater effluent or prepare synthetic wastewater matching its ionic composition. Spike samples with a target mixture of micropollutants (e.g., pharmaceuticals like sulfamethoxazole or industrial chemicals). Characterize initial parameters including pH, chemical oxygen demand (COD), and UV254 absorbance [130].

• Plasma Reactor Configuration: Utilize a dielectric barrier discharge (DBD) plasma reactor. Configure with a high-voltage power supply (e.g., 10-20 kV, 50-500 Hz), a reaction chamber containing the water sample, and a gas distribution system for introducing carrier gases (e.g., oxygen, air, or argon) to modulate plasma chemistry and reactive species formation [130].

• Treatment and Process Optimization: Treat samples with varied plasma exposure times (e.g., 5-30 minutes). Systematically adjust operational parameters such as discharge power, pulse frequency, and carrier gas flow rate to optimize degradation efficiency. This phase requires close collaboration between plasma physicists and chemical engineers.

• Post-Treatment Analytical Workflow:

  • Chemical Analysis: Quantify micropollutant removal using Liquid Chromatography with tandem Mass Spectrometry (LC-MS/MS). Identify transformation products via high-resolution mass spectrometry (HRMS) to elucidate degradation pathways.
  • Toxicological Assessment: Apply in vitro bioassays to evaluate the reduction of apical effects. Key endpoints include estrogenic activity (ERα bioassay), oxidative stress response (AREc32 bioassay), and cytotoxicity. Compare results against established Effect-Based Trigger Values (EBT) to determine environmental relevance [131] [130].

Research Reagent Solutions

Table: Key Reagents and Materials for Plasma Treatment Studies

Reagent/Material	Function/Application	Technical Specification Example
Pharmaceutical Standards	Target micropollutants for spiking and quantification	High-purity (>98%) Diclofenac, Sulfamethoxazole
LC-MS/MS Mobile Phase	Chromatographic separation and ionization	Ammonium acetate in water (mobile phase A), Acetonitrile (mobile phase B)
Bioassay Kits	Assessment of residual biological activity	ERα-CALUX kit for estrogenicity, AREc32 cell line for oxidative stress
Dielectric Barrier	Essential component of DBD plasma reactor	High-purity alumina (Al₂O₃) or quartz glass

Case Study 2: The Mistra SafeChem Programme – An Integrated SSbD Approach

Framework for Safe and Sustainable by Design (SSbD) Innovation

The Mistra SafeChem research programme is a large-scale, multi-stakeholder initiative in Sweden with a vision to enable a safe and sustainable chemical industry. Its core philosophy is the integration of Safe and Sustainable by Design (SSbD) principles from the earliest stages of chemical process and product development [132]. The programme brings together experts in organic chemistry, catalysis, chemical engineering, toxicology, ecotoxicology, and life cycle assessment (LCA) to collaborate on developing novel synthesis methods and the tools to assess their safety and sustainability profiles. The programme is highly relevant to the implementation of the EU's Chemical Strategy for Sustainability [132].

Table: Mistra SafeChem's Integrated Research Components

Research Pillar	Key Activities	Outputs for SSbD
Catalysis & Biocatalysis	Development of novel synthesis routes; Waste valorization	Greener synthesis pathways; Use of renewable feedstocks
Hazard & Exposure Screening	In silico & in vitro tool development; Exposure modeling	Early-stage hazard identification; Risk assessment data
Life Cycle Assessment (LCA)	Chemical footprinting; Prospective LCA of new processes	Evaluation of environmental impacts across the life cycle

Experimental Protocol: Integrated Hazard Screening for Novel Chemicals

A critical output of Mistra SafeChem is a fit-for-purpose screening framework that combines computational and bioanalytical methods for early-stage hazard assessment [132]. This protocol is designed for use by chemists and engineers during the R&D phase.

Workflow Overview: An integrated hazard and risk assessment workflow for novel chemicals.

Step-by-Step Methodology:

• In Silico (Computational) Hazard Profiling:

  • Tool Application: Use suite of in silico models, including those based on advanced machine learning (ML) and artificial intelligence (AI).
  • Endpoints: Predict key hazard endpoints such as mutagenicity, endocrine disruption (e.g., estrogen receptor binding), and aquatic toxicity [132].
  • Uncertainty Quantification: Employ conformal prediction theory to generate reliability metrics and define the applicability domain for each prediction, providing confidence estimates crucial for decision-making [132].

• Miniaturized Synthesis: For chemicals passing the initial in silico screening, synthesize milligram quantities using promising novel catalytic routes (e.g., bio-catalysis or sustainable homogeneous catalysis) developed within the programme [132].

• Bioanalytical Effect-Based Assessment:

  • Bioassay Battery: Test synthesized compounds and their transformation products in a panel of in vitro bioassays. Relevant endpoints mirror those used in environmental monitoring [131] and include:
    • Xenobiotic metabolism activation (e.g., AhR, PPARγ, PXR)
    • Endocrine activity (ERα for estrogenicity)
    • Developmental neurotoxicity (using SH-SY5Y cell line)
    • Cytotoxicity
  • Analysis: Measure specific effects and compare to effect-based trigger values to determine potential concern [131].

• Exposure and Risk Integration: Integrate hazard data from Steps 1 and 3 with predicted or measured environmental exposure data and degradation fate to conduct an early-stage risk assessment. This integrated data informs the go/no-go decisions and guides the redesign of molecules or syntheses towards safer and more sustainable profiles, closing the SSbD loop [132].

Quantitative Data and Comparative Analysis

The effectiveness of collaborative research is demonstrated by its ability to generate robust, quantitative data on pollution and treatment performance. The following tables consolidate key findings from recent studies.

Table 1: Micropollutant Detection and Biological Effects in Surface Waters (Guandu River, Brazil) [131]

Parameter	Finding	Environmental Relevance
Chemicals Detected	269 compounds (mostly pharmaceuticals & pesticides)	Highlights complexity of contamination
Prominent Bioassay Result	Elevated estrogenic activity (ERα activation)	Primary risk driver; often exceeded EBTs
Contribution of Particulate Matter	SPM contributed more to cytotoxicity than aqueous phase	Critical to assess whole water samples
Explained Effect by Analytics	<1% of measured effects in AhR, PPARγ, SH-SY5Y, AREc32 assays	Majority of toxicity from unknown/untargeted compounds

Table 2: Performance of Advanced Treatment Technologies for Micropollutant Removal

Technology	Target Contaminants	Removal Efficiency	Key Findings
sPAC-Ultrafiltration Hybrid [133]	Benzothiazole (BZT), Diclofenac (DFC)	>80% removal	Superfine Powdered Activated Carbon (sPAC) outperforms conventional PAC; provides robust pathogen removal (>3-log)
Thermally Activated Peroxydisulfate [134]	Benzophenone-1 (BP1)	High degradation achieved	AOP effective for UV filter degradation; pathways elucidated via DFT calculations; matrix effects are significant
Adsorption on Waste-Based Sorbents [134]	Acid Blue 193 dye	High adsorption capacity confirmed	Post-coagulation sludge effective; aligns with circular economy principles

Industry-academia collaborations, as demonstrated by the PLANTED ETN and Mistra SafeChem programmes, are indispensable for generating the innovative technologies and integrated assessment frameworks required to tackle the global challenge of micropollutants. These partnerships successfully merge deep scientific inquiry with practical applicability, accelerating the transition to a sustainable, circular economy. Future success will depend on continued investment in multidisciplinary networks, the widespread adoption of SSbD principles, and the development of standardized, effect-based methods to accurately monitor complex environmental mixtures. For researchers and drug development professionals, engaging in these collaborative models is no longer optional but a strategic imperative to ensure that chemical innovation aligns with the overarching goals of environmental protection and sustainable development.

Conclusion

The effective management of micropollutants is an indispensable component of achieving the UN Sustainable Development Goals, particularly those pertaining to clean water, good health, and responsible consumption. This synthesis demonstrates that addressing this challenge requires a multi-pronged approach: a deep understanding of micropollutant sources and impacts, the development and deployment of advanced remediation technologies, the fundamental redesign of chemical products and processes through Green Chemistry, and robust regulatory frameworks like SSbD for validation. For biomedical and clinical research, the path forward entails a paradigm shift towards preventative environmental risk assessment integrated into the earliest stages of drug design and development. Future efforts must prioritize interdisciplinary collaboration, investment in green and sustainable chemistry innovations, and the adoption of a holistic 'One Health' perspective to successfully mitigate the risks posed by micropollutants and safeguard ecosystem and human health for future generations.

References

• 1. Review Emerging organic micropollutants as serious ... [https://www.sciencedirect.com/science/article/abs/pii/S0048969724081051]
• 2. Environmental impact and source-controlled approaches ... [https://www.sciencedirect.com/science/article/abs/pii/S0278691524006045]
• 3. Emerging Contaminants: A Rising Threat to Urban Water ... [https://www.mdpi.com/2073-4441/17/16/2367]
• 4. Emerging contaminants: A One Health perspective - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC11096751/]
• 5. Micropollutants and Their Interactions With Relevant ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12488536/]
• 6. Addressing the global data imbalance of contaminants of ... [https://pubs.rsc.org/en/content/articlehtml/2025/su/d5su00144g]
• 7. Pharmaceutically active micropollutants: origin, hazards ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10901114/]
• 8. A Case Study of the Mascara WWTP (Algeria) [https://www.mdpi.com/2227-9717/13/10/3205]
• 9. Understanding emerging contaminants in water and ... [https://www.sciencedirect.com/science/article/pii/S2772416625001664]
• 10. Micropollutant - an overview | ScienceDirect Topics [https://www.sciencedirect.com/topics/earth-and-planetary-sciences/micropollutant]
• 11. Examples and challenges based on selected EU countries [https://www.sciencedirect.com/science/article/abs/pii/S1462901120304743]
• 12. Contamination of water, soil, and plants by micropollutants ... [https://www.sciencedirect.com/science/article/pii/S0048969723065920]
• 13. Goal 6 | Department of Economic and Social Affairs [http://sdgs.un.org/goals/goal6]
• 14. Detailed Examination of the Adverse Effects ... [https://link.springer.com/chapter/10.1007/978-3-032-03530-1_6]
• 15. Goal 6: Ensure access to water and sanitation for all [https://www.un.org/sustainabledevelopment/water-and-sanitation/]
• 16. Contaminants of emerging concern (CECs), including ... [https://www.epa.gov/wqc/contaminants-emerging-concern-including-pharmaceuticals-and-personal-care-products]
• 17. Environmental Pollution from Pharmaceuticals - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC12471260/]
• 18. Increasing the focus on input prevention and integrated ... [https://pubmed.ncbi.nlm.nih.gov/30380490/]
• 19. (Micro)plastics and the UN Sustainable Development Goals [https://www.sciencedirect.com/science/article/pii/S2452223621000535]
• 20. Chemistry & the UN Sustainable Development Goals [https://www.acs.org/green-chemistry-sustainability/education/chemistry-sustainable-development-goals.html]
• 21. Persistent, Bioaccumulative and Toxic Chemicals (PBTs) [https://toxicfreefuture.org/toxic-chemicals/persistent-bioaccumulative-and-toxic-chemicals-pbts/]
• 22. Risk Assessment of Micropollutants for Human and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12030910/]
• 23. Industrial Applications, Environmental Fate, Human ... [https://www.mdpi.com/2673-4672/5/4/43]
• 24. Micropollutants but high risks: Human multiple stressors ... [https://www.sciencedirect.com/science/article/abs/pii/S0304389423017806]
• 25. Insights into sorption, electrochemical degradation, and ... [https://www.sciencedirect.com/science/article/pii/S0048969724040804]
• 26. Environmental Chemistry of Micropollutants [https://envchem.ethz.ch/about-us/sanderm/sanderm_research/sanderm_res_micropol.html]
• 27. Global Scientists Issue Nobel Declaration Calling for Urgent ... [https://environment.yale.edu/news/article/nobel-declaration-calling-urgent-implementation-green-sustainable-chemistry]
• 28. The One Health Concept - Frontiers Publishing Partnerships [https://www.frontierspartnerships.org/journals/british-journal-of-biomedical-science/articles/10.3389/bjbs.2024.12366/full]
• 29. One planet: one health. A call to support the initiative on a ... [https://enveurope.springeropen.com/articles/10.1186/s12302-022-00602-6]
• 30. 目标14： 保护和可持续利用海洋和海洋资源以促进可持续发展 [https://www.un.org/sustainabledevelopment/zh/oceans/]
• 31. #可持续发展目标在学术界—可持续发展目标中心（目标6） [https://www.un.org/fr/node/85873]
• 32. 土壤等多介质环境中的迁移转化与生态效应。揭示新污染物 ... [http://iae.cas.cn/xwrw_hj/fx_xwrw/]
• 33. 中国科学院生态环境研究中心环境化学与环境毒理全国重点实验室 [http://et.rcees.ac.cn/rcdw/yjz/z1_43924/cdxm/]
• 34. Screening and risk assessment of priority organic ... [https://www.sciencedirect.com/science/article/abs/pii/S0304389425007976]
• 35. Sustainable analytical approaches for microplastics in ... [https://www.sciencedirect.com/science/article/pii/S2772582025000312]
• 36. Advanced Analytical Techniques for the Detection and ... [https://www.mdpi.com/journal/molecules/special_issues/UV72U71B6O]
• 37. Predicting Micropollutant Removal in Wastewater Treatment ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12550809/]
• 38. Engaging Stakeholders to Solve Complex Environmental ... [https://www.mdpi.com/2073-4441/15/19/3441]
• 39. A Comprehensive Review of Agricultural Residue-Derived ... [https://www.mdpi.com/2073-4441/17/14/2141]
• 40. The use of agro-waste-based adsorbents as sustainable ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10245173/]
• 41. Optimization of Organic Micropollutant Adsorption onto ... [https://www.mdpi.com/2297-8739/12/9/254]
• 42. Adsorption of micropollutants from wastewater using iron ... [https://www.sciencedirect.com/science/article/abs/pii/S0304389421025747]
• 43. Modelling competitive adsorption of organic ... [https://www.sciencedirect.com/science/article/pii/S0043135425015349]
• 44. Removal of organic micropollutants from wastewater effluent [https://www.sciencedirect.com/science/article/pii/S1383586622018585]
• 45. Predictive modeling of micropollutant removal in fixed-bed ... [https://www.sciopen.com/article/10.26599/ECS.2025.9600026]
• 46. Removal of organic micropollutants from water by adsorption ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10584748/]
• 47. A Review on the Application of Magnetic Nanomaterials for ... [https://www.mdpi.com/2305-6304/13/10/814]
• 48. Tiny tech, big impact: How nanotechnology is driving SDGs ... [https://www.sciencedirect.com/science/article/pii/S2405844024074243]
• 49. Integrating green nanotechnology with sustainable ... [https://link.springer.com/article/10.1007/s43621-024-00610-x]
• 50. Recent advances in magnetic nanoparticles: Key ... [https://www.sciencedirect.com/science/article/abs/pii/S2214993724001659]
• 51. Review on Recent Progress in Magnetic Nanoparticles [https://pmc.ncbi.nlm.nih.gov/articles/PMC8314212/]
• 52. Advances in Magnetic Nanocomposite Adsorbents for ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12472344/]
• 53. Magnetic nanomaterials assisted nanobiocatalysis to abate ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10106955/]
• 54. Environmental applications of magnetic nanohybrid materials [https://pubs.rsc.org/en/content/articlelanding/2025/ra/d5ra03470a]
• 55. Advancements in Magnetic Nanoparticles for Microplastic ... [https://ui.adsabs.harvard.edu/abs/2025WASP..236..680G/abstract]
• 56. Mathematical models for predicting the toxicity of ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12455698/]
• 57. Machine learning models for predicting the rejection of ... [https://www.sciencedirect.com/science/article/abs/pii/S0043135424012624]
• 58. Finishing treatment processes for micropollutant ... [https://chemrxiv.org/engage/chemrxiv/article-details/65f85cb366c13817293f44a2]
• 59. Anionic Micropollutant by Ion-Exchange Resin... Removal [https://link.springer.com/article/10.1007/s11814-025-00564-4]
• 60. A machine framework to predict PPCP learning through... removal [https://pubs.rsc.org/en/content/articlelanding/2025/ew/d4ew00892h]
• 61. Comparative overview of advanced oxidation processes ... [https://www.sciencedirect.com/science/article/abs/pii/S0301479721004667]
• 62. Recent Strategies for Bioremediation of Emerging Pollutants [https://pmc.ncbi.nlm.nih.gov/articles/PMC9413587/]
• 63. Bioremediation of environmental wastes: the role ... [https://www.frontiersin.org/journals/agronomy/articles/10.3389/fagro.2023.1183691/full]
• 64. Advanced oxidation processes for water and wastewater ... [https://www.sciencedirect.com/science/article/pii/S2405844024064338]
• 65. Comparative experimental evaluation and empirical ... [https://www.nature.com/articles/s41598-025-18131-6]
• 66. The Role of Green Chemistry in Generic Drug Development [https://www.drugpatentwatch.com/blog/the-role-of-green-chemistry-in-generic-drug-development-a-sustainable-approach-to-medicine/?srsltid=AfmBOorQHH2LOXG1mb7Xs1DUhv1PDkAz-7LN_Ee8n7rtiXKxHnybIs-l]
• 67. Scaling up green chemistry principles for pharma ... [https://pharmaceuticalmanufacturer.media/pharmaceutical-industry-insights/latest-pharmaceutical-manufacturing-industry-insights/scaling-up-green-chemistry-principles-for-pharma-manufacturi/]
• 68. Principles of green chemistry: Advancing pharma ... [https://instituteofsustainabilitystudies.com/insights/guides/principles-of-green-chemistry-advancing-pharma-sustainability/]
• 69. Attainment of water and sanitation goals: a review and agenda ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9396604/]
• 70. Environmental impact and source-controlled approaches ... [https://www.sciencedirect.com/science/article/pii/S0278691524006045]
• 71. Risk Assessment of Micropollutants for Human and ... [https://www.mdpi.com/2305-6304/13/4/275]
• 72. Preventing the Environmental Release of Pharmaceuticals [https://www.genevaenvironmentnetwork.org/events/preventing-the-environmental-release-of-pharmaceuticals-solutions-at-the-source/]
• 73. The Sustainable Development Goals Report 2025 [https://unstats.un.org/sdgs/report/2025/]
• 74. ELRIG 2025: Integrating Sustainability in Drug Development [https://www.news-medical.net/life-sciences/Shaping-a-Greener-Sustainable-Future-in-Drug-Development-Insights-From-ELRIG-2025.aspx]
• 75. Product sustainability [https://www.astrazeneca.com/content/astraz/sustainability/climate-change/product-sustainability.html]
• 76. Pesticides & Organic Micropollutants Conference 2025 [https://www.eu-parc.eu/events/international-conferences/pesticides-organic-micropollutants-conference-2025]
• 77. Emerging Micropollutants: Risks, Regulatory Trends, and ... [https://www.frontiersin.org/journals/environmental-chemistry/articles/10.3389/fenvc.2025.1675784/full]
• 78. Goal 13 | Department of Economic and Social Affairs [http://sdgs.un.org/goals/goal13]
• 79. Urgent action to combat climate change and its impacts ... [https://www.sciencedirect.com/science/article/pii/S1877343517302385]
• 80. Micropollutant Removal Efficiency of Advanced ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10492480/]
• 81. Enzyme-Catalysed Multicomponent Reactions (MCRs) for ... [https://www.sciencedirect.com/science/article/pii/S2211715625008197]
• 82. Microbial Immobilized Enzyme Biocatalysts for Multipollutant ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11355015/]
• 83. Nanobiohybrids: Synthesis strategies and environmental ... [https://www.sciencedirect.com/science/article/pii/S0013935123011210]
• 84. Nanozymes expanding the boundaries of biocatalysis [https://www.nature.com/articles/s41467-025-62063-8]
• 85. Removal of micropollutants from municipal wastewater ... [https://www.sciencedirect.com/science/article/abs/pii/S0301479720312263]
• 86. Organic micropollutant removal in stormwater: a review ... [https://pubs.rsc.org/en/content/articlelanding/2025/ew/d5ew00306g]
• 87. CASE STUDY ON CLIMATE ACTION | City of L.A. Sustainable ... [https://sdg.lacity.gov/our-work/projects/case-study-climate-action]
• 88. Decarbonization pathways in medical waste management ... [https://www.nature.com/articles/s41598-025-26635-4]
• 89. Can We Create a Circular Pharmaceutical Supply Chain ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7712437/]
• 90. EST Index: Circular Economy & Waste Management l ... [https://www.sanofi.com/en/our-company/sustainability/responsible-business-values/environment-social-governance-index/circular-economy-and-waste-management]
• 91. Waste and circularity [https://www.astrazeneca.com/content/astraz/sustainability/nature/waste-circularity.html]
• 92. Efficient utilization of renewable feedstocks [https://pmc.ncbi.nlm.nih.gov/articles/PMC5719221/]
• 93. Pharmaceuticals go green [https://healthcare.evonik.com/en/news-and-events/blog/pharmaceuticals-go-green-how-evonik-health-care-is-adopting-sustainability-practices-principles-and-225584.html]
• 94. Circular economy application in pharmaceutical supply ... [https://www.sciencedirect.com/science/article/pii/S0377221725003662]
• 95. The role of green processes in supporting the transition to ... [https://www.sciencedirect.com/science/article/pii/S2666188825005982]
• 96. Medicinal Chemistry: A Key Driver in Achieving the Global ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11998007/]
• 97. Addressing adoption barriers and accelerating market ... [https://pubs.rsc.org/en/content/articlehtml/2025/su/d4su00706a]
• 98. How Barriers and Policies Influence the Transition to ... [https://www.nordicsustainableconstruction.com/news/2025/january/barriers-report]
• 99. Waking up to the costs of green technology adoption ... [https://link.springer.com/article/10.1007/s43621-025-01239-0]
• 100. Green technology adoption under uncertainty, increasing ... [https://www.sciencedirect.com/science/article/pii/S0167268125000733]
• 101. US Tariffs and The Damaging Impact on Sustainability in ... [https://www.winssolutions.org/impact-2025-us-tariffs-on-sustainability/]
• 102. Managing the systemic use of chemicals in Europe [https://www.eea.europa.eu/en/analysis/publications/managing-the-systemic-use-of-chemicals]
• 103. Implementation of the Chemicals Strategy [https://environment.ec.europa.eu/strategy/chemicals-strategy/implementation_en]
• 104. Safe and sustainable by design - Research and innovation [https://research-and-innovation.ec.europa.eu/research-area/industrial-research-and-innovation/chemicals-and-advanced-materials/safe-and-sustainable-design_en]
• 105. The European Commission's safe and sustainable by design ... [https://enveurope.springeropen.com/articles/10.1186/s12302-025-01246-y]
• 106. Survey opens on a revised Framework for safe and sustainable by design chemicals and materials - Research and innovation [https://research-and-innovation.ec.europa.eu/news/all-research-and-innovation-news/survey-opens-revised-framework-safe-and-sustainable-design-chemicals-and-materials-2025-07-28_en]
• 107. An E.U. Plan to Slash Micropollutants in Wastewater Is ... [https://e360.yale.edu/features/europe-water-micropollutants]
• 108. Call for better management of micropollutants in wastewater [https://www.su.se/stockholm-university-baltic-sea-centre/policy-analysis/policy-briefs-and-fact-sheets/call-for-better-management-of-micropollutants-in-wastewater-1.590634]
• 109. Optimizing the implementation of safe and sustainable by ... [https://www.sciencedirect.com/science/article/pii/S258900422501377X]
• 110. In Silico Hazard Screening and Risk Evaluation [https://pmc.ncbi.nlm.nih.gov/articles/PMC11768813/]
• 111. Ecosystem risk-based prioritization of micropollutants in ... [https://www.sciencedirect.com/science/article/abs/pii/S0043135424010674]
• 112. Using bioanalytical tools to detect and track organic ... [https://www.sciencedirect.com/science/article/abs/pii/S0304389420321257]
• 113. Chemicals and waste - Sustainable Development Goals [http://sdgs.un.org/topics/chemicals-and-waste]
• 114. Classifying micropollutants by environmental risk in ... [https://www.sciencedirect.com/science/article/abs/pii/S0048969723032096]
• 115. Research hotspots and trends in sustainable development ... [https://www.sciencedirect.com/science/article/pii/S2665972725001436]
• 116. Life Cycle Assessment: The ultimate expert guide to LCA in ... [https://p6technologies.com/lca/]
• 117. Goal 14: Oceans - United Nations Sustainable Development [https://www.un.org/sustainabledevelopment/oceans/]
• 118. Why Every Product Should Have a Life Cycle Assessment ... [https://www.tunley-environmental.com/en/insights/why-every-product-should-have-a-life-cycle-assessment-in-2025]
• 119. Life Cycle Assessment (LCA) – Everything you need to know [https://ecochain.com/blog/life-cycle-assessment-lca-guide/]
• 120. Simplifying life cycle Assessment: Basic considerations for ... [https://www.sciencedirect.com/science/article/pii/S1470160X25006405]
• 121. November-December 2025 LC Net Newsletter [https://www.lifecycleinitiative.org/november-december-2025-lc-net-newsletter/]
• 122. Frontiers | Emerging Micropollutants : Risks, Regulatory Trends, and... [https://www.frontiersin.org/journals/environmental-chemistry/articles/10.3389/fenvc.2025.1675784/abstract]
• 123. Monitoring of micropollutants and water quality in the ... [http://sdgs.un.org/partnerships/monitoring-micropollutants-and-water-quality-hydrographic-basin-itaipu-reservoir]
• 124. The role of wastewater treatment in achieving sustainable ... [https://www.sciencedirect.com/science/article/pii/S2772427122000729]
• 125. REACH Regulation - Environment - European Commission [https://environment.ec.europa.eu/topics/chemicals/reach-regulation_en]
• 126. Trump transition: Updates and impacts on the... | DLA Piper [https://www.dlapiper.com/en-pe/insights/publications/2025/02/updates-and-impacts-on-the-environmental-and-regulatory-landscapes]
• 127. EHS Guidelines: Chemicals [https://www.ifc.org/en/insights-reports/general-environmental-health-and-safety-guidelines/ehs-guidelines-chemicals]
• 128. Strategies for mitigating organic micropollutants in drinking ... [https://orbit.dtu.dk/en/publications/strategies-for-mitigating-organic-micropollutants-in-drinking-wat/]
• 129. World Water Day 2025 | Sustainable Development Goals [https://sdgresources.relx.com/special-issues/world-water-day-2025]
• 130. PLANTED [https://enlight-eu.org/university-about-us/funded-projects/1369-planted]
• 131. Dissolved and particulate micropollutant mixtures in ... [https://www.sciencedirect.com/science/article/pii/S0160412025003290]
• 132. Progress and future outlook towards a safe ... [https://www.nature.com/articles/s42004-025-01785-8]
• 133. Improved removal of micropollutants and pathogens from ... [https://www.sciencedirect.com/science/article/pii/S221334372503338X]
• 134. ECOpole'25 Programme [https://ecopole-conference.com/programme/]